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Abstract
The main aim of this project has been to study the extrinsic and intrinsic factors 
involved in the axonal growth rate of sensory and sympathetic neurons during the 
early stages of their development. Using in vitro assays it was shown that Hepatocyte 
Growth Factor (HGF)/Met signalling significantly enhanced the survival and neurite 
length of early DRG neurons grown in the presence of NGF. This synergism was 
specific for NGF but not for the related neurotrophins BDNF or NT-3 (Maina et al., 
1997). HGF/Met signalling was also shown to accelerate the differentiation of 
sympathetic neurons as well as promoting the survival of sympathetic neuroblasts but 
not postmitotic neurons. HGF was also shown to cooperate with NGF to enhance the 
axonal growth rate as well as increasing the amount of neurite branching of NGF- 
dependent sympathetic neurons throughout development (Maina et al., 1998). HGF 
was also shown to enhance the survival and growth of developing parasympathetic and 
proprioceptive neurons. The demonstration that HGF only enhanced the survival and 
growth of proprioceptive TMN neurons when grown in CNTF but not when grown in 
BDNF which promoted their survival as effectively as CNTF demonstrates that within 
the same neurons, the effects of HGF on survival and growth are selectively dependent 
on which other signalling pathways are concurrently activated. The anti-apoptotic 
protein Bcl-2 has been shown to play a key role in regulating cell survival in the 
nervous system. Cultured neurons expressing antisense Bcl-2 RNA have an attenuated 
srrrvival response to neurotrophins, and neurons of postnatal Bcl-2 deficient mice die 
more rapidly following NGF deprivation in vitro and are present in reduced numbers in 
vivo. Here I show that Bcl-2 also plays a key role in regulating axonal outgrowth rates 
in embryonic neurons (Hilton et al., 1997). The effect of Bcl-2 on axonal growth rate
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was shown not to be a consequence of its well documented role in preventing 
apoptosis.
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CHAPTER 1 
GENERAL INTRODUCTION
1.1 Early development of the nervous system
Topographically the nervous system is comprised of two parts, the central and 
peripheral nervous system. The central nervous system (CNS) lies in the longitudinal 
axis of the body and comprises the brain and spinal cord, whilst the peripheral nervous 
system (PNS) consists of cranial and spinal nerves that arise from the brain and cord, 
and of the ganglionated tmnks, plexuses and nerves which constitute the peripheral 
autonomic components of the nervous system. Vertebrate neurodevelopment is a 
multistage process that begins with neural induction in which the cells of the dorsal 
ectoderm are induced by the underlying precaudal mesoderm, A midline furrow arises 
along the anterior-posterior axis of the neural plate causing the lateral edges or the 
neural folds to elevate. The neural plate rounds up allowing the neural folds to meet in 
the dorsal midline, thus forming the intact neural tube. This is a process termed 
neurulation (Schoenwolf & Smith, 1990). The neural tube gives rise to the central 
nervous system, i.e. the brain and spinal cord. The fusion of the neural tube begins in 
the cervical region and proceeds in both cephalic and caudal directions. During the 
invagination of the neural plate, a group of cells migrate from the dorsal neural tube and 
emerge in a rostral to caudal sequence along the entire length of the axis of the neural 
groove (Weston, 1962). These cells are known as neural crest cells and form an 
intermediate zone between the neural tube and surface ectoderm. Neural crest cells 
give rise to most of the peripheral nervous system (PNS) including neurons of the 
dorsal root ganglia and cranial sensory nerves (proximal neurons of the trigeminal 
ganglia and the proximal ganglia of DC and X cranial nerves) post ganglionic neurons
of the sympathetic, autonomic and enteric nervous system and various supporting cells 
within the PNS such as Schwann cells (Weston, 1962).
Some cranial sensory neurons are derived from neurogenic placodes* These placodes 
are ectodermal thickenings that contribute neurons to the distal pait of the trigeminal 
ganglia, geniculate, the vestibular cochlear and distal ganglia of the cranial nerves IX 
and X (Le Douaiin, 1982). Whilst the majority of primaiy sensoiy neurons are located 
within spinal or cranial sensory ganglia, the neural crest derived proprioceptive neurons 
of the mesencephalic nucleus of the trigeminal nerve (TMN) aie situated within the 
CMS.
1.2 Programmed cell death
During development, programmed cell death (apoptosis) is an active and 
widespread mechanism responsible for actively removing excess cells and cells that 
have served their purpose (Oppenheim et al., 1991; Williams, 1991). Cell death by 
apoptosis occui's when a cell activates an internally encoded suicide program following 
either extrinsic or intrinsic signals. Apoptotic cell death is characterized by plasma 
membrane blebbing, cytoplasmic condensation, pyknosis and degradation of nuclear 
DNA in to oligosomal lengths (Wyllie et al., 1980). Many extracellulai* signals that 
regulate apoptosis in different cell types have been identified, but less is known about 
the intracelliilai' mechanisms that activate apoptosis within the cell. Early studies 
demonstrating that the inhibition of RNA or protein synthesis in various cell types was 
able to inhibit apoptosis suggested that apoptosis was dependent upon the activation of 
a program of gene expression within the dying cell (Cohen & Duke, 1984; Scott & 
Davies, 1990). Genetic analysis of the nematode Caenorhabditis elegans has led to the 
isolation of mutants defective for different steps in the apoptotic pathway. Mutation 
studies have identified ced-3 and ced-4 as being necessary for apoptosis as their 
inactivation results in increased cell survival (Ellis & Horvitz, 1986). In contiast, ced-9 
appears to be necessaiy for cell survival, as a loss-of-function mutation of ced-9 results 
in extensive cell death via the ced-3 and ced-4 pathways (Hengartner et al., 1992). 
Ced-3 has been shown to encode an aspartate-specific cysteine protease (Yaun et al., 
1993; Xue et al., 1996). Studies have shown the presence of several mammalian 
homologs of the nematode gene Ced-3 which have been termed 'caspases' (for cysteine 
aspase). The first mammalian homology identified was interleukin-Ip (IL-lp) 
coverting enzyme (ICE), a cysteine protease responsible for the processing of pro-IL- 
ip to the active cytokine (Yuan et al., 1993). Overexpression of ICE or Ced-3 in Rat-1 
fibroblasts induces apoptosis, suggesting that ICE is functionally and structurally 
related to Ced-3 (Miura et al., 1993). In contrast the cowpox virus CimA gene product
and the haculovirus p35 protein both interfere with the protease function of ICE-related 
proteases and inhibit apoptosis (Tewari et al., 1995; Xue et al., 1995; Miura et al., 
1995; Bump et al., 1995) suggesting that ICE-related proteases are involved in 
apoptotic pathways. Eight mammalian homologs of Ced-3 and ICE have been 
characterized: ICH-1 (Kumar et al., 1994; Wang et al., 1994b), CPP-32 (Fernandes- 
Alnemri et al., 1994; Nicholson et al., 1995; Tewari et al., 1995), ICH-2 (Faucheu et 
al., 1995; Kamens et al., 1995; Munday et al., 1995), ICErel-111 (Munday et al.,
1995) Mch-2 (Fernandes-Alnemri et al., 1995a), Mch-3 (Duan et al., 1996; Fernandes- 
Alnemri et al., 1995b; Lipke et al., 1996), FLICE (Muzio et al., 1996) and ICE-LAP6 
(Duan et al., 1996). Ectopic expression of these ICE/Ced-3 homologs in a variety of 
cells causes apoptosis. All caspases cleave their substrates after specific aspartic acids 
and are themselves activated by cleavage at specific aspartic acids. Caspases mediate 
apoptosis by cleaving selected intracellular proteins, including proteins of the nucleus, 
nuclear lamina, cytoskeleton, endoplasmic reticulum, and cytosol. Some of the cleaved 
proteins activate other destructive processes within the cell and thereby enhance 
apoptosis (Chinnaiyan & Dixit, 1996). Ced-9 has since been identified as a homolog 
of the mammalian proto-oncogene Bcl-2 (Hengartner & Horvitz, 1994). 
Overexpression of Bcl-2 is able prevent the ectopic cell death that occurs in ced-9 loss- 
of-functiong mutants (Hengartner & Horvitz 1994), demonstrating that the molecular 
mechanism of apoptosis is conserved through out evolution.
The Bcl-2 gene was first isolated from the breakpoint of the t(14;18) 
chromosmal translocation found in many human B cell lymphomas (Tsujimoto et al., 
1985; Bakhshi et al., 1985; Cleary & Sklar, 1985). This translocation places the Bcl-2 
gene under the influence of a powerful enhancer element in the immunoglobulin (Ig) 
heavy chain locus, resulting in a marked overexpression of Bcl-2 in B cells and the 
development of neoplasia due to the suppression of cell death (Seto et al., 1988). The 
Bcl-2 protein is an intracellular integral membrane protein with a molecular mass of 26
KD (Cheiî-Levy et al., 1990). Bcl-2 bas been shown to play an important role in 
regulating the survival of B and T lymphocytes within the immune system (reviewed in 
Linette & Korsmeyer, 1994). During development, Bcl-2 expression in B and T cell 
lines is downregulated during periods of increased proliferation, but upregulated during 
positive selection of immature B and T cells. Mice containing a targeted null mutation in 
the Bcl-2 gene show a marked reduction of B and T cells as a result of increased 
apoptosis (Strasser et al. 1991; Nakayama et al., 1993, 1994; Veis et al., 1993), 
whereas mice carrying a transgene resulting in overexpression of Bcl-2 within the 
immune system show extended survival of B and T cells (McDonnell et al., 1989, 
1990). However, overexpression of Bcl-2 cannot prevent the death of haematopoeitic 
cell lines deprived of interleukin -2 (IL-2) or IL-6, although it can rescue cells deprived 
of DL-3, IL-4 or granulocyte macrophage colony stimulating factor (Nunez et al., 
1990).
Bcl-2 has also been shown to be capable of promoting the survival of neurons. 
For example, over expression of Bcl-2 reduces the death of cultured sympathetic and 
sensory neurons which have been deprived of growth factors (Garcia et al., 1992; 
Allsopp et al., 1993). DRG neurons from mice that constitutively overexpress Bcl-2 
show extended survival in vitro without trophic support, as compared to wild-type 
neurons (Faïlie et al., 1995). Overexpression of Bcl-2 also prevents motor neuron 
death induced by facial nerve axotomy (Dubois-Dauphin et al., 1994) and sciatic nerve 
axotomy (Farlie et al., 1995). Conversely, reduction or elimination of endogenous 
Bcl-2 reduces neuronal survival both in vitro and in vivo (Allsopp et al., 1995; 
Michaelidis et al., 1996; Pinon et al., 1997). Bcl-2 does not have a universal role in 
promoting neuronal cell survival, since overexpression of Bcl-2 cannot rescue 
parasympathetic neurons following CNTF deprivation (Allsopp et al., 1993).
Bcl-2 is the founder member of a family of cytoplasmic proteins that modulate 
the response of many cell types to the diverse extracellular signals that affect their
survival (Davies, 1995). While some rnembeis of the family are anti-apoptotic, other 
family members appear to promote apoptosis. Among the death inhibitors are Bcl-2 
(Hockenbery et al., 1990), Bcl-xL (Boise et al., 1993), Bcl-w (Gibson et al 1996), 
McI-1 (Reynolds et al., 1994), A-1 (Lin et al., 1993), adenovirus EIB 19K (Han et al.,
1996), Epstein-Barr virus (EBV) BHRFl (Henderson et al., 1993) and CED-9 
(Hengartner & Horvitz, 1994). Pro-apoptotic members include Bax (Oltvai et al.,
1993), Bik (Boyd et al., 1995), Bid (Wang et al., 1996), Bim (O'Connor et al., 1998), 
Bok/Mtd (Hsu et al., 1997; Inohara et al., 1998) Hrk (Inohara et al., 1997), Bak 
(Chittenden et al., 1995), Bcl-xs (Minn et al., 1996) and Bad (Yang et al., 1995). The 
role of Bax in mediating neuronal survival has been well characterized. The 
overexpression of Bax accelerates neuronal death following neurotrophin withdrawal 
(Vekrellis et al., 1997; Martinou et al., 1998). In contrast, the reduction or elimination 
of endogenous Bax promotes the survival of neurons without neurotrophic factors in 
culture and prevents their death in vivo (Deckwerth et al., 1996; Gillardon et al., 1996; 
Miller et al., 1997; White et al., 1998).
Bcl-2 related proteins share homology in four regions designated the Bcl-2 
homology (BH) domains BHl, BH2, BH3, and BH4, with the greatest similarity in 
the proteins encoded by the genes of the Bcl-2 family being observed in BHl and 
BH2. Mutational analysis of Bcl-2 suggests that both BHl and BH2 domains are 
required for the anti-apoptotic function of members of the Bcl-2 family (Yin et al.,
1994). However, recent studies have shown that while all four homology regions are 
present in some family members, such as Bcl-2 and B c1-Xl , many other proteins lack 
one or more of the domains. For example, certain pro-apoptotic proteins, such as Bad 
and Bid, contain only the BH3 domain, suggesting that the BH3 domain is a potent 
death domain (Kelekar & Thompson, 1998). In addition, members of the Bcl-2 family 
contain a less well conserved 19 amino acid hydrophobic C-terminus domain which is 
thought to be important for the attachment of the proteins to the cytosolic side of cell
membranes (Nguyen et al., 1993; Tanaka et al.. 1993). Iminunoprecipitution and yeast 
two hybrid studies have demonstrated that Bcl-2 family members are capable of 
forming either homodimers or heterodimers (Sato et al., 1994). For example, the pro- 
apoptotic protein Bax associates in vivo as a heterodimer with the anti-apoptotic protein 
Bcl-2 as well as forming homodimers (Oltvai et al., 1993;). It has been proposed that it 
is the ratio of pro-apoptotic to anti-apoptotic proteins (rheostat model) that determines 
whether a cell survives or undergoes apoptosis following an apoptotic signal 
(Korsmeyer et al., 1993). Site directed mutagensis has shown that the mutation of 
Glyl45 in the BHl domain or Trp 188 in the BH2 domain of Bcl-2 prevents Bcl-2 
from forming heterodimers with pro-apoptotic proteins. These mutations inactivate the 
anti-apoptotic action of Bcl-2, but do not prevent the formation of Bcl-2 homodimers 
(Yin et al., 1994). These findings suggest that Bax/Bcl-2 heterodimers prevent cell 
death by reducing the number of Bax homodimers.
The mechanism by which Bcl-2 acts to inhibit apoptosis is unclear and 
controversial. Numerous mechanisms have been proposed based on the intracellular 
localization of Bcl-2 to the outer mitochondrial membrane, endoplasmic reticulum (ER) 
membrane and nuclear envelope (Chen-Levy et al., 1989; Hockenbery et al., 1990; 
Jacobson et al., 1993). The localization of Bcl-2 to the mitochondrial membrane 
suggests the'possibility that it might protect against apoptosis by altering mitochondrial 
function. However, mutant cell lines which lack mitochondrial DNA continue to 
undergo apoptosis following serum deprivation, and are protected from apoptosis by 
overexpression of Bcl-2 (Jacobson et al., 1993). The presence of Bcl-2 within the 
membranes of the endoplasmic reticulum (ER) raises the possibility that Bcl-2 might 
regulate intracellular calcium levels, since release of calcium from ER stores 
accompanies apoptosis in certain cells. In line with this, overexpression of Bcl-2 in 
lymphoma cells reduces the efflux of calcium from the ER and prevents apoptosis (Lam 
et al., 1994). However, studies in a neuronal cell line suggests that a rise in the
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intracellulai' concentration of free calcium is not a prerequisite for apoptosis (Zhong et 
al., 1993b). The presence of Bcl-2 at major sites of oxygen free radical generation, 
together with the demonstration that reactive oxygen species might be involved in 
causing apoptosis in different cell types (Buttke & Sandstrom, 1994), has raised the 
possibility that Bcl-2 might prevent apoptosis by acting either as an antioxidant or by 
inhibiting production of free radicals (Kane et al., 1993; Kinouchi et al., 1991). 
Another theory is that Bcl-2 related proteins may play a role in intracellular signal 
transduction, since Bcl-2 is phosphoiylated on serine residues in response to a variety 
of stimuli (May et al., 1994; Haider et al., 1995; Chen & Palier, 1996). 
Phosphorylation of Bcl-2 is associated with a loss of its ability to promote sumval. 
Bcl-2 has been shown to associate with p72Rafl, a serine/threonine specific protein 
kinase (Wang et al., 1994), and p23-R-Ras a GTPase member of the Ras family 
(Fernandez & Sarabia, 1995) which promotes apoptosis following growth factor 
removal (Wang et al., 1995). Another potential mechanism by which Bcl-2 may 
function has been suggested by the analysis of the 3D structure of B c1-x l . B c1-x l  
comprises two central hydrophobic a  helices surrounded by five amphipathic helices, 
as well as a 60 residue flexible loop (Muchmore et al., 1996). This tertiary structure 
shows a high degree of homology with the pore-forming domains of certain bacterial 
toxins, such as colicins A and El and diphtheria toxin, that act as ion channels 
(Muchmore et al., 1996). It is thought that anti-apoptotic protiens such as Bcl-2 and 
Bcl-XL may form pores involved in homeostasis which may protect the cell against 
electrochemical changes which occur under stressful conditions, whilst pro-apoptotic 
family members might interfere with the assembly or the function of such pores, thus 
eliminating the ability of anti-apoptotic family members to protect cells against cell 
death (Minn et al., 1997; Schlesinger et al., 1997; Schendel et al., 1997).
There is growing evidence that some members of the Bcl-2 family control the 
release of cytochrome c from the mitochondria which promotes a cascade of caspase
activation by interacting with the adaptor protein apf 1 which in turn activates pro- 
caspase-9 (Li et ai., 1997b; Qin et al., 1999). Pro-apoptotic members of the family like 
Bax and Bak increase mitochondrial permeability allowing cytochrome c to pass into 
the cytosol, whereas anti-apoptotic members like Bcl-2 and Bcl-xL prevent cytochrome 
c release (Kharbanda et al., 1997; Kluck et al., 1997; Yang et al., 1997; Shimizu et al., 
1999). Inhibiting the release of cyctochrome c from mitochondria cannot entirely 
account for the means by which pro-apoptotic members of the Bcl-2 family prevent 
apoptosis because overexpression of these proteins can prevent apoptosis in cells in 
which cytochrome c is present in the cytosol (Li et al., 1997a; Rosse et al., 1998). 
There is evidence that Bcl-2 can regulate the activity of membrane associated pro- 
caspase-3 independently of cytochrome c (Krebbs et al., 1999) and Bcl-xL can bind 
directly to Apf-1 preventing it from activating pro-caspase-9 (Hu et al., 1998; Pan et 
al., 1998).
Examination of the expression pattern of the Bcl-2 protein has revealed that it is 
widely expressed in the developing nervous system during embryonic development. In 
the PNS, neurons and supporting cells of sympathetic and sensory ganglia all exhibit 
high levels of Bcl-2 expression during development which is retained throughout life 
(Merry et al., 1994). In the developing CNS, Bcl-2 expression is observed in 
numerous structures including proliferating neuroepithelial cells of the ventricular zones 
as well as the postmitotic cells of the cortical plate, cerebellum, hippocampus and spinal 
cord (Abe-Dohmae et al., 1993; Merry et al., 1994). Unlike the PNS, Bcl-2 expression 
in the CNS decreases with age, with postnatal expression only being observed in the 
granule cells of the cerebellum and the dentate gyms of the hippocampus (Merry et al., 
1994). Bcl-2 expression has also been shown to be widespread in various non­
neuronal cell types and tissues characterized by high cell turnover, such as the spleen 
and thymus (Negrini et al., 1987; Hockenbery et al., 1991), duct cells in exocrine
glands, basal kératinocytes, cells located at the bottom of colon crypts and neurons 
(Abe-Dohmae et al., 1993; Lu et al., 1993)
Mice containing a homozygous null mutation of the Bcl-2 gene are viable at 
birth but die between two and ten weeks after birth (Nakayama et ah, 1993; Veis et ah, 
1993; Kamada et al., 1995). Bcl-2 deficient mice develop polycystic kidney disease 
and have elevated levels of urea and creatinine in their blood compared to their wild- 
type and heterozygous litter mates. Bcl-2 deficient mice also exhibit a massive 
involution of the spleen and thymus as well as developing hypo-pigmented hair 
(Nakayama et ah, 1993; Veis et ah, 1993; Kamada et ah, 1995). There is also a 
reduction in the number of oocytes and primordial follicles in postnatal females, 
suggesting a role for Bcl-2 in preventing follicular atresia (Ratts et ah, 1995). 
Sui-prisingly, certain tissues, including intestine, skin and the nervous system, show 
no gross abnormalities in Bcl-2 deficient mice despite the fact that these tissue show 
high levels of Bcl-2 expression in wildtype mice.
1.3 The N«^urotronhic Theory
Neurons aie initially generated in excess during neurodevelopment. Shortly 
after neurons begin to innervate their target tissue, large numbers die by apoptosis 
(Oppenheiih, 1991). The neurotrophic theory states that neuronal tai'get fields regulate 
the number of neurons surviving during the phase of target field innervation by 
synthesizing limited quantities of a neurotrophic factor that the innervating neurons 
require for survival (Davies, 1988a,b; Purves, 1988; Barde 1989). The most important 
evidence to support the neurotrophic theoiy has come from experiments that have 
altered the availability of NGF to neurons both in vitro and in vivo. Such experiments 
have demonstrated that sympathetic and certain sensory neurons require NGF to 
survive during the period of target field innervation (Levi-Montalcini, 1987; Crowley et 
al., 1994).
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Further evidence for the role of neurotrophic factors in regulating neuronal 
survival has come from the demonstration that NGF is synthesized within the target 
field of sensory and sympathetic neurons during development. NGF synthesis 
commences at the onset of target field innervation (Davies et al., 1987a; Korsching & 
Thoenen, 1988) and the amount of NGF synthesized is in proportion to the final 
innervation density of the target field (Harper & Davies, 1990). Specific neuronal cell 
surface receptors mediate rapid uptake of NGF within the target field. NGF is 
transported by retrograde axonal transport to the cell bodies of the innervating neurons 
where NGF exerts its survival promoting effects (Korsching & Thoenen, 1983a; 
Palmatier et ah, 1984; Davies et ah, 1987a). The generality of the neurotrophic 
hypothesis was established following the cloning and purification of brain derived 
neurotrophic factor (BDNF), a protein with extensive sequence homology to NGF 
(Barde et ah, 1982; Leibroch et ah, 1989). BDNF has been shown to promote the 
survival of certain populations of sensory neurons in vitro (Lindsay et ah, 1985; 
Davies et al 1986a,b) and to prevent naturally occurring cell death in vivo following 
BDNF administration to chicken embryos during the period of naturally occurring cell 
death (Hofer & Barde, 1988).
More recently NGF has been shown to be the founder member of a family of 
six structurally related homologous proteins termed “the neurotrophins’* which also 
include NT-3 (Ernfors et ah, 1990a, Hohn et ah, 1990; Jones & Reichardt 1990; 
Maisonpierre et ah, 1990b Rosenthal et ah, 1990), NT-4/5 (Berkemeier et al., 1991; 
Hallbook et al 1991; Ip et al 1992), NT-6 (Gotz et al., 1994) and NT-7 (Nilsson et ah, 
1998; Ko et ah, 1998). These proteins will be discussed in turn.
Nerve Growth Factor
The presence of large quantities of NGF within the adult male mouse 
submandibular gland facilitated its purification and characterization of its primary
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structure (Cohen 19o0, AngeltUi & Bradshaw 1971, Angeletti et al 1973). Other 
sources of NGF include exocrine tissues and their secretions, such as snake venom 
(Cohen, 1959; Bailey et ah, 1975; Oda et al., 1989) and the prostate glands of guinea 
pig, rabbit and bull (Harper et ah, 1979, Harper & Thoenen, 1980). Analysis of the 
cDNA sequence of murine NGF has shown that the mature NGF protein is generated 
following proteolytic cleavage of a 305 amino acid precursor protein termed pre- 
proNGF (Scott et ah, 1983; Ullrich et ah, 1983). The NGF gene has been cloned from 
several species, with nucleotide sequence analysis showing that the mature NGF 
protein has been highly conserved during evolution (Scott et ah, 1983; Ullrich et ah, 
1983; Meier et ah, 1986; Ebendal et ah, 1986; Selby et ah, 1987; Whittemore et al., 
1988; Schwarz et ah, 1989). NGF derived from the mouse submandibular gland is 
found as an acidic protein complex termed 7sNGF with a moleculai' weight of 130 KD. 
This is composed of 3 subunits termed a  , (3 and y (Varon et al 1968). Only the P 
subunit has been shown to possess neurotrophic activity and is a basic protein 
composed of two identical 118 amino acid chains (Greene et ah, 1969, Angeletti et 
al., 1971; Smith et ah, 1969). The y subunit, an arginine esteropeptidase, is thought 
to be involved in the processing of the p NGF. The a  subunit shows no enzymic 
activity and is believed to protect P NGF from enzymatic degeneration, as well as 
regulating the activity of both the p and y subunits. The mouse gene encoding PNGF is 
45Kb in length and consists of 5 exons separated by 4 introns. The mature protein is 
encoded from a single 3' exon within the NGF gene (Ullrich et ah, 1983, Edwards et 
al., 1986). The remaining exons aie smaller and undergo alternative splicing to produce 
at least 4 transcripts which encode precursor proteins that differ in their amino termini 
(Selby et al., 1987).
In vivo and in vitt'o studies have demonstrated that NGF can exert a variety of 
ti'ophic effects on neurons including regulating neuronal survival during development, 
maintaining the phenotype of mature neurons and enhancing the regeneration of injured
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neurons of the PNS (Reviewed by Thoenen & Bmde 1980, Levi-Montalcini, 1987, 
Lindsay, 1988, Barde, 1989). In particular, NGF has been shown to support the 
survival of sympathetic neurons and a subpopulation of neural crest-derived sensory 
neurons during development (Cohen & Levi-Montalcini, 1956; Cohen, 1960; Thoenen 
& Barde, 1980; Davies & Lindsay, 1985; Levi-Montalcini, 1987; Davies, 1994c). 
Within the CNS, NGF exerts trophic effects on cholinergic neurons of the basal 
forebrain (Williams et al., 1986; Hartikka & Hefti, 1988; Knusel et al., 1990). In vitro 
and in vivo studies have shown that NGF promotes an increase in axonal branching 
and terminal and dentritic arborization in neonatal and adult sympathetic and sensory 
neurons, whilst NGF deprivation results in a reduction in both terminal and dentritic 
arborizations (Bjerre et al., 1975a,b; Snider, 1988, Ruit et al., 1990; Ruit & Snider, 
1991; Yasuda et al 1990; Scott & Davies, 1993).
Northern blot analysis and in situ hybridization have shown that NGF mRNA 
is expressed at high levels in the target tissues innervated by NGF responsive 
sympathetic and sensory neurons (Korsching & Thoenen, 1983; Korsching et al., 
1985; Heumann et al., 1984; Shelton & Reichardt 1984). The identity of the cells that 
synthesize NGF has been determined in a detailed developmental study of mouse 
whisker pad, the target field for developing trigeminal sensory neurons (Davies et al., 
1987a). Enzymatic dissociation of the developing whisker pad into its principle 
components, the mesenchyme (presumptive dermis) and epithelium (presumptive 
epidermis) and subsequent analysis of NGF expression revealed that the highest levels 
of NGF mRNA are found in the epithelium (Davies et al., 1987a). Subsequent analysis 
has shown that the levels of NGF mRNA expressed within the peripheral target tissues 
of sensory neurons during the period of neuronal death is proportional to their final 
innervation densities (Harper & Davies, 1990). The onset of NGF synthesis within the 
peripheral target fields of sensory and sympathetic neurons coincides with the onset of 
target field innervation which suggests that NGF regulates the number of neurons
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innervating peripheral taigeis after the tai'get tissue has been contacted (Korsching & 
Thoenen, 1983; Harper & Davies, 1990).
Analysis of mice that are homozygous for a null mutation of the NGF gene has 
helped to determine the role that NGF plays in the development of the nervous system 
in vivo. NGF -/- mice are viable at birth, but do not gain weight in comparison with 
their wildtype littermates and die within the first month of life (Crowley et al., 1994). 
They also fail to respond to noxious mechanical stimuli. Histological examination has 
shown that NGF deprivation results in severe neuronal cell loss within sensory 
trigeminal and dorsal root sensory ganglia by birth and a complete absence of 
sympathetic ganglia by postnatal day 10 (Crowley et al., 1994). Histological 
comparison of DRG ganglia from wildtype and NGF deficient mice has shown that 
null mutant mice exhibit a complete absence of small diameter DRG neurons as well as 
a reduction in the number of neurons expressing CGRP or substance P 
immunoreactivity. This observation supports the view that NGF is required for the 
development of small peptidergic DRG neurons which are thought to mediate pain 
(nociceptive and thermal receptive functions) (Crowley et al., 1994). These findings 
aie consistent with earlier antibody deprivation studies which showed that anti-NGF 
antibodies administrated during the phase of tai'get field innervation eliminated sensory 
and sympathetic neurons, and these neurons could be rescued by exogenous NGF 
(Levi-montalcini & Angeletti, 1968; Johnson et al., 1980; Hamburger & Yip, 1984; 
Carrol et al., 1992; Ruit et al., 1992). In contrast, transgenic mice overexpressing 
NGF within the epidermis exhibit hypertrophy of peripheral sensory and sympathetic 
neurons and an increase in the expression of CGRP. In addition, both trigeminal and 
superior cervical ganglia contain more neurons in NGF overexpressing mice, indicating 
a reduction of programmed or naturally occurring cell death (Albers et al., 1994). 
Transgenic mice expressing high levels of NGF mRNA also exhibit profound 
hyperalgesia to noxious mechanical stimulation (Albers et al, 1994). In contrast to
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previous observations (Hartikka & Heiti, 1988a,b), NGF null mutant mice show no 
loss of basal forebrain cholinergic neurons which maintain their phenotype throughout 
the limited life span of the NGF null mice. Basal cholinergic neurons of NGF knockout 
mice do, however, display lighter staining for the transmitter biosynthesis enzyme 
cholinecetyltransferase (ChAT) when compared to wildtype mice (Crowley et al., 
1994). These results are consistent with observations which show that NGF increases 
(Hartikka & Hefti, 1988a) and anti-NGF decreases (Vantini et al., 1989) ChAT 
expression in basal forebrain cholinergic neurons.
Brain Derived Neurotrophic Factor
BDNF is the second member of the NGF family of neurotrophins to be 
identified and was initially purified from pig brain (Barde et al., 1982). BDNF is a 
basic protein (pi > 10.1) with a molecular weight of 12.3 KD (Barde et al., 1982). 
Sequence analysis of the BDNF cDNA has shown that mature BDNF is synthesized as 
a precursor protein containing a single peptide, an amino-terminal precursor region and 
a highly conserved carboxyl terminal domain. Proteolytic processing of the precursor 
protein releases a 119 amino acid mature form of BDNF (Leibrock et al., 1989). Like 
NGF, biologically active BDNF exists as a tightly associated homodimer 
(Radziejewski et al., 1992). The rat BDNF gene is contained within 4.0Kb of genomic 
DNA and consists of four 5' exons, linked to separate upstream promoters, and one 
3'exon which encodes the mature BDNF protein. Alternative promoter usage and 
differential splicing results in eight different BDNF mRNAs with four different 5' 
untranslated exons. BDNF mRNAs containing exons I, II, and III are expressed 
predominantly in the brain, whilst transcripts containing exon IV predominate in the
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iuiig and heart (Timiiiusk et al., 1993a; Metsis et ai., 1993). The porcine, murine and 
human genes encoding BDNF have also been cloned and the primary structures 
determined (Leibrock et al., 1989; Hofer et al., 1990; Maisonpierre et al., 1991). 
Comparison of the primary structures of BDNF and NGF has revealed a 55% 
homology with 51 identical amino acids. BDNF also shows a high degree of homology 
between different species. Included in the conserved residues between BDNF and 
NGF sequences are all 6 cysteine residues that form disulphide bridges, suggesting that 
the 3-dimensional stmcture of BDNF is similar to NGF (Leibrock et al., 1989).
BDNF has been shown to support the survival of several populations of central 
and peripheral neurons. In the PNS, BDNF has been shown to promote the survival 
of certain sensory neurons (Lindsey et al., 1985; Davies et al., 1986b; Davies et al., 
1987b; Hofer & Barde 1988). In the CNS, BDNF has been shown to support the 
survival of embryonic mesencephalic dopaminergic neurons in the substantia nigra 
(Hyman et al., 1991; Knusel et al., 1991), basal forebrain cholinergic neurons 
(Alderson et al., 1990), retinal ganglion cells (Johnson et al., 1986) embryonic motor 
neurons (Oppenheim et al., 1992; Yan et al., 1992; Sendtner et al., 1992; Koliatsos et 
al., 1993) and pyramidal neurons of the visual cortex (McAllister et al., 1995, 
1996,1997).
Northern blot analysis of BDNF mRNA expression in adult mice and rats has 
shown that the CNS is the predominant site of BDNF mRNA expression (Liebrock et 
al., 1989; Hofer et al., 1990; Maisonpierre et al., 1990a, Yan et al., 1997). The 
highest levels of BDNF mRNA are found within the cerebellum, cerebral cortex and 
the hippocampus, where it is confined to a subset of pyramidal and granular neurons. 
Detectable levels of BDNF mRNA are also observed in the central target fields of 
BDNF responsive sensory neurons, namely the spinal cord and hindbrain (Ernfors et 
al., 1990a; Ernfors et al., 1990b; Hofer et al., 1990; Philips et al 1990). In the 
peripheral nervous system, BDNF mRNA expression has been detected in developing
16
sensory neurons within dorsal root, trigeminal and jugular ganglia as well as in 
sympathetic ganglia (Ernfors et ah, 1990; Schecterson & Bothwell, 1992; Wright et 
al., 1992; Robinson et al., 1996b). The observation that BDNF expression is largely 
restricted to developing NGF dependent neurons during the period of naturally 
occurring neuronal death rules out a BDNF autocrine loop supporting the survival of 
embryonic neurons and suggests that BDNF functions in a paracrine manner 
(Robinson et al., 1996a). A BDNF autocrine loop does promote the early maturation of 
newly differentiated sensory neurons (Wright et al., 1992) and supports survival of a 
subset of adult DRG neurons (Acheson, et al., 1995). Low levels of BDNF mRNA 
have also been detected in heart, lung and muscle (Maisonpierre et al., 1990a; 
Schecterson & Bothwell, 1992). Increased expression of BDNF mRNA containing 
exons I, n, and HE has been demonstiated in hippocampal neurons following addition 
of the glutamate analog, kainic acid (KA) and the y-aminobutyric acid subtype A 
(GAB A a) receptor antagonist bicuculline, as well as stimulation of the 
septohippocampal pathway. This suggests that the levels of BDNF mRNA expressed 
by hippocampal neurons is controlled by the balance between the activity of 
GABAergic and glutamatergic systems (Zafra et al., 1991, Zafra et al., 1990).
Mice that are homozygous for a null mutation in the BDNF gene are viable at 
birth. Most inutants die within 2 days of birth, although some may live for 2-4 weeks. 
BDNF null mutants exhibit severe deficiencies in coordination and balance, which is 
believed to be associated to the increase neuronal loss in several sensory ganglia 
including the vestibular ganglia (Ernfors et al., 1994a; Jones et al., 1994). Histological 
analysis of BDNF null mice revealed significant neuronal loss in trigeminal, geniculate, 
vestibulai* and nodose ganglia (Ernfors et al., 1994a; Jones et al., 1994). Contrary to 
previous studies showing that BDNF can promote the survival of motor, hippocampal, 
dopaminergic and cortical neurons, no obvious defects were seen in these populations 
in the absence of BDNF. A possible explanation for this is that the function of BDNF
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is compensated for by other neurotrophins in the mutant mice. For example, BDNF, 
NT-3 and NT-4 have all been shown to promote motor neuron survival in vitro 
(Henderson et al., 1993).
Although the gross morphology of the CNS of BDNF mice showed no abnoimalities, 
histological examination of BDNF mutants showed reduced expression of neuropeptide 
Y (NPY) and the calcium binding proteins paravalbumin and calbindin (Ernfors et al., 
1994b; Jones et al., 1994). Due to the fact that BDNF mutants exhibit early postnatal 
lethality, they may not survive long enough for a wider phenotype to be observed. 
These observations suggest that BDNF is an essential factor for the survival of certain 
sensory neuronal populations, but is not essential for the early development of the 
central nervous system (Ernfors et al., 1994a; Jones et a l ., 1994).
Neuro trophin-3
NT-3 was first isolated by the polymerase chain reaction (PCR) using 
degenerate primers whose sequences were based on the nucleotide sequences of 
conserved domains of NGF and BDNF. NT-3 has since been isolated and cloned in 
mouse, rat, and humans (Hohn et al., 1990; Maisonpierre et al., 1990a; Jones & 
Reichardt 1990). Structural analysis of NT-3 has revealed that it is initially synthesized 
as a precursor protein of 258 amino acids. Mature NT-3 is predicted to consist of 119 
amino acids and be a basic protein (pi > 9.3) with a moleculai* weight of 13.6 KD. 
Comparison of the mature form of NT-3 with other members of the neurotrophin 
family has revealed a high degree of sequence homology (57%-48%) with 54 amino 
acids being conserved, including all six disulphide linked cysteine residues (Hohn et 
al., 1990).
The NT-3 gene consists of two small upstream exons, termed lA, and IB, and 
a large downstream exon termed exon II, which encodes the mature NT-3 protein 
(Leingartner & Lindholm, 1994). Two classes of NT-3 transcripts have been
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identified, termed transcripts À and B, which aie generated by alternative splicing of 
exons lA or exon IB to the common exon II. The NT-3 gene also contains within both 
upstream exons several transcription start sites. Exon II, contains three different 
poly adénylation sites, which give rise to multiple NT-3 mRNA variants which differ 
slightly in length (Leingartner & Lindholm, 1994).
Northern blot analysis has revealed that NT-3 is expressed in various tissues including 
heart, kidney, spleen, and lung. NT-3 is also expressed in several regions of the adult 
CNS including the cerebellum, medulla oblongata and hippocampus (Hohn et al., 
1990; Jones & Reichardt et al., 1990; Maisonpierre et al., 1990a,b; Rosenthal et al., 
1990). The broad spectmm of peripheral tissues containing NT-3 mRNA suggests that 
in the PNS, NT-3 could serve as a target-derived factor for sympathetic and sensory 
neurons. In situ hybridization has been used to further determine the spatio-temporal 
expression pattern of mRNA. NT-3 transcripts are present in the iris, cochlea and 
vestibular organs of embryonic and early postnatal rats, as well as in the epithelium of 
the whisker follicles, the target of trigeminal neurons (Ernfors et al., 1992; Pirvola et 
al., 1992; Hallbook et al., 1993). Northern blot analysis has demonstrated that NT-3 
mRNA is expressed in the peripheral trigeminal target field before the arrival of the 
earliest axons, with the expression of NT-3 mRNA peaking during the early stages of 
target field innervation and declining following the loss of neuronal responsiveness to 
BDNF and NT-3 (Buchman & Davies, 1993). Within the CNS, NT-3 expression 
appears to be more restricted than other members of the neurotrophin family, with NT- 
3 mRNA being detected in the dentate gyrus of the hippocampus, cerebellum (Ernfors 
et al., 1990b; Hohn et al., 1990), nucleus basalis and the visual cortex (Jones et al.,
1990).
In the PNS, NT-3 has been shown to promote the differentiation of sensoiy 
neurons from their progenitors in vitro, as well as enhancing early maturational 
changes in dorsal root ganglion neurons before they become dependent on
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neurotrophins for survival (Wright et al., 1992; Buchniann & Davies, 1993; Elshamy 
et ah, 1996). NT-3 also supports the survival of spinal sensory and sympathethic 
neurons (Maisonpierre et ah, 1990; Rosenthal et ah, 1990 Wyatt et ah, 1997). 
However, among DRG's, NT-3 most effectively promotes the survival of lumbar and 
cervical neurons which contain many proprioceptive neurons (Hory-Lee et ah, 1993). 
In vivo and in vitro studies have also shown that NT-3 is required for the survival of 
developing muscle sensory neurons (Hohn et ah, 1990; Ericksson et ah, 1994; Oakley 
et ah, 1995). Several additional populations of sensoiy neurons have been shown to 
respond to NT-3, these include neurons from the trigeminal (Buchman & Davies, 
1993; Willdnson et ah, 1996) and nodose ganglia (Gaese et ah, 1994; Ockel et ah, 
1996) and neurons of the spiral ganglia (Gao et ah, 1995; Ernfors et ah, 1995). 
Recently, NT-3 has been demonstrated to be required for survival of a subset of 
sympathetic neurons that also require NGF (Francis et al., 1999). Functional analysis 
of NT-3 within the CNS, has shown that NT-3 supports the survival of certain 
neuronal populations and certain glia. For example, NT-3 stimulates expression of c- 
fos in hippocampal neurons and promotes their survival (Collazo et al., 1992; Ohsawa 
et ah, 1993). NT-3 also promotes the survival of oligodendrocyte precursors in the 
embryonic rat hippocampus (Bertollini et al., 1997).
NT-3 has also been shown to promote neurite out growth within different 
neuronal populations. NT-3 stimulates dendritic growth of pyramidal neurons within 
the developing visual cortex (McAllister et ah, 1995; 1997). In addition, NT-3 
promotes neurite outgrowth from embryonic sensory neurons and supports the 
development of distinct axon morphologies (Dijkhuizen et ah, 1997; Lentz et ah, 
1999). NT-3 enhances the sprouting from the corticospinal tract during development 
and after adult spinal cord lesions (Schnell et ah, 1994). Mice containing a 
homozygous null mutation for the NT-3 gene are viable at birth but exhibit a severe 
defect in limb movement suggesting deficits in proprioception. Most NT-3 null mice
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die sfiortly after birth (Ernfors et aL, 1994; Farinas et ai., 1994; Tessaroilo et ah, 
1994). Significantly, it has been shown that the main components of the proprioceptive 
system, (muscle spindles, Goigi tendons and large diameter myelinated dorsal root 
sensory neurons) are completely missing in NT-3 deficient mice (Ernfors et ah, 1994b; 
Carr & Nagy, 1993). Interestingly, muscle spindles and Golgi tendon organs are 
reduced by 50% in NT-3 heterozygous mice, suggesting that the concentration of NT-3 
is limiting during development (Ernfors et ah, 1994b). NT-3 deficient mice also 
exhibit severe neuronal losses in nodose, trigeminal, superior cervical and spiral 
ganglia (Ernfors et ah, 1994b; Tessaroilo et al., 1994; Bovolenta et ah, 1996; Farinas 
et ah, 1996; Fritzsch et ah, 1997; Wyatt et ah, 1997). Neuronal cell loss has been 
observed in the dorsal root ganglion before the onset of the period of programmed cell 
death, suggesting that NT-3 prevents the death of proliferating sensory neuron 
precursor cells (ElShamy & Ernfors, 1996). Selective expression of NT-3 in skeletal 
muscle of mice lacking endogenous NT-3 rescues proprioceptive neurons (Wright et 
ah, 1997). Cutaneous overexpression of NT-3 increases the number of sensory and 
sympathetic neurons in peripheral ganglia in addition to enlarging touch dome 
mechanoreceptor units and increasing hair follicle inneiwation (Albers et al., 1996).
Neurotrophin 4/5
NT-4/5 is the fourth member of the neurotrophin family to be identified. NT- 
4/5 was discovered and isolated from Xenopus learis following a phylogenetic analysis 
of the DNA sequences of members of the neurotrophin family (Hallbook et al., 1991). 
NT-4 is a 13.9 kD protein derived from a 236 amino acid precursor which is processed 
into the 123 basic amino acid mature NT-4 protein. NT-4 exhibits 50-60% amino acid 
homolgy with members of the neurotrophin family, including all six disulphide linked 
cysteine residues (Hallbook et ah, 1991). Homologues of human and Xenopus NT-4 
have subsequently been isolated from rat and termed mammalian NT-4 (Ip et ah.
21
1992a) or NT-5 (Berkemeier et al., 1991). It appears as if both proteins are identical 
and the mammalian equivalent of Xenopus NT-4 is often referred to as NT-4/5. The 
human NT-4 gene has been localized to chromosome 19, band ql3.3 (Berkemeier et 
al., 1992). Northern blot analysis of Xenopus tissue only detected NT-4 mRNA in the 
ovary (Hallbook et al., 1991). However RNAase protection assay and Northern blot 
analysis have revealed that NT-4/5 mRNA is widely expressed both in the central 
nervous system and in peripheral organs in developing and adult rat tissue (Berkemeier 
et al., 1991; Ip et al., 1992; Timmusk et al., 1993). In the CNS, NT-4/5 mRNA is 
expressed in several regions including the cerebral cortex, brain stem, hippocampus, 
hypothalamus, thalamus and cerebellum. In the periphery, NT-4/5 mRNA is expressed 
in the lung, kidney, thymus, muscle, heart and stomach (Berkemeier et al., 1991; 
Timmuk et al., 1993b). During development, the peak of NT-4/5 mRNA expression in 
peripheral tissue coincides with the peak of naturally occurring neuronal cell death in 
peripheral ganglia, suggesting that NT-4/5 may function as a target-derived trophic 
factor in vivo.
Functional analysis of the neurotrophic activity of NT-4/5 in the PNS has 
shown that NT-4/5 transiently supports mouse NGF-dependent trigeminal and jugular 
neurons at early stages of target field innervation, as well as mouse BDNF-dependent 
enteric neurOns of the nodose ganglia during the phase of naturally occurring cell death 
(Davies et al., 1993; Ibanez et al., 1993). Other peripheral nemons supported by NT- 
4/5 include dorsal root and paravertebral sympathetic neurons (Hallbook et al., 1991) 
and postnatal spiral ganglion and vestibular neurons ( Zheng et al., 1995a; Zheng et al., 
1995b). Mammalian NT-4/5 does not support the survival of chicken BDNF- 
dependent dorsomedial (DMTG), ventrolateral trigeminal (VLTG) neurons or 
trigeminal mesencephalic (TMN) sensory neurons (Davies et al., 1993). A chick NT- 
4/5 homologue has not yet been isolated. In the CNS, NT-4/5 supports the survival 
of developing and adult motor neurons (Henderson et al., 1993; Koliatsos et al., 1994;
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Freidman et al., 1995; Funakoshi et ai., 1995) and conicospinai neurons of neonatal 
rats (Junger & Varon, 1997). NT-4/5 also promotes the development and maintenance 
of sympathetic preganglionic neurons innervating the adrenal medulla (Schober et al.,
1998). Furthermore NT-4/5 has also been shown to support the survival and, or 
differentiation of numerous sub-populations of neurons within the CNS including 
those from the substantia-nigra, striatum and cerebellum (Gao et al., 1995; 
Ventimilglia et al., 1995; Studer et al., 1995). NT-4/5 also supports adult rat retinal 
ganglion cell survival (Cohen et al., 1995).
Mice homozygous for a null mutation of the NT-4/5 gene are viable at birth, 
but display a loss of sensoiy neurons in the nodose-petrosal and geniculate ganglia. In 
contrast, there is no loss of neurons from the facial motor nucleus, ciliary ganglion or 
the substantia nigra (Conover et al., 1995; Liu et al., 1995; Erickson et al., 1996).
Neurotrophin-6 (NT-6)
NT-6 was cloned from a genomic library of the platyfish Xiphophorus 
maculatus, during attempts to clone the fish NGF gene (Gotz et al., 1994). NT-6 is a 
16 KD protein derived from a 286 amino acid precursor protein, with a molecular 
weight of 31.4 KD, which is processed into a 143 amino acid mature NT-6 protein. 
Examination of the structure of NT-6 has revealed that it contains a hydrophobic 
domain at the N-terminus with the characteristics of a signal peptide, a pro-region 
containing basic motifs necessary for the proteolytic cleavage of the precursor protein, 
and all six conserved disulphide linked cysteine residues present in all other members 
of the neurotrophin family. A feature unique to NT-6 is the presence of 22 amino acid 
residues inserted between the second and third conseiwed cysteine domain. Northern 
blotting and in situ hybridization analysis of NT-6 gene expression has revealed that 
NT-6 mRNA is expressed in several teleost fish tissues including developing and adult 
brain and adult gill, liver, skin, heart, spleen, eye and muscle. (Gotz et al., 1994). NT-
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6 has been shown to support the survival of NGF-dependent spinal sensory (DRG) 
and sympathetic neurons. However, NT-6 showed no survival effect on ciliary or 
BDNF-dependent nodose neurons, suggesting that the spectrum of responsive neurons 
is similar to that of NGF (Gotz et al., 1994).
Neurotrophin 7
NT-7 is the most recent member of the neurotrophin family to be identified, and was 
isolated from the Carp Cyprinus carpio and Zebrafish Danio rerio using the polymerase 
chain reaction (PCR) (Nilsson et al., 1998; Ko et al., 1998). A characteristic feature of 
the neurotrophin structure is a conserved B turn of variable length flanked by two 
cysteine residues known as variable region III (McDonald et ah, 1991). NT-7 contains 
a 15 aa residue insertion in a B-tum region in the middle of the mature protein, a 
position that coixesponds to the insertion of 22 aa in NT-6. Apart from being rich in 
glycine and proline residues, the sequence in this region is unlike that of any other 
member of the neurotrophin family. However, amino acid sequence analysis of NT-7 
has revealed a high degree of homology with fish NGF and NT-6 (65% and 63% 
respectively) (Nilsson et al., 1998; Ko et al., 1999). NT-7 supports the survival and 
neurite outgrowth of chicken DRG neurons. NT-7 interacts with the human p75 
neurotrophin receptor and phosphorylation assays of Trk receptors in fibroblast cells 
have shown that NT-7 is able to induce tyrosine phosphorylation of rat TrkA (Nilsson 
et al., 1998; Ko et al., 1998).
1.4 Neurotrophin Receptors
The biological actions of members of the neurotrophin family are mediated 
through binding to two types of transmembrane receptors which possess different 
binding affinities (Meakin & Shooter, 1992; Barbacid, 1994). Low affinity binding is 
via p75, a transmembrane protein of 75KD, which contains a highly glycosylated
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extraceiluiar region rich in cysteine residues and a short cytoplasmic domain that is 
required for biological activity (Johnson et ah, 1986; Radeke et al., 1987). The p75 
neurotrophin receptor belongs to a family of transmembrane molecules including Fas 
and CD40 (Chao, 1994) which serve as receptors for the tumor necrosis factor family 
of cytoldnes. p75 binds to all members of the neurotrophin family with similar affinity 
with a dissociation constant of (10"  ^ to 10-^M) (reviewed by Chao et al., 1986; 
Hempstead et al., 1991; Radeke et al., 1997). High affinity binding (lO'^o iq-U 
of neurotrophins is mediated via the products of the trk proto-oncogenes (Cordon- 
Caido et al., 1991; Hempstead et al., 1991; Kaplan et al., 1991a, 1991b; Klein et al., 
1991a). TrkA binds to NGF and NT-3 (Cordon-Caido et al., 1991; Hempstead et al., 
1991; Kaplan et al., 1991a; IGein et al 1991a) whilst TrkB binds NT-4/5, BDNF and 
NT-3 (Berkemeier et al 1991; Klein et al 1992) and TrkC binds NT-3 (Lamballe et al
1991) see figure 1.1. Neurotrophin binding to Trk stimulates Trk autophosphorylation. 
This in turn activates a number of signalling pathways including those involving Ras 
and PI-3 kinase (Barbacid, 1994; Kaplan & Stephens, 1994, Greene & Kaplan, 1995; 
Kaplan & Miller, 1997).
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Adapted h'tom Davies, 1994b
Figure 1.1 Schematic diagram summarizing the interaction of neurotrophins with 
members of the Trk family of tyrosine kinase receptors.
The Low Affinity NGF receptor (p75)
The gene encoding the human p75 was first identified by gene transfer assays 
followed by immunological detection of transfected NGF receptor expressing cells 
(Chao et al., 1986). The p75 gene has since been cloned in rat and chicken (Johnson et 
al., 1986;Radeke et al., 1987; Large et al., 1989). The 222 amino acid long 
extracellular domain has four cysteine repeats chaiacteristic of a loose family of cell 
surface receptors that includes; the lymphocyte surface antigen CD30 (Durkop et al.,
1992), CD40 (Stamenkovic et al., 1989), 0X40 (Mallet et al., 1990), the apoptosis- 
mediating fas cell surface antigen (Itoh et al., 1991), and the type I and U receptors for 
tumor necrosis factor (TNF) (Loetscher et al., 1990; Schall et al., 1990).
p75 is widely expressed in the PNS and CNS (Ernfors et al., 1988; Yan & 
Johnson, 1989). In-situ hybridization has revealed that in the PNS, p75 mRNA is 
expressed during development in NGF-dependent spinal and cranial sensory neurons, 
as well as sympathetic neurons (Heuer et al., 1990; Hallbook et al., 1990). In the 
CNS, p75 is expressed throughout brain development, with high levels being detected 
in the cerebellum and septum. p75 mRNA is present in a variety of non-neuronal cells 
of neuroectodermal origin including melanocytes, meningeal cells, glial cells and 
Schwann cells. Schwann cells secrete a proteolytically cleaved form of p75 of 
unknown function (Distefano & Johnson., 1988). Several other tissues also express 
P75 mRNA including basal kératinocytes, epithelial cells within the ducts and acini of 
mammary and prostatic glands and spleen cells (Thomson et al., 1988; Chesa et al., 
1988).
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Functional analysis has revealed that the functions of p75 are very diverse and 
complex. Kinetic studies have demonstrated that p75 is able to bind all neurotrophins 
with similar affinity, although the dissociation rate of NGF is greater than that of either 
NT-3 or BDNF (Rodriguez-Tebar et al., 1992). In vitro studies have demonstrated that 
NGF binding to p75 enhances the sensitivity of embryonic cranial sensory and 
postnatal sympathetic neurons to NGF at different stages of development (Horton et 
al., 1997; Ryden et al,, 1997). Coexpression of TrkA or TrlcB with p75 increases the 
binding affinity of TrlcA for NGF and TrkB for BDNF (Makadeo et al., 1994; Bidel et 
al., 1999). Overexpression of p75 in MAH cells expressing TrkA increases NGF 
stimulated Trk autophosphorylation (Verdi et al., 1994), whilst inhibiting of NGF 
binding to p75 in PCI2 cells reduces NGF mediated TrkA autophosphorylation 
(Barker et al. 1994). The p75 receptor plays a role in ligand discrimination by the Trk 
receptors. The ability of NT-3 to activate TrkA in the PC 12 cells is enhanced when the 
binding of NT-3 to p75 is prevented by function-inhibiting antibodies, or when p75 
expression is very low (Benedetti et al., 1993; Clary & Reichardt, 1994). Likewise, 
sympathetic neurons from postnatal p75-deficient mice are more sensitive to NT-3 than 
sympathetic neurons from wild-type mice, suggesting that p75 reduces the ability of 
NT-3 to signal via TrkA. Likewise, studies with mutated BDNF and NT4/5 proteins 
that bind TrkB normally but fail to bind p75 suggest that p75 also plays a role in TrkB 
ligand discrimination. Whereas the BDNF mutant activates TrlcB as effectively as does 
wild-type BDNF, the NT4/5 mutant activates TrkB less effectively than wild-type 
NT4/5 (Ryden et al., 1995).
More recently, evidence has emerged to support the idea that under certain 
circumstances p75 can promote cell death. Increasing p75 expression in PC12 cells 
cultured without NGF stimulates increased cell death (Rabizadeh et al., 1993), whereas 
addition of anti-sense p75 oligonucleotides to postnatal DRG neurons in culture, 
promotes neuronal survival. In contrast anti-p75 oligonucleotides do not rescue
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embryonic DRG neurons grown without NGF, rather they reduce the survival 
promoting effects of NGF, suggesting that the role of p75 undergoes a developmental 
switch from enhancing the survival-promoting actions of NGF during the fetal period 
to promoting neuronal death in the absence of a ligand postnatally (Barret et al., 1994). 
Recently, p75 has also been demonstrated to mediate cell death in a ligand-dependent 
fashion by mediating a cytotoxic response to neurotrophins in certain cell types and 
neurons (Casaccia-Bonnefil et al., 1996; Bamji et al., 1998; Davey & Davies 1998). In 
vitro studies have shown that NGF reduces the survival of chick TMN neurons 
cultured with CNTF, but not BDNF. The killing effect of NGF can be inhibited by 
anti-p75 antibodies, suggesting that NGF mediated cytotoxicity occurs via a p75 
dependent mechanism (Davey & Davies 1998). Evidence for this new ligand dependent 
function of p75 has also been demonstrated in avian retina, mouse sympathetic ganglia 
and developing spinal cord of mice (Frade et al,, 1996; Frade & Barde, 1998, Bamji et 
al., 1998; Frade & Baide, 1999).
Mice containing a homozygous null mutation for the p75 gene are viable and 
fertile (Lee et al., 1994). p75 deficient mice display neuronal loss in populations of 
sensory and sympathetic neurons in the PNS. In contrast the CNS exhibits no 
neuronal loss (Lee et al., 1994). Embryonic and postnatal trigeminal and dorsal root 
ganglion sensory neurons and postnatal sympathetic neurons from the superior 
cervical ganglia from p75-deficient mice show a decreased sensitivity to NGF, 
requiring higher concentrations of NGF for survival than heterozygous and wild-type 
neurons. This observation supports the hypothesis that p75 enhances the sensitivity of 
NGF-responsive neurons to NGF. In contrast, p75 deficient neurons do not show 
decreased sensitivity to other members of the neurotrophin family (Davies et al., 
1993b; Lee et al., 1994). Immunohistochemical studies have shown that the foot pads 
of mutant mice are characterized by reduced sensory innervation by NGF dependent 
calcitonin gene-related peptide (CGRP) and substance P-immunoreactive nociceptive
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neurons. This loss of nociceptive innervation accounts for the decieased response to 
thermal stimuli exhibited by p75 deficient mice, in addition to the observed ulceration 
of the exti'emities (Lee et al., 1994).
TrkA
Trk was first identified as a result of an oncogenic transfoimation caused by the 
chromosomal translocation of tropomyosin sequences onto the catalytic domain of 
TrkA in a human colon carcinoma (Martin-Zanca et al., 1986, 1989). TrkA has 
subsequently been identified as a signal transducing receptor for NGF (Kaplan et al., 
1991a,b; Klein et al., 1991a). The human Trk proto-oncogene encodes a 140 KD 
glycoprotein termed gpl40 which is produced from a primary translated product of 
110 KD. This 110 KD protein is processed and glycosylated during translocation 
within the endoplasmic reticulum to yield the mature gp 140 proto-ak xhe Trk 
protooncogene encodes two isoforms of the TrkA protein, one of 790 aa and the other 
of 796 aa (Martin-Zanca et al, 1989; Meakin et al, 1992; Barker et al, 1993). Both 
Trk isoforms possess a typical structure of a tyrosine kinase cell surface receptor 
including; a 32-amino acid long putative signal peptide, a NH2-terminal ligand binding 
extracellular domain rich in consensus sites for N-glycosylation, a single 
transmembfane domain, a cytoplasmic domain containing a catalytic tyrosine kinase 
domain. However, the two isoforms differ by the presence or absence of a 6 amino 
acid insert situated in the extracellular domain close to the transmembrane domain. 
Studies have shown that the 790aa isoform is expressed predominantly in non-neuronal 
cells, whereas the isoform 796 is primarily expressed in neurons (Barker et al., 1993 ). 
NGF was shown to activate each form of the receptor comparably, however the 760 aa 
isofoim showed binding and response to NT-3 (Clary & Reichaidt, 1994). In vitro 
studies have also demonstrated that TrkA mediates NT-3 and NT-4/5 signalling 
(Berkemeier et al, 1991; Davies et al, 1995). TrkA mRNA is expressed by numerous
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neurons wiüiin the PNS, inciiiuing dorsal root, irigeminaî, superior and Jugular and 
sympathetic ganglia (Martin-Zanca et al 1990). In the CNS, TrkA mRNA is expressed 
in the septum, striatum and brainstem as well as in cholinergic neurons in the basal 
forebrain and neostriatum (Ringstedt et al., 1993; Holtzman et al., 1995) and non- 
cholinergic neurons in the paraventricular anterior and thalamic nuclei (Holtzman et 
al., 1995). TrkA mRNA is also found in non-neuronal tissue such as certain activated 
CD4+ T lymphocytes and human monocytes (Ehrhard et al., 1993).
Mice that contain a homozygous null mutation for the TrkA gene are viable at 
birth, but they do not gain weight in comparison to their littermates and die within the 
first month of life (Smeyne et al., 1994; Crowley et al., 1994). TrkA deficient mice 
also exhibit deficits in sensitivity to pain, temperature and noxious olfactory stimuli as 
well as exhibiting extensive sensory and sympathetic neuropathies (Crowley et al., 
1994). Extensive neuronal cell loss occurs in trigeminal, sympathetic and dorsal root 
ganglia of TrkA deficient mice. In the CNS, TrkA deficient mice show a reduction in 
the cholinergic basal forebrain projections to the hippocampus and cerebral cortex 
(Smeyne et al., 1994).
TrkB
TrkB was isolated during analysis of Trk-related sequences from mouse brain 
cDNA libraries (Klein et al., 1989). Mouse TrlcB shows a high degree of sequence 
homology to the human Trk proto-oncogene, with both genes exhibiting 57% 
homology within the extracellular domain, including 9 of the 11 cysteines present 
within the trk proto-oncogene, and 88% homology within their tyrosine kinase catalytic 
domains (Klein et al., 1989). TrkB locus is synthesized as a 821 amino acid precursor 
protein which undergoes post-translational glycosylation to give a glycoprotein of 145 
KD (Klein et al., 1989; 1990; 1991; Middlemas et al., 1991). In the mouse, the TrlcB 
locus exhibits a highly complex transcriptional pattern producing at least eight different
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RNA transcripts, ranging in size From 0.7 to 9 kb which encode iso Forms that possess 
(TrkB^^+) or lack (T rk B ^ K -) the tyrosine kinase domain (Klein et al., 1989; 1990a; 
Middlemas et ai., 991). Two isoforms of the non-signal transducing T rk B ^ K - have 
been identified, both of which contain a very short cytoplasmic domain and lack the 
entire tyrosine kinase catalytic region (Klein et al., 1990a; Middlemas et al., 1991). 
Two novel variants of TrkB have been isolated that are both generated via alternative 
splicing and lack either two or all thr ee of the leucine rich motifs. In the extracellular 
domain, both TrkB^K- and TrkBTK+ isoforms of these leucine motif deleted variants 
exist (Ninkina et al., 1997). Expression studies using fibroblast cell lines which stably 
express these variants show that they do not bind to any of the TrkB ligands, 
suggesting that the leucine rich motifs in TrkB are essential for ligand binding and 
signalling (Ninkina et al., 1997). The pattern of TrkB mRNA expression in the 
developing trigeminal ganglia raises the possibility that BDNF responsiveness in 
developing sensory neurons is modulated by the relative level of catalytic and non- 
catalytic TrkB isoforms. This is supported by the results of microinjection studies that 
show that overexpressing TrkB TrkB' i^ "^ isoforms decreases the sensitivity to BDNF 
(Ninkina et al., 1996). Functional studies have shown that TrkB binds BDNF, 
amphibian NT-4 and mammalian NT-4/5, inducing autophosphorylation of TrkB 
(Berkemeier et al., 1991; Klein et al., 1992). In addition, studies have also 
demonstrated that NT-3 binds and signals via TrkB (Davies et al., 1995; Rarinas et al., 
1998; Haung et al., 1999). Northern blotting and in situ hybridization studies have 
revealed that TrkB is widely expressed in the CNS and PNS (Klein et al., 1990a,b) 
including brain, spinal cord, spinal and cranial sensory ganglia and paravertebral 
sympathetic ganglia (Klein et al., 1989; Ringstedt et al., 1993). Northern blotting has 
revealed that in adult mice TrkB is preferentially expressed in the brain and the spinal 
cord, although significant levels of TrkB RNA have also been shown in non-neuronal 
tissue, such as lung, muscle and ovaries (Klein et al., 1989).
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Mice with a tai'geted mutation in the TrkB gene which prevents expression of 
the TrkBTK+ signalling receptor but not of the non-catalytic TrkB'TK- isoforms are 
viable at birth but are unable to feed and die within the first 48hrs of life (Klein et al.,
1993). Histological studies of the PNS of TrkB deficient mice revealed severe 
neuronal loss in the trigeminal and dorsal root ganglia compared to their wild type 
littermates (Klein et al., 1993). Within the CNS, neuronal loss was observed in TrkB 
null mutant mice in the facial motor nucleus and in the spinal cord at lumbar levels L2- 
L5 (Klein et al., 1993).
TrkC
TrkC was identified following the screening of a porcine brain cDNA library 
with a probe derived from the catalytic domain of the human trk proto-oncogene 
(Lamballa et al., 1991). The product of the TrkC gene is a 145 KD glycoprotein termed 
gpl45^ f^ *^  that shares a high degree of homology to other members of the Trk family. 
To date, four TrkC'^K+ and four TrkC^^' receptor isoforms have been identified 
(Lamballe et al, 1993; Tsoulfas et al., 1993; Valenzuela et al., 1993; Gamer & large,
1994). The TrkC^K+ isoforms, TrkC Kl, K14, K25 and K39, differ in the number 
of additional amino acid residues located after the conserved sequence motif in the 
Idnase domain which contains the putative autophosphorylation sites. The T rkC ^K - 
isoforms have the same extracellular and transmembrane domain as the TrkC tyrosine 
kinases, but lack the kinase domain, and have been designated TrkC- K158, K143, 
K113 and K108 (Tsoulfas et al., 1993; Valenzuela et al., 1993). Functional studies 
utilizing cell lines ectopically expressing TrkC have demonstrated that TrkC is a 
receptor tyrosine kinase for NT-3 (Lamballe et al., 1991). In situ hybridization and 
Northern blot analysis have shown that TrkC transcripts are preferentially expressed 
within the CNS, with transcripts most notably in the hippocampus, cerebral cortex, and 
granular cell layer of the cerebellum (Lamballa et al., 1991). Within the PNS, TrkC has
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been detected within various cranial ganglia (VU, VIIl and X) as well as the trigeminal 
and dorsal root ganglia (Tessarollo et al., 1993; Lamballe et al., 1994). TrkC is also 
expressed within the myenteric plexi which form the ganglia of the enteric nervous 
system (Tessarollo et al., 1993; Lamballe et al., 1994). TrkC transcripts have also been 
detected within non-neuronal tissue including dental papillae, tongue, sublingual glands 
and the olfactory epithelium (Tessarollo et al., 1993; Lamballe et al., 1994). Structures 
within the body cavity expressing TrkC include the mesenchyme surrounding 
mesophenic and urogenital ducts as well as the diaphragm and adrenal gland 
(Tessarollo et al., 1993; Lamballe et al., 1994).
Mice with a targeted deletion of the TrkC kinase domain are viable at birth and 
display no visible defects at birth. However, these mice develop at a reduced rate and 
die within the first month of life (Klein et ah, 1994). TrkC-deficient mice show a 
marked depletion of large myelinated group la axons which innervate muscle spindles 
in the periphery and which extend the collateral la projections to the spinal cord and 
synapse with spinocerebellar neurons. These defects are likely to be responsible for the 
abnormal movements char acteristic of TrkC deficient mice (Klein et al., 1994). TrkC 
deficient mice also exhibit profound deficiencies within the peripheral nervous system 
with TrkC deficient mice exhibiting a reduction in vestibular neurons and a specific 
loss of cochlear neurons which innervate the inner hair cells (Schimmang et al., 1995). 
Spinal sensory ganglia also exhibit sensory neuron deficiencies, with lumbar DRG of 
TrkC deficient embryos exhibiting an 18% reduction in neuron numbers (Klein et al., 
1994; Minichiello et al., 1995). However, neonatal NT-3 deficient mice exhibit a 
66% reduction of lumbar DRG neurons (Emfors et al., 1994a; Farinas et al 1994). The 
number of neurons in spiral ganglia of NT-3 deficient mice exhibit a reduction of 86%, 
whilst TrkC deficient mice exhibit a reduction of 51% (Schimmang et al., 1995). 
These differences may be due to the ability of NT-3 to signal via TrkA and TrkB 
receptors, as NT-3 has been shown to promote the in vitro survival of trigeminal and
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nodose sensory neurons from TrkC deficient embiyos, but not from TrkA or TrkB 
deficient embryos (Davies et al., 1995). Within the CNS, TrkC deficient mice exhibited 
no significant abnormalities even though TrkC is expressed throughout the CNS 
(Klein et al., 1994).
1.5 Other Neurotrophic Factors And Their Receptors
1.5.1 Hepatocyte Growth Factor
Hepatocyte Growth Factor (HGF) also known as hepatopoietin A or Scatter 
Factor (Miyazawa et al., 1989, Nakamura et., 1989, Zamegar et al., 1989; Zamger & 
Michalopoulos, 1989; Furlong et al., 1991; Naldini et al., 1991a; Weidner et al., 1991) 
was originally identified in the serum of partially hepatectomized rats as a potent 
mitogen for cultured rat hepatocytes (Nakamura et al., 1984, Michalopoulos et al., 
1984). HGF has since been isolated from rat platelets (Nakamura et al., 1986) rabbit 
serum (Zarnegar & Michalopoulos, 1989) and from serum of human patients with 
fulminant hepatic failure or following a partial hepatectomy (Seldon et al., 1986; 
Gohda et al., 1988). HGF was purified from rat platelets and shown to be a heat and 
acid-labile cationic protein (Nakamura et al., 1986). Further characterization has 
revealed HGF to have a molecular weight of 82KD and to be a disulphide linked 
heterodimer ie a glycoprotein comprising a heavy alpha 69-55 KD subunit and a 
light beta 32-36 KD subunit (Nakamura et al., 1987, Godha et al ,1988; Zarnegar & 
Michalopoulos, 1989; Gherardi et al., 1989; Welder et al., 1990). Examination of the 
nucleotide sequence of human, mouse and rat HGF cDNA has shown that both the 
alpha and beta subunits are derived from a single open reading frame that encodes a 
728 amino acid polypeptide precursor (Nakamura et al., 1989; Tashiro et al., 1990). 
The HGF alpha subunit is encoded between amino acids 55 to 494, whilst the beta 
subunit is encoded between amino acids 495 to 728. After biosynthesis, the alpha and
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beta subunits are believed to be sepai'ated by a urokinase-type protease (Tashiro et al., 
1990; Mizuno et al., 1992; Naldini et al., 1995). Mutation of critical amino acids within 
the cleavage site generates biologically inactive HGF proteins (Hartmann et al., 1992; 
Lokker et al., 1992), indicating that proteolytic cleavage is necessary for the production 
of biologically active HGF. The amino acid sequence of the rat HGF precursor shows 
considerable sequence homology (38%) to human plasminogen and other related 
proteases involved in blood coagulation. The HGF alpha subunit contains a hairpin 
loop of 27 amino acids at its amino terminus and four unique domains teimed kiingle 
domains, whilst plasminogen contains five kiingle structures ( Nakamura et al., 1989; 
Tashiro et al., 1990). The beta subunit of rat HGF shows a high degree of homology 
(37%) with various serine proteases, however, the histidine and serine residues of the 
protease active site are replaced in the beta chain of rat HGF by glutamine and tyrosine, 
respectively, resulting in HGF showing no proteolytic activity (Tashiro et al., 1990). 
A naturally occurring splice variant of HGF has been identified that lacks 5 amino acids 
within the 1st kringle domain. Functional analysis has suggested subtle differences in 
biological activities between the two isoforms (Seki et al., 1990; Shima et a l ., 1991). 
Analysis of human genomic DNA showed that the multiple domains of the HGF 
protein are encoded as separate exons within the HGF gene (Miyazawa et al., 1991) 
which is localized on chromosome segment 7q 21.1 (Fukuyama et al., 1991; Weidner 
et al., 1991). The mouse HGF gene shows a high degree of homology to human HGF 
and is composed of 18 exons interrupted by 17 introns, spanning 65Kb (Liu et al.,
1994).
HGF has been identified as the ligand for the proto-oncogene c-met, a 
membrane spanning tyrosine kinase receptor. This was initially demonstrated by 
immuno-coprecipitation of HGF/MET complexes and by chemical crosslinking of 
HGF to the beta subunit of the met protein. Upon binding of HGF, the met receptor 
undergoes autophosphorylation on two tyrosine residues, Try 1234 and Tyr 1235
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within the kinase domain, resulting in the upregulaiion of the met receptors kinase 
activity (Bottaro et al., 1991; Ferracini et al., 1991; Naldini et al., 1991a, 1991c; 
Hartmann et al., 1992). Chimeric receptors containing the cytoplasmic domain of the 
c-met receptor fused to the extracellular domain of a tyrosine kinase receptor have 
demonstrated that c-met is able to mediate the biological responses of HGF in 
different cell lines (Rong et al, 1992; Higuchi et al, 1992; Giordano et al, 1993; 
Komada et al, 1993; Weidner et al, 1993). Deletion studies have suggested that the 
binding of HGF to c-met is mediated via both the N-terminal hair pin containing region 
of HGF and the 1st kringle domain (Lokker et al, 1992; Okigaki et al., 1992). Two 
classes of HGF binding sites, have recently been identified on HGF responsive cells 
that differ in their binding affinity for HGF (Arahaki et al, 1992, Komada et al, 1992; 
Naldini et al, 1991b). The c-met receptor is responsible for high affinity binding, 
whilst low affinity binding is mediated by cell surface associated heparin-like 
molecules (Naldini et al, 1991 b). In mammals HGF mRNA is widely expressed in 
cells of mesenchymal origin such as lung, kidney, thymus, liver and gastrointestinal 
tract
(Stoker et al, 1987; Tashiro et al, 1990; Zamegar et al., 1990; Defiances et al., 1992; 
Wang et a l, 1994; Nakamura et al, 1995). HGF mRNA is expressed within 
developing'and postnatal skeletal muscle as well as in skeletal muscle undergoing 
regeneration (Jennische et al., 1993). In addition, HGF mRNA is expressed in both the 
developing and adult mammalian central and peripheral nervous systems (Tashiro et 
al., 1990; Di Renzo et al, 1991; Komada et al, 1992; Thewke et al, 1996). In 
particular HGF mRNA expression is seen within neurons in the hippocampus, cortex 
and granule cell layer of the cerebellum, as well as in glial cells in the cingulum, 
cerebellum, pons and medulla regions of the brain (Jung et al, 1994; Honda et al, 
1995; Yamagata et al, 1995). HGF expression has also been identified within
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Henson’s node, a region of the developing embryo which emits neuralizing signals 
(Streit et al., 1995).
HGF is a pleiotropic factor that exerts a variety of effects on many cell types 
during development and throughout life. HGF is a strong mitogen for hepatocytes 
(Nakamura et al, 1987; Gohda et al., 1988; Zamegar & Michalopoulos 1989; Rubin et 
al, 1991), it is a motility and invasion inducing factor for epithelial and endothelial 
cells, and a potent angionic factor in vitro and in vivo (Stoker et al, 1987; Gherai'di et 
al, 1989; Rosen et al, 1990; Weidner et al, 1990, 1991; Matsumoto et al, 1991; 
Bussolino et al., 1992). HGF also acts as a morphogen in vitro (Stem et al, 1990), 
inducing Iddney epithelial cells to form branching ducts in collagen gels (Montesano et 
al., 1991) and triggering intrinsic morphogenic programs in a variety of epithelial cell 
lines (Brinkmann et al, 1995; Borros et al, 1995; Woolf et al, 1995; Soriano et al., 
1995; Niranjan et al, 1995; Tabata et a l ,1996; Matsubara et a l, 1996). HGF 
stimulates the growth of other epithelial cells, such as kidney tubular epithelium, 
kératinocytes (Kan et al., 1991), endothelial cells and melanocytes (Igawa et al, 1991; 
Rubin et a l, 1991). HGF can also modulate the motility, proliferation and 
proteoglycan rate of synthesis of chondrocytes (Takebayashi et al., 1995). In addition, 
HGF can also function as a renotrophic and pulmotrophic factor in the regeneration of 
kidney and lung respectively (Igawa et al., 1993; Nagaike et al., 1991; Yanagita et al.,
1993), as well as being a hepatotrophic factor involved in liver regeneration (Ishiki et 
al., 1992; Ishibashi et al, 1992; Kawaida et al, 1994). HGF has also been shown to 
be involved in wound repair, with HGF stimulating early repair of rabbit esophageal 
epithelial cells following mucosal damage (Takahashi et a l, 1995). HGF/Met 
signalling enhances tumor development, with high levels of HGF and c-met mRNA 
expression being shown in several tumor tissues (Rong et al, 1992; Di Renzo, 1991; 
Moriyama et al, 1995; Borset et al, 1996). Conversely, HGF also shows anti­
proliferative activity in malignant cells (Shiota et al 1992, Tajima et al 1991) and
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inhibits the growth of certain tumor ceil lines, suggesting that HGF ar*ts as a bi­
directional growth regulator (Higashio et al., 1990; Conner et al., 1997).
There is growing evidence that HGF can function as an anti-apoptotic factor 
(Bardeili et ah, 1996). HGF acts as a survival factor for PC12 cells and promotes the 
survival and differentiation of hepatocytes during development (Matsumoto et al., 
1995; Schmidt et al., 1995). Within the developing central and peripheral nervous 
systems HGF has been shown to posses a wide spectrum of activities (Maina & Klein,
1999). For example, HGF has been shown to act as a muscle derived axonal 
chemoattractant and survival factor for motor neurons in vitro, as well as enhancing 
the neurotrophic actions of ciliary neurotrophic factor (CNTF) on motor neurons 
(Ebens et al., 1996, Wong et al., 1997). HGF also promotes neurite outgrowth from 
neocortical explants and enhances the number of tyrosine hydroxylase (TH)-positive 
neurons in vitro (Hamanoue et al., 1996). HGF is a potent mitogen for rat sciatic nerve 
Schwann cells (Kiasnoselsky et al 1994).
In situ hybridization studies of various embryonic organs have identified 
transcripts of c-met transcripts in specific epithelial cells and expression of the HGF 
gene in cells of mesenchymal origin in adjacent tissue, suggesting a role for HGF/Met 
signalling in mesenchymal-epithelial interactions (Ishibashi et al., 1992; Honda et al., 
1995; Kasai et al., 1996). During early embryonic development, both morphogenesis 
and differentiation of epithelial tissue are Icnown to be influenced by mesenchymal- 
epithelial interactions, supporting the idea that HGF is involved in early embryonic 
development (Sonnenberg et al., 1993).
Experiments on mice with homozygous null mutations of the HGF and p i90 
met genes have facilitated our knowledge of the roles of HGF/Met signalling in vivo. 
Mice homozygous for HGF and c-met null mutations have indistinguishable 
phenotypes and show embryonic lethality between E12.5 and E15.5, as a result of 
abnormal liver development (Schmidt et al., 1995; Uehara et al., 1995). In mutant
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embryos, the liver shows a significant reduction in size as well as extensive loss of 
parenchymal cells (Schmidt et al., 1995). Consistent with the scattering activity of 
HGF, met-deficient embryos show a failure of myogenic precursor cells to migrate, 
preventing normal development of limbs, diaphragm and tongue muscles (Bladt et al.,
1995). Over expression of HGF in transgenic mice induces ectopic development of 
skeletal muscle and melanocytes in the central nervous system, supporting the idea that 
during development HGF acts in vivo as a morphogenic and epithelial scattering factor 
(Takayama et al 1996).
1.5.2 1 9 0 met Receptor
The HGF receptor is a transmembrane receptor encoded by the Met proto­
oncogene (pi90 met)_ The met proto-oncogene was originally identified as an activated 
oncogene in a human osteosarcoma cell line (Cooper et al., 1984). Activation of met 
involved chromosomal reaiTangement and genetic fusion between two distinct genetic 
loci. Met, located on chromosome 7, and a translocated promoter region (tpr) located 
on chromosome 1 (Park et al., 1986). The tpr region of Tpr-Met encodes a leucine 
zipper motif which mediates dimerization of Tpr-Met (Rodrigues & Park, 1993). This 
in turn leads to constitutive phosphorylation and kinase activity of the Tpr-Met 
oncoprotein (Fixman et al., 1996). Oncogenic activity of the Tpr-Met oncoprotein is 
dependent upon phosphorylation of a tyrosine residue (y 489) located within the 
carboxyl terminus which acts as a direct binding site for the Grb2 adaptor protein 
(Kamikura et al., 1996).
The structural and functional properties of the met proto-oncogene have 
demonstrated that it is a member of the receptor tyrosine kinase gene (RTK) family 
(Dean et al., 1985; Park et al., 1987). Structural analysis of the c-met gene product in 
a gastric carcinoma cell line (GTL-16) overexpressing the gene has revealed that the 
mature form of the receptor is a heterodimer of 190 KD consisting of two disulphide
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linked chains of 50KD (p50a) and a 145 KD (pl45p) (Giordano et ah, 1989a). The 
receptor is initially synthesized as a single chain 170KD precursor (prl70), which 
undergoes glycosylation and proteolytic cleavage to generate the mature p i90 ^^ t 
heterodimer (Giordano et al., 1989b). The extracellular ligand binding domain of met is 
derived from the NH2-terminal portion of the pl45p-chain and the p50a chain. The 
cytoplasmic kinase domain is encoded by the carboxy terminal of pl45j3 (Gonzatti- 
Haces et ah, 1988, Park et ah, 1987; Tempest et ah, 1988). Examination of the 
nucleotide sequence of c-met DNA has revealed that the primary stmcture of c-met is 
highly conserved amongst different mammalian species (Liu et ah, 1996). Isolation 
and characterization of human genomic DNA clones has shown that the c-met gene 
spans approximately 120 Kb in length and consists of 21 exons interrupted by 20 
introns (Liu et al., 1998). Two isoforms of Met containing small deletions generated by 
alternative splicing have been described. One lacks 18 amino acids in the extracellular 
domain (Rodrigues et ah, 1991) and the other lacks 47 amino acids in the 
intracytoplasmic juxtamembrane domain (Lee et al., 1995). Two additional isoforms 
of met have been identified, pl40 ^^t and pl30 (Pmt et ah, 1991). pl40 i^^t jg 
membrane bound and contains an a  chain and a carboxy-terminal truncated |3 chain of 
85KD that lacks the cytoplasmic kinase domain. The second isoform p i30 is a 
soluble isoform that consists of an a  chain and a 75KD carboxy-terminal truncated p 
chain (P75P) that lacks the kinase domain. Both truncated isoforms are generated by 
posttranslational proteolysis and are consistently detected together with pl90 i^^t 
different cell lines with p i40 ^^ t^ being present at half the amount of p i90 (Prat et
ah, 1991). Upon binding of HGF, the pl90 receptor undergoes 
autophosphorylation on tyrosine residues of the 145-KD P subunit (Bottaro et ah, 
1991, Naldini et ah, 1991b, 1991c, Lokker et al., 1992). The Idnase activity of pl90 
^Gt is modulated by phosphorylation of regulatory sites. Negative modulation is 
mediated by phosphorylation of a serine residue (ser 985) located within the
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juxtamembrane domain of the p chain. This residue is phosphorylated following 
activation of protein Idnase C or a serine kinase sensitive to intracellular Ca^+ levels 
(Gandino et al., 1990; 1991, 1994). Positive regulation of pl90 ^ ^ t mediated by 
ligand induced autophoshorylation of Tyr 489 (Naldini et al 1991c; Kamikuza et al., 
1996).
The major autophosphorylation site has been identified as Tyr 1235 (Fen^acini 
et al., 1991) and is located within the tyrosine kinase domain in a region homologous 
to major autophosphorylation sites in other receptor and non-receptor kinases (Hanks 
et al., 1988). In the pl90 kinase, Tyr 1235 jg m close proximity to two other 
tyrosine residues, Tyr 1230 and Tyr 1234 This 3 tyrosine motif is highly conserved 
amongst tyrosine Idnase receptors for IGF-1 (Insulin Growth Factor-1 ) and NGF and 
in the products of the c-ros and sevenless genes (Hanks et al., 1988). The substitution 
of both Tyr 1234 and Tyrl235 by another amino acid using site directed mutagenesis 
produces a molecule which is unable to be activated by autophosphorylation (Longati et 
al., 1994; Ponzetto et al., 1994; Zhu et al., 1994; Fixman et al., 1995). In contrast, 
replacement of Tyr 1230 does not decrease the receptor's ability to autophosphorylate, 
showing that following ligand binding both Tyr 1234 and Tyr 1235 but not Tyr 1230 
are essential for activation of the p l9 0 l^Gt kinase (Longati et al., 1994). Experiments 
using cDNA expression vectors encoding hybrid tyrosine kinase receptors containing 
the extracellular domain of a tyrosine kinase receptor and the membrane spanning and 
cytoplasmic domain of c-met, have shown that HGF induced activation of p i90 ^aet ig 
sufficient to mediate HGF induced biological responses (Komada et al., 1993; 
Giordano et al., 1993; Weidner et al., 1993). Following autophosphorylation, the 
subsequent phosphoiylation of tyrosine residues in the non-catalytic carboxy-terminal 
region of pl90l'^®l produces multifunctional high affinity docking sites for effector 
proteins containing Src homology 2 domains (SH2 domains) (Graziani et al., 1991; 
Bardeili et al., 1992; Ponzetto, 1994). The majority of SH2 binding is mediated via a
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single inultifunciional docking site consisting of two phosphotyrosine residues 
(Y1349vhVNATY1356vnv). Mutations of Tyr 1349 and Tyrl356 abrogates all in 
vitro and in vivo Met kinase activity (Ponzetto et al., 1994; Maina et al., 1996), 
including the recruitment of several signal transducers and adaptor molecules, such as 
Grb2, Gabl, SHC, phosphatidylinositol 3-kinase (PI3-kinase) and phospholipase-Cy 
(PLC-T) (Ponzetto et al., 1994; Bardeili et al., 1992). Following docking to activated 
met receptors, SH2 domain containing proteins in turn activate a number of signalling 
pathways including the Ras/Map kinase and JNK/SAP kinase pathways via Grb2 and 
Gabl. In addition met activates phospholipid pathways through PLC-y, 
phosphotyrosine-mediated pathways through interaction with src tyrosine kinase, the 
PI3-kinase pathways, SHP2 tyrosine phosphatase, Nek and the ST AT pathways 
(Ponzetto et al., 1994; Kochhar et al., 1996; Welder et al., 1996; Nguyen et al., 1997; 
Rodrigues et al., 1997; Boccaccio et al., 1998).
Expression studies have shown that c-Met mRNA is widely expressed in a 
variety of mammalian tissues containing an epithelial component including: liver, 
stomach, gut, thyroid, kidney, lung, uterus, ovaries, testicular tissue, skin, prostate, 
intestinal tissue (Naldini et al., 1991a; Tashiro et al., 1990; Zarnegar et al., 1990; 
Sonnerberg et al., 1993; Di Renzo et al., 1993; Krasnoselsky et al., 1994; Honda et 
al., 1995; Ahdennacher et al., 1996; Depuydt et al., 1996 ). c-met expression has also 
been observed in various structures of the embryonic and postnatal nervous system 
including the brain, spinal cord, motor neurons and microglial cells (Sonnernberg et 
al., 1993; Jung et al., 1994; Andermarcher et al., 1996; Yamada et al., 1994; Honda et 
al., 1995). Examination of the subcellular localization of c-met in various epithelial 
tissues has shown that it is predominantly located at the basolateral plasma membrane 
of polarized epithelial cells (Crepaldi et al,, 1994a).
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1.5.3 Neurosrophic Cytokines
Ciliary neurotrophic factor (CNTF), Leukaemia inhibiting factor (LIF), 
cardiotrophin-1 (CT-1), oncostatin-M (OSM) and interleukin-6 (IL-6), are all members 
of a family of proteins, termed cytokines, which have been shown to have multiple 
actions on cells of the nervous system (Sendtner et al., 1994; Stahl & Yancopoulos, 
1994; Pennica et al., 1995a; Horton et al., 1998). Although the different members of 
the family show limited sequence homology (15% at the a.a. level) they do share 
several structural chaiacteristics (Bazan et al., 1991; Robinson et al., 1994; McDonald 
et al., 1995) and signal via oligomeric receptor complexes that have one or more 
common components (Stahl & Yancopoulos, 1994; Wollert et al., 1996).
Ciliary Neurotrophic Factor
CNTF was initially identified and purified from chicken eye tissue as a result of 
its ability to promote the survival of embryonic parasympathetic neurons from chicken 
ciliary ganglia (Alder et al., 1979; Barbin et al., 1984). CNTF was subsequently 
purified from adult rat sciatic nerve (Manthorpe et al., 1986). Based on amino acid 
sequence analysis the cDNAs for rabbit and rat CNTF have been cloned. More recently 
the mouse and human CNTF cDNAs have been identified and analyzed. In mouse the 
CNTF gene is located on chiomosome 19 (Kaupmann et al., 1991) and in humans on 
chromosome 11 (Lam et al., 1991). Mature CNTF is a 200 amino acid acidic protein 
with a molecular weight of 20-24 KD (Lin et al., 1989; Stockli et al., 1989). Within 
the CNS and PNS, CNTF has been shown to support the survival of several neuronal 
populations in vitro. In the PNS, CNTF supports the survival of parasympathetic 
neurons within the embryonic chick ciliary ganglion, sympathetic neurons of the 
lumbar sympathetic ganglia and sensory neurons of the nodose, trigeminal and dorsal 
root ganglia (Barbin et al., 1984; Manthorpe & Varon, 1985; Arakawa et al 1990; 
Oppenheim et a l ., 1991; Martinou et al., 1992; Vejsada et al., 1995; Burnham et al..
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1994; Horton et al., 1998), Overexprcssion of CNTF in vivo has been shown to rescue 
chick ciliary ganglion neurons from cell death (Finn et al., 1998). Within the CNS, 
CNTF is involved in promoting the survival of adult motoneurons in vivo (Masu et 
al., 1993), and can promote the survival of hippocampal neurons (Ip et al., 1991) and 
purkinje cells in vitro (Larkfors et al., 1994). CNTF also prevents the axotomy- 
induced neuronal degeneration of a vaiiety of neurons including facial (Sendtner et al., 
1990) and spinal motor neurons (Li et al., 1994; Vejsada et al., 1995), as well as 
neurons within the thalamic nuclei and dopaminergic neurons of the substantia nigra 
(Clatterbuck et al., 1993; Hagg & Varon, 1993). CNTF mRNA cannot be detected by 
Northern blotting in tissue of newborn rats (Stockli et al., 1989) and significant 
amounts of CNTF mRNA are not expressed until the fourth week postnatally (Dobrea 
et al., 1992). In adult rats, CNTF mRNA is expressed at high levels in a variety of 
neuronal tissues including the optic nerve, sciatic nerve (Williams et al., 1984) 
olfactoiy bulb (Stockli et al., 1989) and spinal cord (Ip et al., 1993a). Low, but still 
significant amounts of CNTF mRNA are expressed within the brain stem, cerebellum, 
hippocampus and the midbrain (Stockli et al., 1991; Ip et al 1993a). Studies have 
shown that CNTF mRNA expression is significantly up-regulated following lesions of 
the hippocampus and cortex, with the maximum level reached after 3 days, and is 
sustained for up to 20 days. This suggests that CNTF may have a role in réponse to 
trauma (Ip et al., 1993b). Mice homozygous for a CNTF null mutation are viable at 
birth and initially thrive. Later in adult life CNTF null mice exhibit a mild progressive 
loss of motor neurons, resulting in minor muscle weakness (Masu et al 1993).
LIF, CT-1, OSM & IL-6
Other cytokines including LIF, CT-1, OSM and IL-6 have all been shown to 
promote the survival of various populations of CNS and PNS neurons. LIF has been 
shown to promote the survival of motoneurons, sympathetic neurons and certain
44
sensory neurons in vitro (Martinou et ai., 1992; Murphy et al., 1993a; Kotzbauer et al 
1994; Thaler et al., 1994; Horton et al,, 1998). LIF also plays a role in promoting the 
survival of fetal motoneurons in vivo (Li et al., 1995; Sendtner et al., 1996). In vitro 
and in vivo studies have shown that LIF plays a role in determining cholinergic 
phenotype, particularly in sympathetic neurons (Ure et al., 1992; Bamber et al., 1994). 
LIF has been shown to promote the differentiation of oligodendrocyte-type-2- 
astrocytes (0-2A) progenitors derived from the optic nerve into both oligodendrocytes 
and astrocytes (Mayer et al., 1994). CT-1 promotes the survival of cultured ciliary 
ganglion neurons (Pennica et al., 1995b), midbrain dopaminergic neurons and motor 
neurons (Pennica et al., 1995b, 1996) and embryonic and postnatal sensory neurons 
(Horton et al., 1998, Hall et al., 1999). IL-6 enhances the in vitro survival of a 
proportion of forebrain cholinergic and midbrain catecholaminergic neurons and 
embryonic sensory neurons (Hama et al., 1989; Kushima et al., 1992; Horton et al., 
1998), whilst OSM promotes the survival of a subset of late fetal DRG neurons in 
culture, as well as embryonic sensory neurons of the trigeminal and nodose ganglia 
(Ware et al., 1995, Horton et al., 1998).
1.5.4 Cytokine Receptors
The neurotrophic cytokines signal via a multicomponent receptor signalling 
system (Fig 1.2). All cytokine receptors consist of dimers of their signal transducing p 
components, consisting of either gpl30 homodimers or gpl30/LIFRP heterodimers. 
Only receptors for CNTF and 11-6 have an additional a  component. Specific receptor 
subunits determine the specificity for each cytokine. CNTFRa and the LIFRp / gpl30 
heterodimer are specific receptors for CNTF, LIFRp / gpl30 heterdimers are specific 
for LIF (Ip et al 1992,) IL-6Ra and the gpl30 / gpl30 homodimer aie specific for EL- 
6 (Bruce et al., 1992), whilst in the case of OSM an additional OSM specific 
component may replace LIFRp (Davis & Yancopoulo, 1993; Stahl & Yancopoulo,
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1994). The CNTF a  receptor lacks transmeinbrane and cytoplasmic domains, and is 
anchored to the cell surface via a glycosyl phosphatidylinositol (GPI) linkage (Bazan et 
al., 1991; Davies et al., 1991; Ip et ah, 1992b; Stahl & Yancopoulos, 1994). CNTFa 
shows a high degree of sequence homology with IL-6Ra. IL-6Ra is not able to 
initiate signalling, but after binding to IL-6 it can bind to gpl30, to initiate signalling 
(Taga et ah, 1989; Hibi et ah, 1990; Kishimoto et ah, 1992).
CT-1 OSM
i J  1
LIF
0
CNTF m-6
if] i.D IJ
gpl30 LIFRP gpl30 gpl30 LIFRP gpl30 LIFRp gpI30 gpl30
Adapted from Stahl and Yancopoulos, 1994
Figure 1.2 Schematic diagram showing the interaction of neurotrophic cytokines their 
receptors.
The first step in the formation of the CNTF receptor involves the binding of the CNTF 
ligand to its CNTFRa component, followed by recruitment of the p components to 
form the complete receptor complex. The p components do not bind to CNTF in the 
absence of CNTFRa (Ip et ah, 1992b; Davis et ah, 1993). In CNTF-responsive cells, 
the binding of CNTF to it receptor induces tyrosine phosphorylation of gpl30 and 
LIFRp initiating subsequent signalling activation (Stahl & Yancopoulos, 1993,1994). 
The specific receptor subunits utilized by each cytokine explains the cell-type specificity 
of the cytokines whilst explaining why certain cytokines appear to have identical
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actions on some targets. In particular, the neural specificity of CNTF is due to tiie 
restricted expression of the CNTFRa and LIFRp subunits. In contrast, the variety of 
actions of LIF are due to the widespread distribution gpl30 and LIFRP, Following 
ligand binding, cytokine signalling is mediated via the activation of Janus kinases Jak 
1, Jak 2 and transcription factors of the ST AT family, in particular* ST ATI and STAT3, 
and the tyrosine phosphatase SHP2 [SH2 (src homology 2) domain-containing 
tyrosine phosphatase] (Stahl & Yancopoulos, 1994).
1.5.5 The TGFp Family of Neurotrophic Factors and Their Receptors,
The transforming growth factor P (TGFp) family of proteins consist of a 
number of structurally related growth factors that regulate cell growth, differentiation, 
motility and cell death during development (Massague, 1994). Recent studies have 
identified a subfamily of the TGFp family consisting of four members and termed the 
GDNF family, which have been shown to act as potent survival factors for cultured 
PNS and CNS neurons. The GDNF family consists of glial cell line-derived 
neurotrophic factor (GDNF) (Linet al., 1993), neurturin (NTN) (Kotzbauer et al.,
1996), persephin (PSP) (Milbrandt et al., 1998), and artemin (ARTN) (Baloh et al., 
1998b).
GDNF and Neurturin both support the in vitro survival of rat sympathetic 
(Kotzbauer et al., 1996), midbrain dopaminergic (Lin et al., 1993; Horger et al., 
1998), dorsal root ganglion (DRG) (Buj-Bello et al., 1995; Molliver et al., 1997), 
nodose ganglion (Kotzbauer et al., 1996) and enteric neurons (Hearn et al., 1998; 
Heuckeroth et al., 1998). Neurturin also plays a role in the development and 
maintenance of the enteric neiwous system in vivo (Heuckeroth et al., 1999). Artemin 
supports sensory, sympathetic and dopaminergic midbrain neurons in culture (Baloh et 
al., 1998b). Persephin promotes the survival of motoneurons but does not support 
PNS neurons (Heuckeroth et al., 1998; Milbrandt et al., 1998). Biochemical
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studies iiave shown that GDNF ligands mediate their activities through a family of 
multicomponent receptors that are composed of the transmembrane tyrosine kinase Ret 
and one of four glycosyl-phosphatidyl inositol- (GPI-) linked proteins termed 
GFRal-GFRa4 (Jing et ah, 1996; Treanor et ah, 1996; Baloh et al., 1997; 1998a; 
Buj-Bello et al., 1997; Klein et al., 1997; Widenfalk et al,, 1997; Naveilhan et al., 
1998; Nomoto et al., 1998; Thompson et al., 1998; Trupp et al., 1998; Worby et al., 
1998). In vitro studies have shown that GFRal is the prefened coreceptor for GDNF 
(Baloh et al., 1997; Buj-Bello et al., 1997; Jing et al., 1997; Klein et al., 1997; 
Sanicola et al., 1997). GFRa2 is the preferred coreceptor for NTN, GFRa3 is the 
preferred coreceptor for artemin (Baloh et al., 1998a) and GFRa4 is the preferred 
coreceptor for PSP (Enokido et al., 1998). Certain members of the GDNF ligand 
family are able to use alternate GFRa-Ret complexes at higher ligand concentrations. 
For example, NTN and aitemin can activate Ret via GFRal in vitro, whereas GDNF 
can activate Ret via GFRa2.
1.5.6 Objectives Of This Study
I) To examine the in vitro effect of HGF/met signaling on neurite outgrowth and 
suiwival in embryonic sensory neurons of the mouse dorsal root ganglia during 
development.
U) To examine the in vivo and in vitro effect of HGF/Met signalling on several 
different developmental processess in neural-crest derived sympathetic neurons at 
different stages during embryonic development.
HI) To examine the in vitro effect of HGF/met signaling on neurite outgrowth and 
survival in chicken embryonic parasympathetic and proprioceptive neurons during 
development.
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IV) To examine the infleunce of the anti-apoptotic cytoplasmic protein Bci-2 on 
regulating &>nai growth rates in embryonic sensory neurons from the trigeminal ganglia 
using Bcl-2- deficient mice.
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Chapter 2 
Material and Methods
2,1 Preparation of the culture substratum
Neurons were grown on a laminin/polyomithine, substratum. For most 
purposes, 35mm or 60mm diameter Nunc (Gibco) plastic tissue culture petii dishes 
were used. 1ml of 0.5mg/ml polyomithine (P-8638, Sigma) in a 0.15M borate 
buffer (pH 8.6) was placed in to each dish and left to stand overnight at room 
temperature. The poly-DL-omithine solution was filter sterilized using a 0.2pm 
filter and stored in glass bottles at 4^0 for up to two weeks. The poly ornithine 
solution was aspirated the following morning and the dishes were washed three 
times with sterile distilled water. The dishes were then left to air dry in a laminar 
flow hood for 20 minutes. 150 pi of a 20 pg/ml solution of laminin in F14 medium 
was placed in the centre of the each dish and using the pipette tip the laminin was 
spread over two thirds of the dish surface. The dishes were then placed in a 4% 
CO2  incubator for at least 4 hours. Laminin (Gibco ) is available as a sterile solution 
which is thawed at 4°C, aliquoted in to sterile Eppendorf tubes and stored at -70°C 
until required. The required number of aliquots were thawed at 4°C and the 
laminin was diluted in F14 immediately before use. Once the laminined dishes 
were removed from the incubator they were washed twice with F 12+ 10% HIHS 
medium. The surfaces of the dishes were not allowed to dry between washes and 
1ml of F14+Sato additives for mouse cultures and 1ml of F14+10% HIHS medium 
for chicken cultures, was placed in each dish after washing.
2.2 Preparation of culture medium
Powdered F14 (a special formulation from Imperial labs) was made up with 
highly purified water that was sequentially passed through a charcoal filter, reverse 
osmosis system and a MiUi-Q system before being double distilled. The F14 
medium was made up from a frozen xlO concentrate (stored in 50ml aliquots kept
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at -40®C ). The xl F14 was made up by adding ig of sodium bicarbonate and a 
50ml aliquot of xlO F14 to 450ml of water. CO2 was bubbled through this medium 
until the pH reached pH7. The medium was then filter sterilised through a 0.2 pm 
filter, and stored at 4°C. For embryonic mouse neurons the following supplements; 
collectively termed Sato additives were added to the F14 medium: 2 mM glutamine,
0 .35 . bovine serum albumin (Pathocyte-4, ICN), 60 ng/ml progesterone, 16 
pg/ml putrescine, 400 ng/ml L-thyroxine, 38 ng/ml sodium selenite and 340 ng/ml 
tri-iodo-thyronine. The use of the Sato supplement was employed as it was not 
conducive for the growth of non-neuronal cells.
2,3 Dissection techniques
Instruments and Equipment
1. All dissections and preparations of neuronal cultures were caixied out in a 
in a laminar flow hood using standard aseptic techniques.
2. Dissections involved using straight and curved fine watch makers forceps and 
tungsten needles.
3. Tungsten needles were made by immersing 3-5cm of bent 0.5mm diameter 
tungsten wife in 5M KOH with a 3-12 V-AC current passing through the wire and 
an electiode immersed in the solution to produce a fine needle.
4. All dissections were canied out in 65 mm petri dishes containing L15 medium 
that had previously been warmed to 37°C.
5. For the final steps of dissection, a good quality stereomicroscope with zoom lens 
capability was used. Illumination was provided by a fibre optic light source.
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2.4 Dissection of Mouse GansHa
Dissection of embryonic mouse sensory and sympathetic ganglia
Embryos were removed from pregnant females under sterile conditions. The 
pregnant females were killed at the requked stage of gestation by cervical 
dislocation and 70% alcohol was then sprayed onto the abdomen of the pregnant 
females to sterilize the area. A small incision was made in the skin of the abdomen 
and the skin was then pulled away from the incision, teaiing it and exposing the 
abdominal muscles beneath. Holding the anterior abdominal muscle with a pair of 
toothed forceps a small incision was made with a pak* of fine scissors, taking care 
not to cut into the intestines. Once air had entered the peritoneal cavity through this 
hole, the incision could easily be extended exposing the embryonic mice. The 
uterine horns were removed from the pelvic cavity using a pair of fine scissors. The 
uterine wall, chorion and amnion were then removed from the embryos using 
watchmaker's forceps.
Dissection of E l l  and E12 trigeminal ganglia
Using tungsten needles, two coronal incisions through the head were made, 
one just above each eye, the other between the maxillary and mandibular processes 
of the first branchial arch. The trigeminal ganglia could be seen as two opaque 
structures in the tissue slice obtained and could be easily removed from the tissue 
slice and freed of any adherent mesenchymal tissue using tungsten needles. To free 
the ganglion of this tissue, one needle was used to steady the ganglion and the other 
to pinch off the adherent tissue against the bottom of the Petri dish. The dissected 
ganglia were then transfered to a 35 mm Petri dish containing pre-heated L15 
medium using a siliconised Pasteur pipette.
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F igure 2.1; Drawing showing the medial aspect o f the head of an E l l  mouse embryo. The 
location of the trigeminal (V) and nodose (X) ganglia are marked. Scale bar = 1mm. (From Davies 
and Lumsden, 1987).
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F igure 2.2: Drawings showing the dissection of the trigeminal ganglia from an E l l  mouse
embryo. A , lateral aspect o f the E l l  head showing the location of the transverse incision 
(interrupted lines) for obtaining a slice of tissue that contains both trigeminal ganglia. B, rostral 
aspect of this slice showing the location of the trigeminal ganglia. Trigeminal ganglion (TG), 
maxillary process (Mx), mandibular process (Mn), fourth ventricle (IV). (Adapted from Davies and 
Lumsden, 1984 ).
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Dissection of mouse superior cervical sympathetic ganglia
In mouse embryos, the (SCG) are situated close to the base of the skull in 
close proximity to the nodose ganglia. The top of the skull and underlying forebrain 
were removed from the embiyo using the same plane of section described for the 
first incision of the trigeminal dissection. The embryos were decapitated and tlie 
head was cut in half along the saggital plane. Using tungsten needles, the hindbrain 
was removed from each bissected head. The cleft-like jugular foramen was then 
opened to the midline by inserting one tungsten needle into the jugular foramen so 
that it lay beneath the base of the skull, medial to the foramen, and bringing a 
second needle into apposition with the first, so as to cut through the intervening 
tissues. Once the jugular foramen was opened, the SCG and the nodose ganglion 
were deary visible lying at the base of the foramen. The nodose ganglion is 
spherical in structure with a prominent vagus nerve attached to its distal aspect. This 
ganglion is clearly distinguised from the SCG which is an elongated structure that is 
attached caudaUy to the sympathetic chain (which is much thinner than the vagus 
nerve) and is situated anterior to the internal carotid artery.
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F igure 2.3; Drawings of the medial aspect of the left half of an E14 mouse embryo head 
showing successive stages in the dissection of the SCG. The bissected midline structures lying 
along and in front of the cranial base are stippled. A. The incision passing from the jugular 
foramen (J) to the midline is shown by the interrupted line. The direction in which the occipital 
bone (O) should be reflected to open up the jugular foramen after making the previous incision is 
shown by the large curved arrow. T, tongue; ACF, anterior cranial fossa; R, root o f the 
trigeminal nerve; IE, inner ear. B. The nodose ganglion (N) and superior cervical sympathetic 
ganglion (S) are revealed after extending the jugular foramen to the midline and reflecting the large 
ossified part of the occipital bone backwards. (Scale bar = 1mm).
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D issection of paravertebral sympathetic chain ganglia
These ganglia are located either side of the midline of the thorax and 
abdomen lying lateral to the vertebral column and ventral to the dorsal root ganglia. 
A pair of curved watchmalcer's forceps was used to remove the thoracic and 
abdominal viscera, exposing the verebral column and dorsal root ganglia. The 
posterior thoracic and abdominal walls were gently washed with LI5 from a 
Pasteur pipette. Using a pair of watchmalcers forceps, the ganglia were gently 
peeled away from the vertebral column and separated from non-neuronal connective 
tissue. Care was talcen to ensure the ganglia were kept intact. The ganglia were then 
removed using a siliconised Pasteur pipette and pooled in a fresh 35mm Petri dish 
containing pre-heated L15 medium.
Dissection of Dorsal Root Ganglia
The DRG are situated in two parallel rows on either side of the vertebral 
column. The head, tail and limbs were removed leaving the thoracic and abdominal 
region. The vential and lateral parts of the thoracic and abdominal walls were 
removed, leaving the dorsal surface of the embryo which contained the visibly 
distinguishable DRG on either side of the spinal cord. The DRG were then 
removed, and cleaned with tungsten needles removing all non-neuronal connective 
tissue.
2.4.1 Dissection of Chicken Ganglia
Dissection of chicken trigeminal mesencephalic nucleus (TMN)
White Leghorn chicken eggs were incubated at 38°C in a forced-draft 
incubator until the desired age. After removing the chicken embryos from the eggs, 
the brains were collected in pre-heated L15 medium (40 to 60 in most preparations). 
The brains were then transfered to a fresh plastic petd dish containing LI5, and the 
dissection was completed with tungsten needles as shown in Figure 2.4. The TMN
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is located close to the posterioi commissure overlying the cerebral aqueduct within 
the midbrain of developing chicken brains. The TMN was isolated by two coronal 
incisions in the tectal vesicle of the midbrain followed by removal of the ventral pia 
mater.
F igure 2.4: Successive stages in the dissection of the median part o f the TMN from an E12
chick embryo. A, Dorsal aspect of the brain showing the location of the two coronal incissions 
(interrupted lines) for isolating the midbrain. B, Caudal aspect o f the isolated midbrain showing 
the location of the two parasagittal incissions for removing the roof of the cerebral aqueduct after 
carefully stripping off the overlying pia mater. C, Dorsal aspect of the cerebral aqueduct showing 
the location of the incisions for cutting out the median part of the TMN. D, Subdissection of the 
median part of the TMN. Abbreviations; tectal vesicle (TV), tectal commissure (TC), posterior 
commissure (PC), cerebral aqueduct (CA) rostral (R), middle (M), caudal (C). (Adapted from 
Davies, 1986)
Dissection of chick ciliary ganglia
The parasympathetic neurons of the ciliary ganglia are located on the medial 
side of optic nerve on the posterior surface of the eye-ball. Chicken embryos were 
decapitated close to the base of the skull. Using curved forceps, the eye-ball was 
gently removed from the eye socket by scoring around the edge of the socket, (care 
was taken not to damage the eye or the underlying tissue within the socket). The 
ciliary ganglia were removed from the eyeball using fine watchmakers forceps. 
Using tungsten needles, non-neuronal connective tissue was removed from the
5 7
ciliar)/ ganglia, which were then transfered using a siliconised pasteur pip^ cite and 
pooled in to a 35mm Petri dish containing L15 medium.
2.5 Tissue dissociation techniques
Dissected neural tissue was incubated with trypsin, washed and triturated to 
give a single ceU suspension. The procedure was similar for all embryonic mouse 
and chicken tissue, but the strength of the trypsin and incubation times were 
adjusted for the particular tissue. Using a Pasteur pipette, the dissected ganglia 
were transferred to a 10 ml conical tube containing 1 ml of calcium/magnesium- 
free Hanks Balanced Salt Solution (CMF-HBSS). The ganglia were washed, by 
agitation and the CMF-HBSS was then removed. For early mouse ganglia, 0.95 
ml of fresh CMF-HBSS and 0.05 ml of 1% trypsin (Worthington) were added. 
The lower end of the tube was then immersed in a water bath at 37°C for between 
5 and 10 minutes depending on the ganglia being dissociated. These times were 
adjusted for different batches of trypsin. The optimum time was discovered to be a 
compromise between neuronal damage due to over-trypsinization and neuronal 
damage due to the vigorous trituration required to dissociate under-trypsinized 
tissue. If the tissue started to disaggregate before trituration, the time was too long. 
If the tissue' dissociated with difficulty and incompletely with trituration, then the 
time was not long enough. After trypsinization, most of the trypsin solution was 
removed and the embryonic tissue was washed with 2 x 10 ml of Hams F12 or 
FI4 medium containing 10% heat-activated horse semm to remove and inactivate 
the residual trypsin. Removal of the medium was facilitated by pelleting the tissue 
between washings in a benchtop centrifuge, at 2000 x g, for 1 to 2 min. After 
washing, the tissue was dissociated into a single-cell suspension by trituration. 
Trituration was caiTied out using a siliconized Pasteur pipette, the tip of which had 
previously been flame polished using a bunsen burner flame to form a fine bore. 
The tissue was triturated in 1.5 ml of culture medium or CMF-HBSS. Trituration 
was perfoimed by taking the tissue and medium up into the polished Pasteur
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pippette, holding the pipette against the bottom of the tube and slowly expelling the 
contents with firm pressure. If done correctly, the eaily ganglionic tissue was 
completely dissociated after three to five passages. When using older tissue, some 
connective tissue fragments were left after all of the neurons had dissociated. 
These larger tissue fragments were allowed to settle after the first two or tiiree 
passages. The trituration was monitored using an inverted phase contrast 
microscope, by examining a drop of the dissociated cell suspension on a glass 
slide. One characteristic of over-trituration is the loss of neuronal processes; 
neurons that have been triturated carefully should have long processes attached to 
their cell bodies.
2.5.1 Separation of neurons from non-neuronal cells
A variety of different non-neuronal cells synthesize and release neurotrophic 
factors in culture. It is therefore desirable to remove these cells prior to culture 
when studying the effects of neurotrophic factors on any population of neurons. If 
non-neuronal cells are not removed, the percentage neuronal survival in control 
cultures may be unacceptably high. Furthermore, if non-neui'onal cells are present, 
it cannot be concluded whether the effect of a factor or reagent on neuronal survival 
is due to a direct action of the factor on the neurons, or whether it is mediated via 
the non-neuronal cells. Neuronal and non-neuronal cells were seperated using a 
technique called differential sedimentation. This technique was only used in 
experiments using chicken neurons, as chicken neurons are significantly larger than 
chicken non-neuronal cells. Early mouse neurons are similar in size to mouse non­
neuronal cells and cannot be separated by this technique. In the case of mouse 
cultures, the use of the defined Sato medium, which does not support the suiwival 
of non-neuronal cells, reduced the number of non-neuronal cells.
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2,5.2 Differential sedimentation of embxyonic chicken neurons
This technique depends on differences in sedimentation rates of cells in a 
liquid medium. Generally, the larger the cell, the faster its rate of sedimentation, 
therefore neurons sediment more quickly than non-neuronal cells because of their 
greater size. Several variations of the method described by Miller and Phillips 
(1969) have been applied to embryonic neui'al tissue (Lam, 1972; Barkley, et al., 
1973; Cohen, et al., 1973; Cohen et al; 1978; Berg & Fischbach, 1978). This 
method is applicable to all populations of neurons in the peripheral nervous system 
and is very efficient (at least 60% of the neurons in the starting tissue aie recovered 
uncontaminated by other cells). Furthermore, since the cells sediment through 
culture medium, neuronal viability is very high.
Sedimentation was carried out in a 100 ml cylindrical, siliconised glass 
dropping funnel with a ground glass outlet tap (Figure 2.5). Funnels were sterilised 
before use by autoclaving. Each funnel was filled to a height of 8 to 10 cm with 
F14 medium plus 10% heat-inactivated horse serum (thoroughly mixed and filtered 
through a 0.2 pm millipore filter beforehand). Funnels were clamped vertically in a 
stand and placed on a vibration-free surface, at a temperatuie of 2°C, and left 
overnight with foil coverings. The dissociated cell suspension was usually made up 
to a volume bf about 2 ml in HBSS. The cell suspension was carefully layered on 
the medium, by running it down the inside wall of the funnel, and the foil on top of 
the dropping funnel was then replaced. After an hour, the foil was removed from 
the spout and 4 to 5 ml aliquots were run off into sterile tubes. 0.5 ml samples of 
each fraction were taken and placed in a 24 multi-well plate (with 16 mm diameter 
wells). These were examined with a phase contrast microscope to determine which 
fractions contained only neurons. Mid-embryonic and older neurons were clearly 
distinguished from other cells by their characteristic rounded phase bright cell 
bodies and elongated processes. All of the neuronal fractions were pooled and were 
plated in Nunc tissue culture dishes, as described below.
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Figure 2.5: Drawing of a dropping funnel showing a cell suspension (heavy stipple) layered on 
culture medium (light stipple). (Scale bar= 2 cm).
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2.5.3 Seeding the neurons
For cohort studies the most reliable results were obtained when the neurons 
were plated at a density of between 20 and 40 per dish. The suspension of neurons 
was placed in a suitable volume of medium in a large screw-top tube (eg 50 ml 
centrifuge tube) and the neurons were evenly distributed in the medium by gently 
rocking the tube end-over-end several times. The neuronal suspension was 
dispensed to each dish using a 1ml pipette, in two lots of 0.5 ml (to ensure even 
distribution). It was important to avoid touching the medium in the dishes with the 
pipette tip, otherwise small quantities of neurotrophic factor could be transferred to 
other dishes. Dishes were returned to a humidified CO2 incubator at 37°C (5% 
CO2  was used for F14 medium). Because of the very low neuron density required, 
the most reliable method of estimating the correct neuron density at the time of 
plating neurons was observation by eye. A 1ml aliquot of the cell suspension was 
placed in a test culture dish and, the resulting neuronal suspension was examined 
with a phase contrast microscope.
2.5.4 Quantification of neuronal survival
For this, a standard graticule for examining the same area of each culture dish was 
used. Thesd were made from the base of a 90 mm plastic petri dish. A scalpel blade 
was used to inscribe a 6x6 grid of 2 mm^ squares in the center of the dish. This 
graticule was mounted on the stage of an inverted phase contrast microscope with 
the inscribed surface uppermost. To determine the number of neurons seeded per 
dish, several dishes were examined after 6 hours in culture. Each dish was centred 
over the graticule, and the number of neurons within the inscribed area was 
counted. For the initial survival count, all phase bright attached cells were counted. 
A small percentage of neurons (usually less than 10%) are damaged during 
dissociation, and do not attach to the substratum, these neurons were ignored and 
only those that had attached were counted. The number of surviving neurons in all 
dishes was counted after a further 24 or 48 hrs in culture. The survival responses
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of neurons to a particular neurotrophic factor aie expressed as percentage survival; 
the number of surviving neurons expressed as a percentage of the initial number of 
neurons in the 12x12 mm grid.
2.5.5 Cohort Studies
In some experiments the survival of individual neurons, as opposed to the 
neuronal population as a whole, was determined. This was done by following the 
fate of individual neurons within an initial cohort of neurons over a set period of 
time, identified after 6 hours of plating. The position of individual identified 
neurons was marked by reference to 144 mm  ^grid. In some experiments, neurons 
that differentiated in culture from progenitors were also identified at set time points 
and their fate followed during further periods in culture. The fates of all the neurons 
in each cohort is expressed as a percentage of the size of the initial cohort 
identified at 6 hrs. To avoid any effects of neurotrophins on the size of the initial 
cohort, neurotrophins were added after the identification of the cohort at 6 hours.
2.5.6 Axonal Growth rate
To examine axonal growth rates, accurate, serial, camera lucida drawings of 
the same individual neurons over a set period were made with the aid of a drawing 
tube. Neurons were cultured in 60mm  ^ diameter poly ornithine /laminin coated 
dishes, with a 6x6ram square grid scored on the undersurface. Neurons were plated 
at a density of 20-40 neurons per dish. To exclude any differences in axonal growth 
rate that could arise as a consequence of differences in neuronal viability, only 
neurons that survived throughout the culture period were include in the analyses. 
Between 20-40 neurons were drawn and analysed in each cohort. The total axon 
length was determined by tracing the drawings onto a digitising pad linked to a 
computer containing an NIH Image program
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2.6 Genotypiïig
Genotyping of Bcl-2 and met D/D knockout mice was done using a 
polymerase chain reaction (PCR). The PCR technique is a method for the 
enzymatic amplification of specific DNA sequences. The PCR method employed 
for genotyping used thiee synthetic oligonucleotide primers to amplify the wildtype 
and mutant alleles. One primer was common to both alleles, one was unique to the 
wild-type allele and one primer was unique to the mutant allele. The PCR cycle 
consists of three steps: Strand sepai'ation, primer hybridization and extension of 
primers by DNA synthesis, all of which are driven by changes in temperature. All 
primers were ordered from Gibco.
To determine the genotype of mice used in transgenic experiments a sample 
of tail or embryonic tissue was collected and digested over night in 500|i.l of 
Proteinase K solution at 55°C. The next day, 210jil of SMNaCl was added, and 
following thorough mixing, the sample was spun for lOmin at 13000g to pellet 
debri and precipitated protein. Next, 400pl of the supernatant, which contained the 
DNA, was added to 400|xl of cold 100% ethanol, which resulted in the production 
of a cloudy DNA precipitate. The DNA was pelleted for 5 minutes at 13000g and 
the ethanol was aspirated with a 1ml micropipette. The DNA pellet was washed 
with 70% "ethanol, before being allowed to air dry. The dried pellet was 
resuspended in 400-100|li1 of distilled water.
(i). Bd-2 Mice
For genotyping Bcl-2, a separate 0.5ml microfuge tube for each DNA sample 
contained a 20.0 jrl reaction volume, made up as follows:
1.2 pi 25mMMgCl2
2 p i  10 X Taq buffer (Buffer B, Promega)
Ipl 5mM dNTPs (Phaimacia)
0.2 pi Primer cDNA3 (20pM)
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0.1 pi Primer pGKNM (20pM)
0.216 pi Primer cDNA5 (20pM)
0.5 pi Taq-thermostable DNA polymerase (Promega)
1 pi template DNA
14pl dd H2O
Following addition of the genomic DNA to the PCR reagents, the two solutions 
were mixed and overlaid with 40pl of mineral oil in order to prevent evaporation of 
the reactants within the tube. The solutions were then transfered to the heating block 
of a PCR machine where they were subjected to a sequence of 33 repeat cycles of 
denaturing annealing and elongation. Each PCR reaction was repeated twice to 
ensure accurate genotypes were obtained.
Bcl-2 PCR Program
Step 1: 94°C-5minute 
Step 2: 94°C-1 minute 
Step 3: 64°C-1 minute 
Step 4: 72°C-1 minute 30 seconds 
Step 5: 72°C-10minutes 
4°C soak
Steps 1 and 2; Strand separation. Step 3; Annealing. Steps 4 and 5; DNA 
synthesis. The cycle was repeated 33 times.
The primer sequences were as follows:
pGKNM 5’ -GCC TAG CCG CTT CCA TTG CTC AGC 3' 
cDNA5 S' -GCC CAG ACT CAT TCA ACC AGA CAT 3' 
CDNA3 S' -CGT CCC TCT TCA TCA CCT TTC AGC 3'
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Knockout and wildtype bands were 400bp and 900bp respectively.
The PCR products were seperated by electrophoresis on 2% agarose gels.
(ii). Met Mice
For genotyping met*^  ^embryos a separate 0.5ml microfuge tube for each DNA 
sample contained the following.
1.2 pi 25mMMgC12
2 pi 1 Ox Taq buffer (Buffer B, promega)
ipl 5mM dNTPs
0.16pl Primer 610 sense
0.64pl Primer 611 antisense
0.16pl Primer 655 sense
0.5pl Taq Polymerase DNA polymerase (Promega)
13.5 pi ddHzO
Ipl template DNA
Following addition of the genomic DNA to the PCR reagents, the two solutions 
were mixed'and overlaid with 40pl of mineral oil in order to prevent evaporation of 
the reactants within the tube. The solutions were then transfered to the heating block 
of the PCR machine where they were subjected to a sequence of 33 repeat cycles of 
denaturing, annealing and elongation. Each PCR reaction was repeated twice to 
ensure accurate genotypes were obtained.
Met PCR Program
Step 1: 94°C 5minutes
Step 2: 94°C 1 minute
Step 3: 56°C 1 minute
Step 4 :12^C 1 minute 30 seconds
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Step 5: ll^C  lOminutes
4°C minutes soak
The cycle was repeated 33 times.
The primers used were:
610 sense 5' -AGGATTGATCATTGGTGCGGTC 3'
611 anti-sense 5' -CATCTCTGTAGTTGGACTTACAC 3'
655 sense 5* -CAGCTCATTCCTCCCACTC 3»
Knockout and wildtype bands were 550bp and 390bp respectively.
The PCR products were then seperated by electrophoresis on 2% agarose gels.
Separation of amplified DNA fragments was carried out using 
electrophoresis through agarose gels. This process relies on the principle that 
negatively chai'ged DNA wiU migrate from the cathode to the anode when a 
potential difference is applied across the gel. Tris-acetate (TAE) electrophoresis 
buffer was used for agarose gel electrophoresis. TAE was prepaied as a 50x stock 
solution consisting of 242grams of Tris base, 57.1 ml glacial acetic acid and 100ml 
0.5M EDTA (pHS.O) diluted in 1 litre of deionized water. 4 grams of ulti*apure 
nuclease free agarose (Gibco BRL) was added to 200ml of IxTEA and melted in a 
microwave oven. The intercalating dye, ethidium bromide was added to both the 
molten agai'ose gel at a concentration of 0.5pg/ml. Once set, the gel was placed in 
an electrophoresis tank filled with TAE buffer and the weU forming combs were 
removed. DNA samples, which were mixed with with the appropriate volume of 
6x gel-loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, and 30% 
glycerol in deionized water) were then loaded into the wells of the gel. To determine 
the molecular size of the DNA fragments, DNA size markers containing DNA 
fragments of known lengths were also loaded onto the gel for comparison. A
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voltage of 200v was applied across the gel for 30 minutes, after which DNA bands 
were viewed under U.V. light.
Solutions and Media 
HBSS
Hank's balanced salt solution without calcium and magnesium (GibcoBRL).
0.1% Trypsin
50 mg of trypsin (Worthington) was added to 5ml of Ca/Mg free PBS (GibcoBRL) 
and sterilised with an 0.22|Lim filter (Gelman Sc.).
PoIv°DL“Ornithine
0.5 mg/ml poly-DL-omithine (Sigma) in 0.15M boric acid (4.6 grams boric acid, 
BDH, in 500ml distilled water, pH 8.4) was sterilised with an O.22|0,m filter 
(Gelman Sc.).
Laminin
Natural mouse laminin (Gibco) was stored at -70°C at a concentration of 1.08 
mg/ml, in aliquotes of 20)0,1. 20 ml of concentrated laminin stock was diluted in 
1ml of Ham's F-14 medium.
L 1 5
A IL unit of L-15 powder (GibcoBRLO wa added to IL of double distilled water 
containing 100 mg streptomycin (Sigma) and 60 mg penicilhn (Sigma), pH 7.3, 
and sterilised with an 0.22jO,m filter (Gelman Sc.).
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Ham's F .12
A IL unit of F12 powder (GibcoBRL) was added to IL of double distilled water 
containing 100 mg streptomycin (Sigma) and 60 mg penicillin (Sigma), pH 7.3, 
and sterilised with an 0.22p,m filter (Gelman Sc.).
Ham's F-14
10 X concentration stock solution:
A lOL unit of F14 powder (GibcoBRL) was added to IL of double distilled water 
containing 500 mg streptomycin (Sigma) and 300 mg penicillin (Sigma).
The lOX stock was stored in 50 ml aliquots at -40°C.
Ix working solution of F14:
A 50 ml lOx aliquot was diluted into 450 ml double distilled water. 1 gram of 
sodium hydrogen carbonate (NaHCO]) (BDH) was added and the solution was 
adusted to pH 7 with dry ice and sterilised with an 0.22|im filter (Gelman Sc.).
HIHS
Heat-inactivated horse serum (Gibco).
Neurotrophic Factors
Recombinant human NGF was supplied by Genentech.
Recombinant rat BDNF was supplied by Regeneron Pharmaceuticals. 
Recombinant rat NT-3 was supplied by Regeneron Pharmaceuticals.
Recombinant rat CNTF was supplied by Amon Rosenthal 
Polyclonal anti-HGF antibodies were supplied by R&D Systems.
Neurotrophins Factors were kept in F-14 plus 10% HIHS, pH5.5, at -80°C until 
use.
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CHAPTERS
The role of HGF/MET signalling in 
Sensory neuron development
3.1 Introduction
HGF is a pleiotropic factor that exerts its effects by binding to the Met 
receptor tyrosine kinase (Gherardi & Stoker 1991; Brinkmann et al., 1995; Bladt et 
al., 1995; Schmidt et al., 1995; Uehara et al., 1995; Maina et al., 1996). Prior to 
carrying out the work described in the Chapter, there were several published 
observations which suggested that HGF and Met signalling play a role in neural 
development. First, Met expression had been observed in vaiious structures of the 
embryonic and postnatal nervous system, including spinal cord motoneurons and 
migrating neural crest cells (Sonnenberg et al., 1993; Jung et al., 1994; 
Andermarcher et al., 1996). Second, HGF had been shown to be a chemoattractant 
and survival factor for spinal motor neurons in vitro and HGF deficient mice 
showed marked deficits in motor fibres (Ebens et al., 1996). To further investigate 
the potential role of HGF in neural development, I canied out a series of in vitio 
investigations of the effect of HGF on the differentiation, survival and growth of 
sensory neurons of embryonic mouse dorsal root ganglia (DRG).
Sensory neurons within DRG are a heterogenous population specialized for 
conveying different modalities of sensory infoimation. Different subpopulations of 
neurons innervate separate types of peripheral sensory end organs and each has a 
distinct axonal arboriation in the spinal cord. Recent studies using gene knockouts 
have shown that different subpopulations of DRG neurons depend on specific 
neurotrophins for their survival, with small nociceptive DRG neurons being NGF 
dependent (Crowley et al., 1994; Smeyne et al., 1994), large proprioceptive DRG 
neurons being dependent on NT-3 (Ernfors et al., 1994, Farinas et al., 1994; Klein 
et al., 1994), and a subpopulation of DRG neurons which may include
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mechanoreceptors, arc dependant on BDNF (Klein et al, 1993; Jones et al., 1994). 
Some studies also suggest that certain sensory neurons may be sensitive to more 
than one neurotrophin (Davies et al., 1986; Gaese et al., 1994).
The studies reported in this Chapter on the effects of HGF on cultured DRG 
neurons has demonstrated that HGF cooperates with NGF but not other 
neui'otrophins to enhance differentiation, neuronal survival and axonal outgrowth.
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3.2 Results
3.2.1 HGF cooperates with NGF to enhance sensory neuron 
differentiation and survival
To determine if HGF exhibits neurotrophic activity for DRG neurons, DRG 
were dissected from E12 mouse embryos, dissociated and cultured in defined semm 
free medium, containing either HGF alone or with HGF in a combination with the 
neurotrophins NGF, BDNF or NT-3. Defined cohorts of cells were identified at 6 
hours and the fate of the cells was monitored at regular inteiwals over 72 hrs in cultuie 
(Fig. 3.1). HGF (5ng/ml) alone did not enhance neuronal survival compared to conti'ol 
cultures. This showed that HGF alone does not exhibit neurotrophic activity on DRG 
sensory neurons. However, when neurons were cultured with HGF and NGF, both at 
5ng/ml, there were substantially more neurons surviving in cultuie compared to 
cultures containing NGF alone (Fig. 3.2). The cohort experiments in which the fate of 
individual cells were followed over a set time period, indicated that the increase in 
neuron survival was the result of two effects of HGF. First in the presence of NGF, 
HGF increased the length of time that differentiated neurons survive. Secondly, HGF 
in combination with NGF also increased the number of neurons that differentiated from 
progenitor Cells in culture. In contrast, HGF did not increase the survival of DRG 
sensory neurons treated with either BDNF (Fig. 3.3) or NT-3 (Fig. 3.4) at a 
concentration of 5ng/ml. HGF also did not increase the number of neuron 
differentiating from progenitors in cultures containing BDNF or NT-3 at these 
concentrations. HGF failed to enhance the effects of higher concentration of BDNF (50 
ng/ml) data not shown. However experiments with higher concentrations of NT3 were 
not done because NT3 is known to cross-reactive with the NGF receptor TrkA, that 
would almost certainly lead to stimulation of NGF dependent neurons (Klein et al., 
1991; Davies et al, 1995).
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3.2.2 HGF cooperates wuh NGF to enhance axonal outgrowth from 
cultured DRG neurons
To investigate whether HGF influences the growth of axons emanating 
from developing DRG neurons, I studied the growth rate of axons in dissociated 
DRG neurons cultured in NGF (10 ng/ml) alone or in combination with HGF 
(5ng/ml or 25ng/ml) (Fig.3.5). The axonal growth rate of individual E12 DRG 
neurons was significantly enhanced in the presence of HGF plus NGF, compared 
to NGF alone (p< 0.005; t tests), demonstrating that HGF enhances the axonal 
growth rates of neurons surviving with NGF. Due to the fact that the results were 
obtained from neurons grown at veiy low densities, these results further indicate 
that HGF exerts a direct effect on NGF dependent neurons rather than acting 
indirectly on other cells. The typical appearances of E12 DRG neurons grown for 
72 hrs with NGF plus HGF and NGF alone are shown in figure 3.6.
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Figure 3 .1 : Bar charts showing the results of cohort experiments to determine the survival of 
thoracic DRG neurons that differentiate after different periods in culture. Neurons were grown either 
without factors (control) or with 5 ng/ml of HGF. Similar results were obtained in three separate 
experiments.
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Figure 3 .2 :  Bar charts showing the results of cohort experiments to determine the survival of 
thoracic DRG neurons that differentiate after different periods in culture. Neurons were grown either 
with 5 ng/ml of NGF or NGF plus 5ng/ml HGF. Similar results were obtained in three separate 
experiments.
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Figure 3 .3 ;  Bar charts showing the results of cohort experiments to determine the survival of 
thoracic DRG neurons that differentiate after different periods in culture. Neurons were grown either 
with 5 ng/ml o f BDNF or BDNF plus 5ng/ml HGF. Similar results were obtained in three 
separate experiments.
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Figure 3.4: Bar charts showing the results of cohort experiments to determine the survival of 
thoracic DRG neurons that differentiate after different periods in culture. Neurons were grown either 
with 5 ng/ml of NT3 or NTS plus 5ng/ml HGF. Similar results were obtained in three separate 
experiments.
7 7
E12 DRG neurons
4
I
1
3 J
2 ,
1 -
NGF lOng/ml 
NGF + HGF 5ng/ml 
NGF + HGF25ng/mI
24 IF 72
Time in culture (hours)
Figure 3.5: Graph of the axonal growth rates of E12 DRG neurons incubated with NGF alone 
or NGF plus HGF at 5ng/ml and 25ng/ml. The means and standard errors of serial measurements 
of between 79 and 89 neurons in each experimental group (compiled from three separate 
experiments) are shown.
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F igure 3.6: Camera lucida drawings of the typical appearance of thoracic E12 DRG neurons 
after being cultured in NGF and NGF plus HGF for 72 hrs. (Scale Bar = 2mm).
3 .3  D i s cu ss i o n .
To investigate the effects of HGF on sensory neuron survival, I cultured 
embryonic mouse DRG neurons at low density, either without factors, with HGF 
alone or with HGF plus neurotrophins. DRG neurons cultured without added 
factors or with HGF alone died rapidly. However, there was significantly greater 
neuronal survival in cultures containing HGF plus NGF compared to NGF alone. 
Cohort studies, in which the fates of individual cells were followed, indicated that 
this increase in the number of surviving neurons is the result of two effects of 
HGF. In the presence of NGF, HGF appeared to increase the survival of 
differentiated neurons and to increase the number of neurons tliat differentiated 
from progenitor cells. In contr ast to the enhanced survival of NGF-dependent 
neurons, HGF did not increase the number of sensory neurons treated with either 
NT-3 or BDNF. These in vitro assays show that HGF in combination with NGF 
but not BDNF or NT-3 can promote the differentiation and survival of DRG 
neurons, but cannot mediate any of these effects on its own. Measurements of 
axonal growth rate additionally revealed that in combination with NGF, HGF 
increases the growth rate of DRG axons.
The above findings suggest that within DRG neurons, the down stream 
signalling pathways of Met and the NGF receptor, TrKA, converge. This is 
different from the situation in motoneurons, where HGF alone is effective in 
promoting the survival of motoneurons on its own in culture (Ebens et al 1996; 
Wong et al 1997; Yamamoto et al 1997). Interestingly, HGF is unable to enhance 
the activities of NGF on another population of sensory neurons located in the 
trigeminal ganglion, indicating that the effects of HGF on DRG neurons are not due 
to a generalized increased fitness of sensory neurons (A. Forgie and A.M. Davies, 
unpublished observation). The results presented here raise the possibility of cell 
type-specific effector(s) of TrkA whose signalling is enhanced by activated Met 
receptors, either by stabilizing signalling activities or by blocking a specific 
inhibitor of the TrkA pathway. Since HGF is unable to promote survival or neurite
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outgrowth in combination with NT-3 or BDNF, there is no evidence for the 
possible interactions between Met and TrkB or TrkC, the receptors for BDNF and 
NT3, respectively (Klein, 1994; Barbacid, 1995).
Analysis of the development of sensory neurons in Met mutant mice has 
strengthened the observations reported in this chapter and demonstrated a role for 
HGF/Met signalling in the development of sensory neurons in vivo (Maina et al., 
1997). Detailed examination of the innervation of the skin of the limbs and thorax 
of embryos that possess a non-functional met receptor mutant embryos) has
shown that sensory nerves that are much reduced in length and elaborate fewer 
terminal branches. The overall patterning of the spinal nerve network appears to be 
preserved in mutant embryos, suggesting a role for Met signalling in
terminal nerve growth and branching, rather than in initial axonal guidance. In 
addition to reduced growth of sensory nerve fibres in mutant embryos, there
was also a consistent increase in cell death in these embryos (Maina et al., 1997). 
TUNEL staining of DRG sections either preceeding (Ell.5) or during the period of 
Met-dependent neurite outgrowth (E12.5) showed a two-fold increase in the 
number of apoptotic cells within Dorsal root ganglia of met (^embryos compared 
to littermate wild-type embryos. These results demonstrate that Met signalling is 
required for the survival of a subset of DRG neurons in vivo.
NGF and its receptor TrkA are important for the survival of pain and 
temperature-sensitive DRG neurons whose peripheral axons largely terminate in the 
skin (Crowley et al., 1994; Smeyne et al., 1994; Wall, 1995; Indo et al., 1996). 
The dual requirement observed in vitro for HGF and NGF explains the lack of 
superficial neiwe branches in the sldn of met ^  mutant embryos. NGF is currently 
being developed as a therapeutic drug for the treatment of peripheral sensory 
neuropathies, often observed in human patients suffering from diabetes or 
undergoing cancer therapy (Barinaga, 1994). Considering the strong enhancement 
of NGF-induced sprouting by HGF, combination of the two factors may prove to 
be even more effective (Nishi, 1994).
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Chapter 4
Effects of HGF on sympathetic 
neurite outgrowth.
4.1 Introduction
Having demonstrated that HGF cooperates with NGF to enhance the 
differentiation, survival and growth of DRG neurons in vitro (Chapter 3) together 
with in vivo data that show that mouse embryos carrying a signalling mutant of Met 
{met have fewer DRG neurons than wild type neurons and have much shorter 
less branched sensory neiwes in vivo (Maina et al., 1997), I wished to extend the 
analysis of the function of HGF in neural development to sympathetic neurons. I 
was particularly interested in studying these neurons because the results of a 
semiquantitative RT/PCR screen of several tissues from mouse embryos mice 
revealed the presence of HGF and Met mRNAs in the superior cervical sympathetic 
ganglion (SCG) throughout its embryonic development (S. Wyatt, personal 
communication).
Neuroblast proliferation, differentiation and survival during the early stages 
of neuronal, development are easily studied in paravertebral sympathetic ganglia. 
These ganglia can be dissected from mouse embryos as early as E l2.5 when the 
ganglia consist predominantly of proliferating cells. These dividing cells exhibit a 
variety of neuronal chai’acteristics, including; the expression of catecholamines 
(Cohen, 1974), dense-core vesicles, high-affinity noradrenaline uptake (Rothman et 
al., 1978), tyrosine hydroxylase expression (Rothman et al., 1980), tetanus toxin 
receptors (Rohrer and Thoenen, 1987), expression of the neuron-specific antigens 
SCGIO, B2 (Anderson & Axel, 1986) and Q211 (Rohrer & Thoenen, 1987), 
neurofilament protein (DiCicco-Bloom & Black, 1988) and short neuritic processes 
(DiCicco-Bloom et al., 1990). These proliferating, neuron-like cells have been 
termed precursor cells (Anderson and Axel, 1986), neuroblasts (DiCicco-Bloom
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and Black, 1988) and immature neurons (Enisberger et al., 1989a). To distinguish 
these proliferating cells from post-mitotic neurons, I have used the term neuroblast.
Sympathetic neuroblasts and postmitotic sympathetic neurons initially 
survive in culture in the absence of added neurotrophic factors. With increasing 
embryonic age, an increasing proportion of sympathetic neurons become dependent 
on NGF for survival. The first neurons start responding to NGF at E14 and almost 
all are dependent on NGF by E l8 (Wyatt & Davies, 1995). Between E16 and E l8, 
the survival of some sympathetic neurons additionally becomes dependent on a 
supply of NT-3 in vivo (Wyatt et al., 1997), and the proportion of NT-3 dependent 
neurons increases in the postnatal period, during which most neurons become 
dependent on both or either NT-3 and NGF (Levi-Montalcini, 1987; Crowley et 
al., 1994; Emfors et al., 1994; Smeyne et al., 1994; Zhou & Rush, 1995; Fagan et 
al,, 1996; Davies, 1997; Wyatt et al., 1997; Francis et al 1999). The onset of NGF 
responsiveness is correlated with a marked increase in the expression of the NGF 
receptor tyrosine kinase, TrkA (Wyatt & Davies, 1995), which also mediates the 
response of the neurons to NT-3 (Davies et al., 1995; Wyatt et al., 1997).
In the studies reported in this chapter, I have addressed the question of 
whether HGF/Met signalling influences the differentiation, survival and axonal 
growth rate' of nemites emanating from sympathetic neurons during embryonic 
development. The approach has been to follow individual neurons, calculating cell 
survival, neurite outgrowth and branching at regular intervals. This approach has 
enabled me to show that HGF/Met signalling accelerates the differentiation of 
sympathetic neurons as well as promoting the survival of sympathetic neuroblasts 
but not postmitotic neurons. HGF was also shown to cooperate with NGF to 
enhance the axonal growth rate as well as increasing the amount of neuiite 
branching of NGF-dependent sympathetic neurons throughout development. To 
investigate the significance of Met signalling in the development of neurons, I 
compared the in vitro development of neurons obtained from wild-type embryos 
with those from embryos containing a loss of function mutation of the met receptor.
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In summary these results indicatet that HGF plays several distinct roles in 
sympathetic neuron development at different embryonic stages.
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4.2 Results
4.2.1 HGF/Met signalling accelerates the differentiation of 
sympathetic neurons
Sympathetic neuroblasts are proliferating neuron-like cells that make up the 
majority of cells in early sympathetic ganglia (Rothman et al., 1987, 1980; Rohrer 
and Thoenen, 1987). They have distinctive morphologies in culture with respect to 
post-mitotic sympathetic neur ons. Whereas sympathetic neuroblasts possess small, 
phase-dark often irregularly shaped cell bodies and short neurites, post-mitotic 
sympathetic neurons have larger, spherical, phase-bright cell bodies and long 
neurites (Fig. 4.1). The fate of each cell type was followed over time in cohort 
experiments. Cells with the neuroblast morphology were often observed to divide 
whereas cells with the neuron morphology were never obserwed to divide. Because 
neuroblasts exhibit a variety of neuron-like characteristics (Anderson and Axel, 
1986; Cohen, 1974; DiCicco-Bloom and Black, 1988; DiCicco-Bloom et al., 1990; 
Rohrer and Thoenen, 1987; Rothman et al., 1978; Rothman et al., 1980), it is not 
possible to use a neuron-specific marker to distinguish neurons from proliferating 
neuroblasts in cells of developing sympathetic ganglia. Over 90% of the cells in 
dissociated cultures of early sympathetic ganglia (E12.5 and E13.5) of mouse 
embryos were neurofilament-positive neuroblasts or neurons. Most of the 
remaining cells had a fibroblast-like morphology.
To investigate if HGF affects the differentiation of sympathetic neuroblasts, 
cohorts of neuroblasts were identified in low-density dissociated cultures of E l2.5, 
E13.5 and E14.5 SCG 6 hours after plating and the proportion of these neuroblasts 
that differentiated into neurons was monitored at regular intervals thereafter. As 
shown in Figure 4.2, anti-HGF antibodies caused a marked, significant decrease in 
the number of neuroblasts that differentiated into neurons compared with control 
cultures and cultures that were supplemented with HGF. This decrease was evident 
as early as 12 hours after plating, and remained significantly lower at 24 and 48
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hours (P values ranging between 0.05 and 0.0005 at each time point; t-tests). The 
number of neuroblasts that differentiated into neurons was not significantly 
increased by HGF compared with control cultures (p>0.05;t-test) (Fig. 4.2). 
Similar effects of anti-HGF on suppressing neuroblast differentiation were observed 
in cultures set up from E12.5 and E14.5 SCG (Fig. 4.3), and in a limited number of 
experiments established from E12.5 and E13.5 thoracic paravertebral sympathetic 
ganglia (TPG) (p>0.05;t-test) (data not shown). These results suggest that 
endogenously produced HGF accelerates sympathetic neuroblast differentiation.
To confirm a requirement for HGF/Met signalling in the differentiation of 
sympathetic neuroblasts, I studied neuroblast differentiation in cohorts established 
from the SCG of wild-type embryos and embiyos that are homozygous for a 
signaling mutation in the met gene {met^^), in which both phosphotyrosine 
residues, that act as multifunctional docldng sites for SH2-containing effectors, aie 
mutated (Maina et al., 1996). For these studies, wild-type and homozygous mutant 
embryos were litter mates and they derived from crossing heterozygous mice for the 
mutant met allele (i.e., met^ "^  x met^^). Whereas in cohorts established from the 
SCG of wild-type mice there were substantially fewer neurons in cultures 
containing anti-HGF, there were no significant differences in the number of neurons 
in HGF-supplemented and anti-HGF-supplemented cohorts established from met^^ 
mutant embryos (Fig. 4.4). In these experiments, aU data were collected and 
analyzed before determining the genotypes of embryos from which the cultures 
were established, and were therefore uninfluenced by observer bias. These results 
not only confirm that HGF/Met signaling plays a role in the differentiation of 
sympathetic neuroblasts but show that the anti-HGF does not exert some non­
specific detrimental effect on the differentiation of sympathetic neuroblasts since it 
does not decrease the number of neuroblasts that differentiate in cultures established 
from met^^ embryos.
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4.2.2 ÏÏGF/^Set signalîing promotes the survival of sympathetic 
neuroblasts but not post-mitotic neurons
To determine if HGF affects the survival of sympathetic neuroblasts and 
neurons, I followed the fates of individual sympathetic neuroblasts and neurons in 
cohort cultures to determine how long they suiwived under different experimental 
conditions. In these experiments, cohorts of neuroblasts and neurons were 
identified 6 hours after plating and each cell in these cohorts was followed at regular 
intervals up to 72 hours in culture. Figure 4.5 plots the number of SCG 
sympathetic neuroblasts that die prior to differentiating into neurons. After 12 
hours, neither anti-HGF nor HGF affected the number of dying cells in these 
cohorts. However, by 24 and 48 hours, significantly more neuroblasts had died in 
cultures containing anti-HGF than in control cultures or cultures supplemented with 
HGF (P values ranging between 0.04 and 0.0001; t-tests). There were, however, 
no significant differences in the number of dying neuroblasts in controls and HGF- 
supplemented cultures at any of these time points (P > 0.05; t-tests). Similar results 
were obtained in cohort studies of early thoracic sympathetic neuroblasts (data not 
shown). These results suggest that endogenously produced HGF enhances the 
survival of sympathetic neuroblasts. The finding that anti-HGF did not increase the 
number of dying neuroblasts in cultures established from met^^ embryos (data not 
shown) indicates that anti-HGF does not exert some non-specific toxic effect on 
sympathetic neuroblasts.
In contrast to sympathetic neuroblasts, HGF does not affect the survival of 
differentiated sympathetic neurons. Figure 4.6 shows that there was no significant 
difference in the number of sympathetic neurons that die in cohorts grown with 
NGF plus anti-HGF compared with those grown with NGF plus HGF at all time 
points from 12 to 72 hours in culture (P > 0.05; t-tests). Although sympathetic 
neurons die more rapidly in the absence of NGF, neither anti-HGF nor HGF 
affected the rate at which they die (Fig. 4.7). These experiments therefore clearly
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demonsiiTite that HGF alone or in combination with NGF does not affect the 
survival of sympathetic neurons.
4.2.3 Defective Met signalling in vivo increases sympathetic 
neuroblast apoptosis and reduces SCG size
To determine if the in vitro effects of HGF/Met signaling on sympathetic 
neuroblast survival are physiologically relevant, a comparative histological study of 
the early SCG of wild-type and embryos was canied out in collaboration
with Flavio Maina. Embryos were prepared for routine histology and the total 
number of cells and the number of cells with pyknotic nuclei were counted in serial 
sections of the SCG. At E14.5, when the SCG consists mainly of sympathetic 
neuroblasts, the crossectional area of the SCG of met^^ embryos was smaller than 
that of wild-type embryos (Figs. 4.8A and 4.8B), and there was a statistically 
significant reduction of 40% in cell number (P < 0.001, t-test, n = 11, Fig. 4.8H). 
The difference in crossectional area between and wild-type embryos was
even more pronounced at E16 (Figs. 4.8E and 4.8F). To exclude the possibility 
that the reduction in the size of the SCG in mef^ embryos is a non-specific 
secondary consequence of the placental defect in these embryos, we counted the 
number of neurons in the nodose ganglia (a cranial sensory ganglion that lies next 
to the SCG) in E l4.5 wild-type and embryos. There was no statistically 
significant difference in the number of neurons in the nodose ganglia of and 
wild-type embryos (P = 0.4, t-test, n = 12, Fig. 4.81).
There was a significant, 79% increase in the number of pyknotic nuclei in 
the SCG of met^^ embryos compared with wild-type embryos (P < 0.005, t-test, n 
= 12, Fig. 4.8G). In addition to recognising apoptotic cells by histological criteria, 
apoptotic cells were also labeled in a limited number of embryos by TUNEL 
staining. The number of TUNEL-positive cells was also clearly greater in the SCG 
of met^^ embryos compared with wild-type embryos, both at E l3.5 (data not 
shown) and E14.5 (Figs. 4.8C and 4.8D). These results suggest that in the absence
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of Met signaling, an increased proportion of neuroblasts undergo apoptosis in the 
eaiiy SCG and this is reflected in a reduction in the total number of cells in this 
ganglion.
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F igure 4 .1: Phase contrast micrograph to show two representative post-mitotic sympathetic 
neurons with spherical cell bodies and long neurites (top and bottom) and a dividing sympathetic 
neuroblast with darkly stained cell bodies and short processes. SCG dissected neurons from E14.5 
embryos were cultured for 20h in the presence of NGF. (Scale bar = 1mm).
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Figure 4 .2 :  Bar graph showing the Percentage of E13.5 SCG sympathetic neuroblasts that 
differentiate over 48 hours in culture without factors, with anti-HGF (1.25pg/ml) or with HGF 
(lOng/ml). The means and standard errors of serial number of differentiated neuroblasts o f between 
75 and 165 neurons in each experimental group (compiled from three to four separate experiments) 
are shown.
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Figure 4.3: Bar graph showing the percentage of E12.5, E13.5 and E14.5 SCG sympathetic 
neuroblasts that differentiate after 24 hours in the presence o f anti-HGF (1.25 mg/ml) or HGF (10 
ng/ml). The means and standard errors of serial number of differentiated neuroblasts of between 75 
and 165 neurons in each experimental group (compiled from three to four separate experiments) 
are shown.
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F igu re 4.4: Bar graph showing the percentage of E13.5 SCG sympathetic neuroblasts from
wild-type and met^^ embryos that differentiate after 24 hours in culture with anti-HGF (1,25 
mg/ml) or HGF (10 ng/ml). The means and standard errors of serial number o f differentiated 
neuroblasts of between 75 and 165 neurons in each experimental group (compiled from three to 
four separate experiments) are shown.
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Figure 4.5: Bar graph showing the percentage of SCG sympathetic neuroblasts that die prior 
to differentiating into neurons over 48 hours in culture without factors, anti-HGF ( 1.25|ig/m l), or 
with HGF (lOng/ml). The means and standard errors of serial number of differentiated neuroblasts 
of between 75 and 165 neurons in each experimental group (compiled from three to four separate 
experiments) are shown.
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.Figure 4.6: Bar graph showing the percentage of post-mitotic sympathetic that die at different 
times in cultures supplemented with NGF (2ng/ml) plus anti-HGF (1.25p,g/ml) or NGF plus HGF 
(lOng/ml). Tlie means and standard errors of serial numbers of surviving neuroblasts or neurons of 
between 70 and ICO neurons in each experimental group (compiled from tliree separate 
experiments) are shown.
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Figure 4.7: Bar graph showing the percentage of post-mitotic sympathetic that die at different 
times in cultures supplemented with HGF (lOng/ml) or with anti-HGF (1.25|ig/m l). The means 
and standard errors of serial numbers of surviving neuroblasts or neurons of between 70 and 100 
neurons in each experimental group (compiled from three separate experiments) are shown.
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Figure 4.8: Photomicrographs of equivalent crossections of SCGs from E14.5 (A-D) and H16.0 
(E,F) wild-type (+/+) (A ,C ,E) and met^^ mutant embryos (B ,D ,F) stained with cresyl violet 
(A ,B,E,F) or by the TUNEL technique (C,D). Note the decrease in size and the increase in 
TUNEL-positive cells in met^^ mutant SCGs. (G,H,I) Quantitative analysis o f the number o f  
pyknotic nuclei (G) and the number o f neurons in SCG (H) and nodose ganglia (I) derived from 
E14.5 wild-type (+/+) and met^^ mutant embryos.
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4.2.4 lîGF cooperates with NGF io enhance axonal Growth of 
Sympathetic neurites.
To investigate the effects of HGF/Met signalling on the growth of neurites 
emanating from sympathetic neurons, I examined the effects of HGF on neurons 
cultured from the SCG and TPG at different stages during embryonic development. 
Because HGF mRNA is expressed in developing sympathetic ganglia, I used 
function blocldng anti-HGF antisemm to inactivate HGF produced in some cultures 
and made serial drawings of neurons grown with NGF alone, NGF plus anti-HGF 
and NGF plus HGF. The total length of each neurite arbor was measuied at 
intervals by digitising the diawings. To avoid any confusion about which neurites 
emanated from each cell body, the neurons were grown at very low density so that 
their neurite arbors did not overlap. To avoid the effects of HGF on neuronal 
differentiation and survival biasing the data, serial drawings were made of the same 
neurons between 3 hours and 72 hours (Davies, 1989) and only neurons that 
survived throughout this period were included in the analysis.
After 48 hrs in culture, the mean neurite length of SCG neurons (Fig. 4.9) 
and TPG (Fig. 4.10) neurons cultured with HGF plus NGF, was shown to be 
significantly greater than neurons cultured in NGF alone or NGF plus anti-HGF, 
at all ages studied (El2.5, E13.5, E14.5, and E15.5; p< 0.0005 in all cases; t 
tests). The difference in neurite outgrowth was most marked in E l4.5 TPG neurons 
whose average neurite length was observed to be 2-fold longer in the presence of 
HGF plus NGF compared to NGF alone or NGF plus anti-HGF. Although the 
neurite outgrowth from neurons cultured with anti-HGF plus NGF was generally 
less than that from neurons cultured with NGF alone, the differences were not 
significant (p> 0.05; t tests) in aU cases except for E14.5 and E15.5 SCG neurons 
(p< 0.05; t tests). Having demonstrated an effect of HGF on neurite outgrowth, I 
then examined the effect of HGF on SCG (Fig. 4.11) and TPG (Fig. 4.12) 
neurons at 24 hour inteivals over 72 hrs. After 24 hrs in culture, there was no 
significant difference in neurite outgrowth between SCG and TPG neurons cultured
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with NGF plus HGF or NGF plus anti-HGF. However, bePween 24 and 48 hrs 
neurite outgrowth in HGF-supplemented cultures increased much more rapidly 
than neurons supplemented with anti-HGF resulting in significantly longer neurites 
in HGF-supplemented cultures at 48 and 72 his (p < 0.0001; t test).
To determine the range of concentrations over which HGF enhances 
sympathetic neurite outgrowth in vitro, E14.5 SCG (Fig. 4.13) and TPG (Fig. 
4.14) neurons were cultured with HGF over a wide range of concentrations (3.2 
pg/ml-50ng/ml), either with or without 2ng/ml NGF. In the case of both SCG and 
TPG neurons the average neurite length in cultures supplemented with NGF and 
HGF was significantly increased when HGF was present at concentrations greater 
than lOng/ml (p< 0.002; t test). This increase was critically dependent on the 
presence of NGF. To determine the range of concentrations of NGF over which 
HGF enhances sympathetic neurite outgrowth, E14.5 TPG and SCG neurons were 
cultured with a constant concentration of HGF (lOng/ml) plus NGF over a wide 
range of concenti'ations (3.2 pg/ml-50ng/ml). In SCG neurons (Fig. 4.15), neurite 
outgrowth of HGF-supplemented neurons was significantly greater in the presence 
of NGF at concentrations ranging from 2-5 ng/ml (p< 0.05, t tests). In TPG 
neurons (Fig. 4.16), neurite outgrowth of HGF-supplemented neurons was 
significantly greater in the presence of NGF at concentrations ranging from 0.4-10 
ng/ml (p< 0.005; t tests) but not at concentrations above or below this. These 
results clearly show that the neurite outgrowth of sympathetic neurons is regulated 
by NGF and HGF over a wide range of concentrations and combinations.
To confirm a requirement for Met signalling in mediating the effects of HGF 
on neurite growth, I studied the neurite outgrowth of sympathetic neurons from 
wild-type embryos and signaling mutant embryos. Whereas the neurites of 
SCG neurons (Fig. 4.17) and TPG neurons (Fig. 4.18) from wild-type embryos 
were significantly longer in medium containing NGF plus HGF than in medium 
containing NGF plus anti-HGF (P < 0.0001; t-tests), there was no significant 
difference in the length of neurite of SCG and TPG neurons from m ef^ embryos
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grown in medium containing NGF plus HGF compared to medium containing NGF 
plus anti-HGF (P > 0.05; t-tests). Moreover, there was no significant difference in 
the length of neurites of neurons from embryos compaied to neurons from 
wild-type embryos grown with NGF plus anti-HGF (P > 0.05 in aU cases; t-tests). 
These results suggest that HGF/Met signalling plays a role in enhancing the overall 
length of sympathetic neurite aitors and show that anti-HGF does not exert a non­
specific detrimental effect on neurite growth since it does not decrease neurite length 
in cultures established from met^^ embryos.
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F igu re 4 .9 ;  Bar graphs showing the results o f neuron cohort experiments comparing neurite 
length o f SCG neurons from different aged embryos after 48 hrs in culture with NGF (5ng/ml), 
NGF plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and standard errors 
are shown of serial measurements made on between 70 and 122 neurons in each experimental 
group (compiled from cultures set up from three separate experiments).
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Figure 4 .1 0 :  Bar graphs showing the results o f neuron cohort experiments comparing neurite 
length o f TPG neurons from different aged embryos after 48 hrs in culture with NGF (5ng/ml), 
NGF plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and standard errors 
are shown of serial measurements made on between 70 and 122 neurons in each experimental 
group (compiled from cultures set up from three separate experiments).
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F igure 4 .1 1 :  Bar graphs showing the results of neuron cohort experiments comparing neurite 
length of SCG neurons from E14.5 embryos cultured with NGF (5ng/ml), NGF plus anti-HGF 
(1.25 mg/ml), or NGF plus HGF (lOng/ml) over 72hrs in culture. The means and standard errors 
are shown of serial measurements made on between 70 and 122 neurons in each experimental 
group (compiled from cultures set up from three separate experiments).
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F igu re 4 .1 2 :  Bar graphs showing the results o f neuron cohort experiment comparing neurite 
length o f TPG neurons from E14.5 embryos cultures in NGF (5ng/ml), NGF plus anti-HGF 
(1.25 mg/ml), or NGF plus HGF (lOng/ml) over 72hrs in culture. The means and standard errors 
are shown of serial measurements made on between 70 and 122 neurons in each experimental 
group (compiled from cultures set up from three separate experiments).
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Figure 4.13: Dose response of the HGF effect on E14.5 SCG neurons. The graph shows neurite 
length after 48 hrs in culture. Neurons were cultured with a range of HGF concentrations either 
with or without 2ng/ml NGF. The means and standard errors are shown of serial measurements 
made on between 70 and 122 neurons in each experimental group (compiled from cultures set up 
from three separate experiments).
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Figure 4.14: Dose response of the HGF effect on E14.5 TPG neurons. The graph shows neurite 
length after 48 hrs in culture. Neurons were cultured with a range o f HGF concentrations either 
with or without 2ng/ml NGF. The means and standard errors are shown of measurements made on 
between 70 and 122 neurons in each experimental group (compiled from cultures set up from 
three separate experiments).
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Figure 4,15; Dose response o f the NGF effect on E14.5 SCG neurons. The graph it shows 
neurite length after 48 hrs in culture. Neurons were cultured with a range o f NGF concentrations 
either with or without lOng/ml HGF. The means and standard errors are shown of serial 
measurements made on between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments).
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Figure 4.16; Dose response of the NGF effect on E14.5 TPG neurons. The graph shows neurite 
length after 48 hrs in culture. Neurons were cultured with a range of NGF concentrations either 
with or without lOng/ml HGF. The means and standard errors are shown of serial measurements, 
made on between 70 and 122 neurons in each experimental group (compiled from cultures set up 
from three separate experiments).
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Figu re 4 .1 7 ;  Bar graphs showing the results o f neuron cohort experiments comparing neurite 
length of SCG from E14.5 Met-deficient and wildtype embryos after 48 hrs in culture with NGF 
plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml) after 48rs in culture. Ttie means and 
standard errors are shown of serial measurements made on between 50-and-100 neurons o f each 
genotype. Data was compiled from cultures set up from the embryos of three separate litters, (+/+  
n = 5, met d/d n = 7).
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F igure 4 .1 8 ;  Bar graphs showing the results of neuron cohort experiments comparing neurite 
length axonal of TPG neurons from E14.5 Met-deficient and wildtype embryos after 48 hrs in 
culture with NGF (5ng/ml) plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml) after 48rs 
in culture. The means and standard errors are shown o f serial measurements made on between 50- 
and-100 neurons of each genotype. Data was compiled from cultures set up from the embryos of 
three separate litters,(+/+ n =  5, met d/d n =7).
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4.2.5 HGF cooperates with NGF to enhance neurite branching of 
Sympathetic neurites
To investigate the effects of HGF/Met signalling in sympathetic neurite 
branching, SCG (Fig. 4.19) and TPG neurons (Fig 4.20) from different stages of 
development (E12.5-E15.5) were cultured. After 48 hrs in culture, neurite 
branching was shown to be significantly greater in neurons cultured with HGF plus 
NGF, than neurons cultured in NGF alone or NGF plus anti-HGF at all ages 
studied (E12.5, E13.5, E14.5, and E15.5; p< 0.0005 in aU cases; t tests). The 
difference in neurite branching was most marked in E14.5 TPG neurons which had 
2-fold more branch points in the presence of HGF plus NGF than in NGF alone or 
NGF plus anti-HGF. Although the neurite branching in neurons cultured with anti- 
HGF plus NGF were generally less than those cultured with NGF alone, these 
differences were not significant (p> 0.05; t tests) in all cases except for E l3.5 
neurons (p< 0.05; t tests). After 24 hrs in culture, there was no significant 
difference in neurite branching between SCG and TPG neurons cultured with NGF 
plus HGF or anti-HGF (Figs. 4.21 and 4.22). However, between 24 and 48 hrs, 
neurite branching of HGF-supplemented neurons increased much more rapidly than 
neurons supplemented with anti-HGF resulting in significantly more neurite 
branching in HGF-supplemented neurons at 48 and 72 his (p < 0.0001; t test).
To determine the range of concentrations over which HGF enhances 
sympathetic neurite branching in vitro, E14.5 TPG and SCG neurons were cultured 
with or without 2ng/ml NGF over a wide range of concentrations (3.2 pg/ml- 
50ng/ml) (Fig. 4.23 and 4.24). For both SCG and TPG neurons the number of 
branch points per neurite was significantly increased in cultures containing NGF 
plus HGF when the concentration of HGF was at 10 ng/ml or greater (p< 0.02; t 
test). To determine the range of concentrations of NGF over which HGF enhances 
sympathetic neurite branching, E14.5 TPG and SCG neurons were cultured with 
NGF over a wide range of concentrations (Fig. 4.25 and 4.26) either with or 
without HGF at lOng/ml. In TPG neurons, the number of branches per neurite
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was significantly greater in HGF supplemented cultures when NGF was present at 
concentrations ranging from 0.4-10 ng/ml (p< 0.005; t test), but not at 
concentrations above or below this. In SCG neurons, the number of branches per 
neurite in HGF-supplemented cultures was significantly greater when NGF was 
present at concentrations ranging from 2-5 ng/ml (p< 0.005; t tests). These results 
clearly show that the neurite branching of sympathetic neurons is regulated by 
NGF and HGF over a wide range of concentrations and combinations.
To confirm a requirement for Met signalling in mediating the effects of HGF 
on neurite growth, I studied the neurite branching of sympathetic neurons of wild­
type embryos and mef^ signaling mutant embryos. Whereas the neurite branching 
of SCG neurons (Fig. 4.27) and TPG neurons (Fig. 4.28) from wild-type embryos 
were significantly greater in medium containing NGF plus HGF than in medium 
containing NGF plus anti-HGF (P < 0.0001; t-tests), there was no significant 
difference in the average number of branche per neurite on SCG and TPG neurons 
from m ef^  embryos grown in medium containing NGF plus HGF compared to 
medium containing NGF plus anti-HGF (P > 0.05; t-tests). Moreover, there was 
no significant difference in the average number of branches per neurite on neurons 
from met^^ embiyos compared to neurons from wild-type embryos grown with 
NGF plus anti-HGF (P > 0.05 in all cases; t-tests). These results suggest that 
HGF/Met signalling plays a role in enhancing sympathetic neurite branching and 
showed that the anti-HGF does not exert a non-specific detiimental effect on neurite 
growth since it does not decrease neurite branching in cultures established from 
met^^ embryos.
4,2.6 Increased branching is a secondary effect
The increased number of branch points in the neurite arbors of sympathetic 
neurons may be due to a direct effect of HGF on branching itself or may be 
secondary to the overall increase in the size of neurite arbors in the presence of 
HGF. If HGF has a direct effect on branching, one would expect branch points to
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occur with increased frequency with distance along axons, whereas if the increase 
in branch points is secondaiy to an overall increase in the size of neurite arbors, one 
would expect no difference in tlie inteiwals at which branch points occur. To 
distinguish between these possibilities, I measured the distance between the cell 
body and the first branch point in each neurite and the distance between subsequent 
branch points. These respective distances were not significantly different for 
neurons growing with NGF plus either HGF or anti-HGF in cultures of SCG and 
TPG established at E12.5, E13.5, E14.5 and E15.5 (p> 0.05 in all cases; t tests). 
This analysis indicates that the greater number of branch points in the arbors of 
neurons growing with HGF is secondary to the effect of HGF on enhancing axonal 
growth.
4.2.7 HGF increases the number or neurites
Although HGF does not have a direct effect on increasing the frequency 
with which an axon branches, it does increase the number of neurites that emerge 
from the cell bodies of cultured sympathetic neurons. In cultures set up from TPG 
(Fig. 4.29) neurons, there were more unipolar neurons in cultures supplemented 
with NGF plus anti-HGF than in cultures supplemented with NGF alone or with 
NGF plus ' HGF. Conversely there were more tripolar neurons in cultures 
supplemented with NGF plus HGF than in cultures supplemented with NGF alone 
or with NGF plus anti-HGF. The typical appearances of E14.5 TPG neurons 
grown for 48 hrs with NGF plus anti-HGF and NGF plus HGF are shown in 
figure 4.30.
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F igu re 4 .1 9 :  Bar graphs showing the results o f neuron cohort experiments comparing neurite 
branching of SCG neurons from different aged embryos after 48 hrs in culture in NGF (5ng/ml), 
NGF plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml) after 48hrs in culture. The 
means and standard errors are shown of serial measurements made on between 70 and 122 neurons 
in each experimental group (compiled from cultures set up from three separate experiments).
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F igu re 4 .2 0 ;  Bar graphs showing the results of neuron cohort experiments comparing neurite 
branching o f TPG neurons from different aged embryos after 48 hrs in culture with NGF (5ng/ml) 
NGF plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and standard errors 
are shown o f counts taken from between 70 and 122 neurons in each experimental group 
(compiled from cultures set up from three separate experiments).
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F igure 4 .2 1 ;  Bar graphs showing the results of neuron cohort experiments comparing neurite 
branching of SCG neurons from E14.5 embryos over 72 hrs in cultures NGF (5ng/ml) plus anti- 
HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and standard errors are shown of 
from between between 70 and 122 neurons in each experimental group (compiled from cultures set 
up from three separate experiments).
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F igu re 4 .22; Bar graphs showing the results o f neuron cohort experiments comparing neurite 
branching of TPG neurons from E14.5 embryos over 72 hrs in culture with NGF (5ng/ml) plus 
anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and standard errors are shown of 
counts taken from between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments).
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F igure 4 ,2 3 ;  Dose response of the HGF effect on E14.5 SCG neurons. The graph shows the 
number of branches after 48 hrs in culture. Neurons were cultured with a range of HGF 
concentrations either with or without 2ng/ml. NGF The means and standard errors are shown of 
counts taken from between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments)
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F igu re 4,24; Dose response of the HGF effect on E14.5 TPG neurons. The graph shows the 
number of branches per neurite after 48 hrs in culture. Neurons were cultured with a range o f HGF 
concentrations either with or without lOng/ml NGF. The means and standard errors are shown of 
counts taken from between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments).
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F igure 4 .2 5 ;  Dose response of the NGF effect on E14.5 SCG neurons. The graph shows the 
number of branches per neurite after 48 hrs in culture. Neurons were cultured with a range of NGF 
concentrations either with or without lOng/ml HGF Tire means and standard errors are shown of 
counts taken from between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments).
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F igure 4 .2 6 ;  Dose response of the NGF effect on E14.5 TPG neurons. Tlie graph shows the 
number of branches per neurite after 48 hrs in culture. Neurons were cultured with a range of NGF 
concentrations either with or without lOng/ml HGF. The means and standard errors are shown of 
counts taken from between 70 and 122 neurons in each experimental group (compiled from 
cultures set up from three separate experiments).
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F igu re 4 .27: Bar graphs showing the results o f neuron cohort experiments comparing neurite 
branching of SCG neurons from E14.5 Met-deficient and wildtype embryos after 48 hrs in culture 
witli NGF (5ng/ml) plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml. The means and 
standard errors are shown of counts taken from between 50-and- 150 neurons o f each genotype. 
The data is compiled from cultures set up from the embryos of three separate litters, +/+ n -  5, 
met d/d n =  7
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F igu re 4 .28: Bar graphs showing the results of neuron cohort experiments comparing neurite 
branching of TPG neurons from E14.5 Met-deficient and wildtype embryos after 48 hrs in culture 
with NGF (5ng/ml) plus anti-HGF (1.25 mg/ml), or NGF plus HGF (lOng/ml). The means and 
standard errors are shown of counts taken from between 50-and-150 neurons of each genotype. Tlie 
data is compiled from cultures set up from the embryos of three separate litters, +/+ n = 5, met d/d 
n = 7.
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Figure 4.29: Bar graph showing the percentage o f  TPG neurons possessing one, two, three. Or 
four neurites after 48 hrs in culture with either NGF plus HGF or NGF plus anti-HGF.
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F igure 4.30: Camera lucida drawings Typical appearance of E14.5 sympathetic neurons grown 
for 48 hours with either NGF plus anti-HGF or NGF plus HGF. (Scale Bar = 2mm).
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4.3 Discussion
The experimental studies described in this chapter demonstrate that HGF/Met 
signalling exerts a variety of specific effects on tlie development of sympathetic 
neuroblasts and neurons of the paiavertebral sympathetic chain both in vitro and in 
vivo. Experiments in which the fates of individual cells were carefully followed 
over time in culture clearly demonstrated that HGF/Met signaling affects 
sympathetic neuroblast differentiation and survival. Consistent with these data, in 
the early SCG of homozygous met^^ mutant embryos there is an increased 
proportion of neuroblasts undergoing apoptosis, and a progressive reduction in the 
total number of cells.
Anti-HGF reduced the number of neuroblasts that differentiated into neurons 
in culture and increased the number of neuroblasts that died before differentiating. 
Both effects of anti-HGF were not observed in neuroblasts obtained from met^^ 
embryos, indicating that Met signalling is required for these effects and that anti- 
HGF does not exert a non-specific detrimental effect on the survival and 
differentiation of progenitor cells. Because HGF and Met are expressed in 
sympathetic ganglia from the earliest stages of their development and Met protein is 
expressed by neuroblasts and neurons in early sympathetic ganglia, it is likely that 
neuroblast survival and differentiation is enhanced by HGF produced by the cells 
themselves. Interestingly, added HGF did not further enhance neuroblast survival 
and differentiation in these cultures, suggesting that endogenously produced HGF is 
maximally effective in enhancing neuroblast survival and differentiation. 
Endogenously produced HGF may act by an autocrine or paracrine mode on 
neuroblasts in early sympathetic ganglia. Although it was not possible to 
distinguish between these two modes of action in the culture system used in these 
studies, the fact that the effects of anti-HGF were observed in extremely low density 
cultures would favour an autocrine mode.
An autocrine role for the neurotrophin BDNF in the early stages of neuronal 
differentiation has previously been reported in early dorsal root ganglion sensory
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neurons which express BDNF mRNA in vivo (Wright et ai., 1992). During the 
earliest stages of their development, these neurons undergo a clearly recognizable 
morphological change. Initially, they have small, spindle-shaped, phase-dark cell 
bodies and short neurites and subsequently develop spherical, phase-bright cell 
bodies and extend long neurites. This change, which takes place in single cell 
cultures, is accelerated by BDNF and retarded by antisense BDNF oligonucleotides. 
These antisense oligonucleotides do not, however, affect the survival of early DRG 
neurons, suggesting that the BDNF autocrine loop is not required for survival at this 
stage (Wright et al., 1992). Similar experiments with antisense BDNF 
oligonucleotides carried out on adult DRG neurons suggest that a BDNF autocrine 
loop maintains the survival of a subset of these older neurons (Acheson et al., 
1995). There is some evidence that another neurotrophin, NT-3, may be required 
for the survival of sensory neuron progenitor cells. It has been reported that the 
majority of cells undergoing apoptosis in the early DRG of NT-3~^ ~ embryos 
(recognized by TUNEL labelling) had also incorporated BrdU administered 5 hours 
earlier (ElShamy and Ernfors, 1996). However, in another study, no BrdU- 
positive/TUNEL-positive cells were observed in the early DRG of NT-3~^ ~ 
embryos, although BrdU-positive/neurofilament-positive cells were observed 
(Farinas et al., 1997).
Previous studies have shown that HGF is effective on its own in promoting 
the survival of cultured motoneurons (Ebens et al., 1996; Wong et al., 1997; 
Yamamoto et al., 1997) and that HGF cooperates with NGF, but not with BDNF or 
NT3, in enhancing the survival of DRG sensory neurons in vitro (Chapter 3). In 
contrast, although I have implicated endogenous HGF in enhancing the survival of 
sympathetic neuroblasts, the survival of differentiated sympathetic neurons is 
unaffected by anti-HGF and is not enhanced by HGF alone. Furthermore, HGF 
does not enhance the survival of sympathetic neurons growing in the presence of 
NGF.
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I observed that HGF increased the number of neurites that grew from the cell 
bodies and increased the overall length and number of branch points in the neurite 
arbors of sympathetic neurons. Analysis of the distance between branch points 
indicated that the increase in the number of branch points in the presence of HGF 
was secondary to the increase in the overall size of the neurite arbors. AU these 
effects of HGF are dependent on Met signalling. In contrast to the lack of effect of 
added HGF on neuroblast survival and differentiation, the laigest changes in neuiite 
growth and branching were observed in cultures supplemented with HGF (as 
opposed to those treated with anti-HGF). This suggests that HGF from sources 
other than the neurons themselves has the potential to regulate sympathetic axon 
growth and branching in vivo.
The studies reported in Chapter 3 showed that HGF enhances neurite 
outgrowth from DRG neurons cultured in the presence of NGF but not when these 
neurons are grown with BDNF or NT3. It is interesting to note that the HGF 
effects described in this and the present chapter occur in the population of sensory 
and sympathetic neurons which aie preferentially dependent on NGF, but not on the 
sensory neurons located in the nodose ganglia that are preferentially dependent on 
BDNF. Tills obseiwation indicates that the effects of HGF are not attributable to 
generalized increased fitness of sensory and sympathetic neurons. It would be 
particularly interesting to understand how these synergism’s occur in terms of 
signaling pathways. Are Met and TrlcA activating different pathways, or enhancing 
the level of activation of one or more pathways, or do they have a synergistic effect 
on the kinetics of activation? Additional Met signaling mutants will help to further 
define this cooperation.
In summary, this study shows multiple effects of HGF/Met signalling on 
sympathetic neuroblasts and neurons. HGF regulates differentiation and survival of 
sympathetic neuroblasts and has the potential to enhance axonal growth of NGF- 
dependent sympathetic neurons. This suggests that HGF can act in an autocrine and
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pai'aciine maimer to regulate sympathetic neuron development during 
embryogenesis.
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Chapter 5
Co-operation between HGF and CNTF in 
promoting the survival and growth of sensory 
and parasympathetic neurons
5.1 Introduction
Previous in vitro studies described in chapters 3 and 4 of this thesis have 
shown that HGF promotes the survival and differentiation of sympathetic neuroblasts 
and that in the presence of NGF, but not other neurotrophins, HGF enhances the 
survival and growth of a subset of DRG neurons and enhances the growth of 
sympathetic neurites. To investigate if HGF influences the survival and growth of other 
classes of neurons in the developing peripheral nervous system and synergises with 
neurotrophic factors other than NGF, I studied its effect on purified cultures of 
parasympathetic neurons of the ciliary ganglion and proprioceptive neurons of the 
trigeminal mesencephalic nucleus (TMN). The survival of the great majority of 
neurons in both populations is supported by CNTF in culture (Barbin et al., 1984; 
AUsopp et al., 1993). The survival of TMN is also supported just as effectively by 
BDNF (Davies et al., 1986a, 1986b; Allsopp et ah, 1995; Davey & Davies, 1998). 
NGF does not, however, promote the survival of either ciliary (Helfand et al., 1976; 
Rohrer & Sommer, 1982) or TMN neurons (Davies et al., 1987). The results presented 
in this chapter show that whilst HGF alone does not promote the survival of either of 
these kinds of neurons on its own, it does increase the number of neurons surviving in 
cultures supplemented with CNTF, but not BDNF. HGF was also shown to increase 
the overall length and branching of the neuiite arbors of these neurons in the presence
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of CNTF, but not BDNF. These results show tliat HGF is able to co-operate with 
CNTF in promoting the smwival and growth of developing parasympathetic and 
proprioceptive neurons. The demonstration that HGF only enhanced the survival and 
growth of TMN neurons when these neurons were grown with CNTF and not when 
they were grown with BDNF (which promoted their survival as effectively as CNTF), 
demonstrates that within the same neurons the effects of HGF on survival and growth 
are selectively dependent on which other signalhng pathways are concurrently 
activated.
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5.2 Results
5.2.1 Survival
To investigate if HGF influences the survival of ciliary and TMN neurons, I 
established low density dissociated cultures of these neurons from embryonic day 
(ElO) chicken embryos, a stage when naturally occurring neuronal death is taking place 
in these populations of neurons in vivo (Landmesser & Pilar, 1974; Rogers & Cowen, 
1974). To ensure that only dhect effects of HGF on neurons were observed, 
differential sedimentation (Davies, 1986) was used to remove almost aU non-neuronal 
cells from these cultures prior to plating (> 95% pure neurons). These neurons were 
grown with HGF alone or HGF plus other neurotrophic factors that are Icnown to 
promote the survival of these neurons (CNTF or BDNF) and the proportion of neurons 
that survived in these cultures and control cultures (no added factors) was determined 
after 48 hours incubation.
5.2.2 Ciliary Neurons
HGF over a broad range of concentrations (from 3.2 pg/ml to 250 ng/ml) had 
no effect on the survival of ciliary neurons on its own (Fig. 5.1). The small number of 
neurons surviving in these cultures (approximately 5% after 48 hours) was not 
significantly different from the number in control cultures (p > 0.05, t-tests). CNTF 
was very effective in promoting the survival of ciliary neurons (Fig. 5.2). Dose 
response analysis revealed that at saturating concentrations (50 ng/ml and above) 
approximately 60% of the neurons were still sumving after 48 hours. Although HGF 
did not support the survival of ciliary neurons on its own, several experiments showed 
that HGF in combination with CNTF promoted the survival of more neurons than 
CNTF alone. To ascertain the concentration at which HGF begins to enhance the 
survival of ciliary neurons incubated with CNTF, ciliary neurons were grown with a
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constant saturating level of CNTF (50 ng/rnl) plus HGF over a range of concentrations 
(Fig. 5.1). The number of neurons growing with CNTF plus HGF at concentrations at 
and above 2 ng/ml was significantly greater than the number suiviving with CNTF 
alone (p < 0.01, t tests). At the highest concentration of HGF used (250 ng/ml) there 
was a 50% increase in neuronal survival compaied with CNTF alone. Very similar 
results were obtained when CNTF was used at a concentration of 5 ng/ml (data not 
shown). To ascertain the concentration range of CNTF over which HGF enhances 
survival, ciliary neurons were grown with a constant level of HGF (2 ng/ml) plus 
CNTF over a broad range of concentrations (Fig 5.2). Neuronal survival in HGF 
supplemented cultures was significantly greater than in cultures containing CNTF alone 
at concentrations of CNTF at and above 2 ng/ml (p < 0.05, t test). Very similar results 
were obtained when HGF was used at a constant concentration of 10 ng/ml (data not 
shown). These results demonstrate that although HGF does not promote ciliary neuron 
survival alone, it co-operates with CNTF in enhancing the survival of these neurons 
over a particular combination of concentrations.
5.2.3 TMN Neurons
Figure 5.3 shows that the survival of the majority of ElO TMN neurons was 
promoted by either BDNF or CNTF alone. HGF alone, however, did not promote the 
survival of these neurons (there was no significant difference between the small number 
of neurons sui*viving in control cultures and those containing HGF (p > 0.05, t test). 
However, there was a significant 57% increase in the number of neurons in cultures 
containing CNTF plus HGF compared with cultures containing CNTF alone (p < 
0.001, t test). In contrast, there was no significant difference between the number of 
neurons surviving in cultures containing HGF plus BDNF compared with cultures 
containing BDNF alone (p > 0.05, t test). The concentrations of CNTF and BDNF 
used in the present studies (10 ng/ml) have been shown to be maximally effective for
133
promoting TMN' survival (Davies et aL, 1986a; Davey & Davies, 1998). Because only 
veiy limited numbers of purified TMN neurons were available from each embryo, it 
was not feasible to undertake the detailed dose response analysis for different 
concentrations of CNTF and HGF that were undertaken for ciliary neurons. However, 
separate experiments in which HGF was used at a concentration of 50 ng/ml also 
specifically enhanced the survival responses of TMN neurons to CNTF but not to 
BDNF (data not shown).
5.2.4 Axonal Growth
To investigate if HGF affects the growth of neurites from ciliary and TMN 
neurons, drawings were made of neurons grown with CNTF alone or CNTF plus 
HGF (additionally, TMN neurons were also grown with BDNF alone or BDNF plus 
HGF). The total length of each neurite arbor was measured at intervals by digitising 
the drawings. To avoid any confusion about which neurites emanated from each cell 
body, the neurons were grown at veiy low density so that their neurite arbors did not 
overlap. To avoid the effects of HGF on neuronal survival biasing the data, serial 
drawings were made of the same neurons between 3 hours and 72 hours (Davies, 
1989) and only neurons that survived throughout this period were included in the 
analysis (Hilton et al., 1997).
5.2.5 Ciliary neurons
After 48 hours in culture, the lengths of the neurite arbors of ciliary neurons 
grown with HGF plus CNTF were significantly greater than those of neurons grown 
with CNTF alone (Fig. 5.4). To ascertain the concentration at which HGF begins to 
enhance the growth of neurites incubated in the presence of CNTF, ElO ciliary neurons 
were grown with a constant level of CNTF (50 ng/ml) plus HGF over a wide range of 
concentrations (Fig. 5.4). The neurite arbors of NGF-supplemented neurons were
134
significantly longer in the present of HGF at concentrations of 2 ng/ml and greater (p < 
0.005 at this concentration; t-test), but not at lower concentrations. To ascertain the 
concentration range of CNTF over which HGF enhances neurite growth, cihaiy 
neurons were grown with a constant level of HGF (2 ng/ml) plus CNTF over a wide 
range of concentrations (Fig. 5.5). The neurite arbors of HGF-supplemented neurons 
were significantly longer in the presence of CNTF at concentrations of 2 ng/ml and 
greater (p < 0.001 at this concentration; t-test) but not at lower concentrations. These 
results indicate that CNTF and HGF co-operate in regulating neurite growth over a 
particular combination of concentration.
In addition to enhancing the overall length of the neurite arbors emanating from 
developing parasympathetic neurons, HGF increased the number of branch points in 
the neurite arbors of these neurons. After 48 hours in culture, the number of branch 
points in the neurite arbors of ciliaiy neurons grown with CNTF plus HGF were 
significantly greater than those of neurons grown with CNTF alone. Figure 5.6 and 
5.7 show that increased branching was observed over similar concentration ranges of 
CNTF and HGF to those that enhanced the overall length of the neurite arbors of ciliary 
neurons (Fig. 5.4 and Fig.5.5). The typical appearance of ElO ciliary neurons grown 
for 48 hrs with CNTF and CNTF plus HGF are shown in Figure 5.10
5.2.6 TMN neurons
Figure 5.8 shows that after 48 hours in culture, the lengths of the neuiite arbors 
of TMN neurons grown with HGF plus CNTF were significantly greater than those of 
neurons grown with CNTF alone (p < 0.0001, t-test). Likewise, there were 
significantly more branch points in the neurite arbors of TMN neurons grown with 
HGF plus CNTF compaied neurons grown with CNTF alone (p < 0.0001, t-test) 
(Fig.5.9). In contrast, there was no significant difference between the overall length 
and number of branch points in the neurite arbors of TMN neurons grown with HGF
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pins BDNF compared with neurons containing BDNF alone (p > 0,05, for both length 
and branch points, t tests). These results show that HGF specifically synergises with 
CNTF but not BDNF in enhancing the growth of TMN neurites. The typical 
appearances of ElO TMN neurons grown for 48 hrs are shown in figure 5.11.
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Figure 5.1; Dose responses showing the effect of HGF and CNTF plus HGF on the survival o f ElO 
ciliary ganglion neurons after 48 hours in culture. The graph shows the percent survival in control 
cultures, cultures containing CNTF alone (50 ng/ml) and cultures containing HGF over a range o f  
concentrations with or without CNTF (50 ng/ml). The mean ±  standard error of the mean (n =  3 for 
each experimental condition) from a typical experiment are shown. Three additional separate 
experiments gave very similar results.
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Figure 5.2; Dose responses showing the effect o f HGF and CNTF plus HGF on the survival of 
ElO ciliary ganglion neurons after 48 hours in culture. The graph shows the percent survival in 
cultures containing CNTF over a range of concentrations with or without HGF (2 ng/ml). The mean ±  
standard error of the mean (n =  3 for each experimental condition) from a typical experiment are shown. 
Three additional separate experiments gave very similar results.
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Figure 5.3; Bar chart of the percent survival o f ElO TMN neurons incubated for 48 hours in control 
cultures, cultures containing HGF, BDNF or CNTF alone or in combination (all at 10 ng/ml). The 
mean ±  standard error o f the mean (n = 3 for each experimental condition) from a typical experiment are 
shown. Two additional separate experiments gave very similar results.
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Figure 5.4: Dose responses of the effect of HGF and CNTF on the survival o f ElO ciliary ganglion 
neurons after 48 hours in culture. The graph shows the length (mm) of the neurite arbors o f neurons in 
cultures containing CNTF alone (50 ng/ml) and cultures containing HGF over a range of 
concentrations with CNTF (50 ng/ml). The mean ±  standard error of the mean (n = 3 for each 
experimental condition) from a typical experiment are shown. Three additional separate experiments 
gave very similar results.
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Figure 5.5: Dose responses showing the effect o f HGF and CNTF on the growth of ElO ciliary 
ganglion neurons after 48 hours in culture. The graph shows the length (mm) o f the neurite arbors of 
neurons in culture containing CNTF over a range o f concentrations with or without HGF (2 ng/ml). 
The mean ±  standard error of the mean (n = 3 for each experimental condition) from a typical 
experiment are shown. Three additional separate experiments gave very similar results.
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Figure 5.6; Dose responses showing the effect o f HGF and CNTF on the branching of ElO ciliary 
ganglion neurons after 48 hours in culture. The graph shows the number of branch points in neurite 
arbors o f neurons in culture containing CNTF alone (50 ng/ml) and cultures containing HGF over a 
range o f concentrations with CNTF (50 ng/ml). H ie mean ±  standard error of the mean (n = 3 for each 
experimental condition) from a typical experiment are shown . Three additional separate experiments 
gave very similar results.
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Figure S.7; Dose responses showing the effect of HGF and CNTF on the branching o f ElO ciliary 
ganglion neurons after 48 hours in culture The graph shows the number of branch points in the neurite 
arbors of neurons in cultures containing CNTF over a range of concentrations with or without HGF 
(2 ng/ml). The mean ±  standard error of the mean (n = 3 for each experimental condition) from a 
typical experiment are shown. Tliree additional separate experiments gave very similar results.
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Figure 5.8: Bar chart o f the total length of neurite arbors of ElO TMN neurons incubated for 48 
hours in control cultures, cultures containing either HGF, BDNF or CNTF alone or in combination 
(all at 10 ng/ml). The mean ± standard error of the mean (n =  3 for each experimental condition) from 
a typical experiment are shown. Two additional separate experiments gave very similar restilts.
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Figure 5.9: Bar chart o f the of branch points of ElO TMN neurons incubated for 48 hours in 
cultures containing either BDNF or CNTF alone or in combination with HGF (all at 10 ng/ml). The 
mean ±  standard error o f the mean (n = 3 for each experimental condition) from a typical experiment are 
shown. Two additional separate experiments gave very similar results.
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Figure 5,10: Camera lucida drawings of the typical appearance of ElO ciliary ganglion neurons 
grown for 48 hours with CNTF (50ng/ml) plus HGF (50 ng/ml) or CNTF (50 ng/ml) alone. (Scale 
Bar = 2mm).
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Figure 5.11: Camera lucida drawings of the typical appearance of ElO TMN neurons grown for 48 
hours with CNTF (50ng/ml) plus HGF (50 ng/ml) or CNTF (50 ng/ml) alone. (Scale Bar = 2mm).
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5.3 DISCUSSION
I have shown that HGF synergises with CNTF in promoting the survival and 
growth of embryonic paiasympathetic and proprioceptive neurons. Although HGF had 
no effect on the survival of these neurons alone, it consistently promoted a statistically 
significant elevation in the number of neurons surviving with satuiating concentiations 
of CNTF, and significantly increased the length and branching of the neurite arbors of 
these neurons in the presence of CNTF. This synergism between HGF and CNTF was 
due to direct effects of both factors acting on the same neurons because the neurons in 
these cultures were grown at very low density and there were vhtually no other cell 
types present to mediate an indirect effect.
It has previously been reported that HGF synergises with CNTF in promoting 
the survival of spinal motoneurons (Wong et al., 1997). However, unlike 
parasympathetic and proprioceptive neurons which do not survive at all with HGF on 
its own, a subset of motoneurons does survive with HGF alone, and the number of 
motoneurons in cultures containing HGF plus CNTF is the sum of the number of 
motoneurons in cultures containing HGF alone and CNTF alone (Wong et ah, 1997). 
Thus, these data do not necessarily indicate that HGF and CNTF act synergistically on 
the same motoneurons to enhance their survival, but that HGF and CNTF promote the 
smwival of separate subsets of spinal motoneurons in culture. Although the level of 
acetyl cholinesterase in motoneuron cultures containing CNTF and NGF was greater 
than the sum of the levels in cultures containing either factor alone, one cannot exclude 
the possibility that this apparent synergism between CNTF and HGF in regulating 
acetyl cholinesterase expression was not mediated indirectly via other cell types which 
were evident in these cultures (Wong et al., 1997).
Compelling evidence for synergism between HGF and NGF has been obtained 
from the in vitro studies on developing DRG and sympathetic neurons outlined in 
Chapters 3 and 4. Although HGF does not promote the survival of early DRG neurons
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on its own, it enhances the survival of neurons grown with NGF but not those grown 
in the presence of either BDNF or NT3. HGF also specifically enhances neurite 
outgrowth from early DRG neurons grown with NGF but not from those grown with 
other neurotrophins and enhances the growth but not the survival of sympathetic 
neurons grown with NGF.
Although these studies indicate that HGF can enhance the survival and/or 
growth of neurons that require NGF for survival, it is not known whether these effects 
of HGF are specifically dependent on concomitant NGF signalling or whether HGF 
would have the same effect on this subset of neurons if their smwival were promoted by 
other neurotrophic factors. Because DRG consist of largely sepaiate subsets of NGF, 
BDNF and NT3-dependent neurons and the NGF-dependent neurons do not uniquely 
respond to another neurotrophic factor, it has not been possible to address this 
important question with this subset of neurons. However, in the experiments reported 
in this Chapter it has been possible to investigate the effect of HGF on a population of 
neurons that is supported by either of two neurotrophic factors. The majority of TMN 
neurons survive in culture with either BDNF or CNTF and the combination of both 
factors does not significantly increase neuronal survival, indicating that the same 
neurons aie supported by either factor (Davies et al., 1986a, 1986b; Allsopp et al., 
1995; Davey ' & Davies, 1998). The demonstration that HGF has no survival 
promoting effect on these neurons alone but that it enhances the survival and growth of 
these neurons in the presence of CNTF but not BDNF clearly shows that response of 
these neurons to HGF depends on the concomitant activation of particular signalling 
pathways (in this case those activated by CNTF), not just any signalling pathway that 
promotes survival.
HGF binds to the Met receptor tyrosine kinase resulting in the activation of 
several signalling pathways including; ST AT, INK kinase, Src tyrosine kinase, 
Ras/MAP kinase, PI-3 kinase and PLC-y (Ponzetto et al., 1994; Kochhar and Iyer,
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1996; Nguyen et al., 1997; Rodriguet et al., 1997; Boccaccio et al., 1998). CNTF 
binds to an oligomeric receptor complex comprised of two transmembrane 
glycoproteins, gpl30 and LIFRp, and a GPI-linked protein, CNTFRa (Davis et al., 
1993; Stahl and Yancopoulos, 1994). The activation of this receptor results in STAT, 
Ras/MAP kinase, PI-3 kinase and PLC-y activation (Boulton et al., 1994; Stahl et al., 
1994; Frank and Greenberg, 1996). Thus, HGF and CNTF have several downstream 
effectors in common in responsive cells. It will be interesting in future work to 
ascertain if convergence of HGF and CNTF signalling at one or more of these 
downstream effectors could explain the synergy between HGF and CNTF.
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Chapter 6 
Bcl-2 influences axonal growth rate in 
embryonic neurons
6.1 Introduction
In previous chapters I described a number of extrinsic influences on axonal 
growth. In this chapter I report the results of studies that implicate Bcl-2, a widely 
expressed cytoplasmic protein, in influencing axonal growth. Although Bcl-2 is 
known to play a role in regulating neuronal survival in the course of studying early 
sensory neurons from Bcl-2 nuU mutant mouse embryos in vitro, I observed that 
neurons from Bcl-2 deficient embryos possessed shorter axons than neurons from 
their wild-type litter mates. I therefore carried out a detailed compaiative study of 
axonal growth rates in low density dissociated neuronal cultures established from 
Bcl-2 deficient and wild-type embryos.
Because the development of the mouse trigeminal ganglion has been 
extremely weU characterised, I decided to focus on these neurons. Duiing 
embryonic development the majority of neurons within the trigeminal ganglion 
differentiate from proliferating progenitor cells between B9.5 and E13.5. The first 
axons emerge from the trigeminal ganglion at E9.5 and reach their peripheral targets 
by E ll. The latest axons aixive at theh targets shortly before E15. The number of 
neurons within the ganglion peaks between E12 and E14 and thereafter decreases 
by 50% to reach a stable number by birth as a result of neuronal apoptosis that 
peaks at E14. The majority of trigeminal neurons require an adequate supply of 
target field derived NGF to survive this period of cell death (Davies & Lumsden, 
1984, 1986: Davies, 1987a, Pinon et al., 1996). Early trigeminal neurons do not 
require neurotrophic factor support during the period that their axons are growing 
towards tlieir peripheral targets. Once the axons of early trigeminal neurons have 
contacted their targets these neurons become dependent on neurotrophic factors for
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sui-vivai (Buchman & Davies, 1993). In vitro studies have shown that most early 
trigeminal neurons are dependent upon BDNF or NT-3 for sui*vival and few 
respond to NGF. However, between E ll and E12 many trigeminal neurons lose 
the ability to respond to BDNF and acquire responsiveness to NGF. The ability of 
NT-3 to promote the in vitro survival of trigeminal neurons is gradually lost 
between E ll and E14 (Buchman & Davies, 1993; Paul & Davies, 1995). The 
acquisition of NGF dependence is accompanied by marked increases in the 
expression of transcripts encoding the NGF receptors, p75 and trkA (Wyatt & 
Davies, 1993).
El 1 and E12 are ideal ages at which to study the role of Bcl-2 in regulating 
process outgrowth from cultured trigeminal neurons for two reasons. First, at these 
ages a large number of trigeminal neurons are sending axons to their peripheral and 
central targets in vivo, hence effects of Bcl-2 on neurite outgrowth found at these 
ages are likely to be of relevence to the process of target field innervation. Second, 
at E ll and E12 trigeminal neurons respond to BDNF, NT-3 and NGF, thus 
allowing the role of Bcl-2 in mediating neurite outgrowth in response to aU three 
neurotrophins to be ascertained.
Careful analysis of process outgrowth from E ll and E12 trigeminal 
neurons obtairied from wild type, heterozygous and Bcl-2 deficient mice has 
shown that Bcl-2 plays a role in the process of neurite outgrowth in response to 
BDNF, NT-3 and NGF. Importantly, I found that the lack of Bcl-2 did not 
significantly reduce the survival of El 1 and El 2 tiigeminal neurons grown with any 
of the neurotrophins. This strongly suggests that the effect of Bcl-2 on axonal 
growth rate is not a consequence of its well documented role in preventing 
apoptosis.
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6.2 ResuUs
E ll and E12 embryos were obtained from overnight matings of mice that 
were heterozygous for a Bcl-2 null mutation (Nakayama et al., 1993; Nakayama et 
al., 1994). Separate low density dissociated cultures of trigeminal ganglion 
neurons, containing either 5ng/ml NGF, NT-3 or BDNF, were established from 
each embryo in each E ll and E12 litter. Some neurons are generated from 
progenitor cells in dissociated cultures of early tiigeminal ganglia and therefore start 
extending axons at different times in culture (Paul & Davies, 1995). Also, Bcl-2 
deficient neurons do not survive as well as wild type neurons when cultured during 
the period of developmental neuronal death (Pinon et al., 1997). Therefore, to 
eliminate the possibility that the lack of Bcl-2 may alter axonal outgrowth as a 
secondary consequence of altering neuronal differentiation or survival, individual 
neurons were identified at the outset of each experiment (after 6 hours in cultuie) 
and serial drawings were made of the axons of these identified neurons at regular 
intervals over a 48 hour culture period. Axon lengths were only calculated from 
drawings of neurons that survived the whole 48 hour culture period. Tissue from 
each embryo was saved at the beginning of each experiment for subsequent 
genotype analysis by PCR. To eliminate the potential for observer bias, drawings 
were made of axons, and the length of these axons were calculated, without 
knowing the genotypes of the neurons in the individual cultures. Genotypes were 
only assigned to cultmes after all calculations of neurite length had been made.
Analysis of E ll cultures showed that neurons from Bcl-2 deficient embryos 
extended their axons at a slower rate than those from either Bcl-2 heterozygous or 
wild-type litter mates. After 48 hrs incubation. E ll Bcl-2-defrcient trigeminal 
neurons cultured in NGF, BDNF and NT-3 were between 44 and 60% shorter than 
wild-type E ll neurons (figures 6.1, 6.2 and 6.3). The difference in axonal length 
between the neurons of Bcl-2 deficient and wild-type embryos were statistically 
significant at 12, 24, and 48 hrs incubation (p<0.0001 in all casesusing t tests). 
The difference in axonal outgrowth between wild-type and Bcl-2 deficient neurons
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was most marked after 48 his in culture. Neurons from wild-type and Bcl-2 
heterozygous embryos grew at similar rates, suggesting that at E ll the effect of 
Bcl-2 on promoting axonal growth was independent of gene dosage. Because only 
neurons that survived throughout the 48 hr period of study were included in the 
analysis, differences in axonal growth rate between Bcl-2-deficient and wild-type 
embryos were not due differences in survival. Moreover, there were no significant 
differences in the overall percentage survival of E ll Bcl-2-deficient and wild-type 
neurons in these cohorts after 48 hrs incubation with NGF, BDNF and NT-3 
(p>0.05 in all cases, using t tests). In BDNF supplemented cultures, 55.1 ± 4.4% 
of neurons survived the 48 hour culture period, whereas 54.1 ± 4.4% Bcl-2 
deficient neurons survived. In NT-3 supplemented cultures, E ll neurons of wild- 
type mice exhibited 55.8 ± 2.9% survival, compaied to Bcl-2 deficient neurons 
which exhibited 49 ± 1.6% survival. In NGF supplemented E ll cultures, 57 ± 
5.1% wild type neurons survived, compared to 51 ± 4.3% Bcl-2 deficient neurons.
Analysis of E12 cultures showed that neurons from Bcl-2 deficient embryos 
also extended their axons at a slower rate than those from either Bcl-2 heterozygous 
or wild-type litter mates. After 48 hrs incubation, E12 Bcl-2-deficient neurons 
cultured in NGF, BDNF and NT-3 were between 35% and 50% shorter than wild- 
type E12 trigeininal neurons (figures 6.4, 6.5 and 6.6). The difference in axonal 
length between the neurons of Bcl-2 deficient and wüd-type embryos was 
statistically significant at 12, 24, and 48 hrs incubation (p<0.0001 in all cases, 
using t tests). As at Ell,  the difference in axonal outgrowth between E12 wild-type 
and Bcl-2 deficient neurons was most mai'ked after 48 hrs in culture and neurons 
from E12 Bcl-2 heterozygous and wild-type embryos grew at similar rates. In 
BDNF supplemented cultures, 59.8 ± 3.3% of E12 wild type trigeminal neurons 
survived for 48 hours compared to 51 ± 3.9% Bcl-2 deficient neurons. In NT-3 
supplemented cultures, the survival of wild type and Bcl-2 deficient trigeminal 
neurons was 57 ± 2.5% and 48 ± 3.0%, respectively. In NGF supplemented 
cultures, E12 neurons of wild-type mice exhibited 59 ± 2.4% survival, compared to
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Bci-2 deficient neurons which exhibited 56 ± 2.6% survival. Since, there were no 
significant differences in the overall percentage survival of E12 Bcl-2-deficient and 
wild-type neurons in identified cohorts after 48 hrs incubation under each 
experimental condition (p>0.05 in all cases, using t tests), the effect of Bcl-2 on 
neurite outgrowth cannot be secondary to effects of Bcl-2 on promoting survival. 
The typical appearances of Bcl-2 deficient and wild-type E ll and E12 trigeminal 
neurons grown for 48 hrs with NGF are shown in Figures 6.7 and 6.8.
155
Ell neurons plus NGF
2 .
1
504020 300 10
+/-
Time in culture (hours)
F igu re 6 .1 :  Line graphs showing the results o f neuron cohort experiment comparing axonal 
growth rates o f trigeminal neurons from Bcl-2-deficient, heterozygous and wild-type embryos, in 
E l 1 cultures in NGF (5ng/ml). The means and standard errors are shown of serial measurements 
made on between 150-and-100 neurons of each genotype, compiled from cultures set up from the 
embryos of three separate litters, Bcl-2+/+ n=6, Bcl-2+/- n=9, Bcl-2-/- n=7.
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Figu re 6.2; Line graphs showing the results o f neuron cohort experiment comparing axonal 
growth rates o f trigeminal neurons from Bcl-2-deficient, heterozygous and wild-type embryos, in 
E l l  cultures in BDNF (5ng/ml). The means and standard errors are shown of serial measurements 
made on between 150-and-lOOneurons of each genotype, compiled from cultures set up from the 
embryos of three separate litters, Bcl-2+/+ n=6, Bcl-2+/- n=9, Bcl-2-/- n=7.
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Figu re 6 .3  Line graphs showing the results of neuron cohort experiment comparing axonal 
growth rates o f trigeminal neurons from Bcl-2-deficient, heterozygous and wild-type embryos, in 
E l l  cultures in NT-3 (5ng/ml). The means and standard errors are shown of serial measurements 
made on between 100-and-150neurons of each genotype, compiled from cultures set up from the 
embryos o f three separate litters, Bcl-2+/+ n=6, Bci-2+/- n=9, Bcl-2-/- n -7.
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F igu re 6 .4 :  Line graphs showing the results of neuron cohort experiment comparing axonal 
growth rates of trigeminal neurons from Bcl-2-deficient, heterozygous and wild-type embryos, in 
E12 cultures in NGF (5ng/ml). The means and standard errors are shown of serial measurements 
made on between 150-and-100 neurons of each genotype, compiled from cultures set up from the 
embryos of three separate litters, Bcl-2+/+ n=5, Bcl-2+/- n=7, Bcl-2-/- n=5.
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F igure 6.5: Line graphs showing the results of neuron cohort experiment comparing axonal 
growth rates o f trigeminal neurons ffom-2-deficient, heterozygous and wild-type embryos, in E12 
cultures in BDNF (5ng/ml). The means and standard errors are shown of serial measurements made 
on between 150-and-100 neurons of each genotype, compiled from cultures set up from the 
embryos of three separate litters, Bcl-2+/+ n=5, Bcl-2+/- n=7, Bcl-2-/- n=5.
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F igu re 6 .6 ;  Line graphs showing the results o f neuron cohort experiment comparing axonal 
growth rates o f trigeminal neurons from-2-deficient, heterozygous and wild-type embryos, in E12 
cultures in NT-3 (5ng/ml). The means and standard errors are shown of serial measurements made 
on between 150-and-100 neurons of each genotype, compiled from cultures set up from the 
embryos of three separate litters, Bcl-2+/+ n=5, Bcl-2+/- n=7, Bcl-2-/- n=5.
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F igu re 6.7: Camera lucida drawings of the typical appearance of E l l  trigeminal neurons from 
Bcl-2 deficient and wild-type embryos grown for 48 hours with NGF (5ng/ml). (Scale Bar = 2mm).
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Figu re 6.8; Camera lucida drawings of the typical appearance of E12 trigeminal neurons from
Bcl-2 deficient and wild-type embryos grown for 48 hours with NGF (5ng/ml). (Scale Bar -  2mm).
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6.3 Discussion.
In this study I have obtained clear evidence for a novel role of Bcl-2 during 
the early stages of neuronal development that is distinct from its well characterized 
anti-apoptotic function, I have demonstrated that sensory neurons from trigeminal 
ganglia of E ll and E12 Bcl-2 deficient mouse embryos, cultured with either NT-3, 
NGF or BDNF, extend axons more slowly in vitro than neurons from wild-type 
embryos of the same age (Hilton et al., 1997). These results suggest that 
endogenous Bcl-2 expression influences axonal growth rate in early sensory 
neurons in culture. Recent evidence supporting the theory that members of the Bel- 
2 family can influence axonal growth has been shown by the demonstration that the 
level of Bcl-2 expression in mouse trigeminal retinal ganglion cells (RGCs) 
influences the ability of these cells axons to regenerate into co-cultured tectal 
explants (Chen et ah, 1997). At early fetal stages, RGCs express high levels of 
Bcl-2 and are able to extend axons into co-cultured tectal tissue of the same age, 
whereas late fetal RGCs express low levels of Bcl-2 and are not able to grow axons 
into tectal tissue. The regenerative ability of early fetal RGCs is substantially 
reduced in retinal explants obtained from Bcl-2 deficient embryos, and late fetal 
and adult RGCs from tr-ansgenic mice over expressing Bcl-2 in neurons retain the 
ability to regenerate into tectal tissue. Likewise, optic nerve axons in Bcl-2 
overexpressing transgenic mice show enhanced regenerative capacity following 
lesion in vivo (Chen et al, 1997). Although these observations provide evidence 
that Bcl-2 can promote axonal regeneration in the central nervous system, their 
significance with regards to the role of endogenous Bcl-2 in the regulating the 
growth of axons to their target during development is uncertain. Furthermore, 
because the numbers of regenerating RGCs, rather than the growth rates of 
individual axons, were measured in this study, it is unclear whether the level of 
Bcl-2 expression affects the growth of regenerating axons or simply affects the 
proportion of neurons that are able to regenerate following axotomy.
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Several previous studies of tumor cell lines have also raised the possibility 
that Bci-2 might play a role in neuronal differentiation. First, Bcl-2 overexpression 
in a neural crest-derived cell line enhances the outgrowth of neuiite-like processes 
and increases the expression of neuron-specific enolase (Zhang et al., 1996). 
Second, midbrain-derived dopaminergic cell lines stably expressing Bcl-2 extend 
longer neurites than control transfected cells but do not show increased expression 
of many neuron-specific proteins (Oh et al., 1996). Finally, Bcl-2 enhances the 
differentiation of PC 12 cells into sympathetic-like neurons when these cells are 
grown without serum, but not when grown with serum (Batistatou et al., 1993). 
The physiological and developmental significance of overexpressing Bcl-2 in tumor 
cell lines is, however, difficult to inteipret.
Recently Bcl-2 has been shown to accelerate the maturation of early sensory 
neurons (Middleton et al., 1998). Shortly after differentiating from progenitor cells, 
sensory neurons undergo a distinct morphological change; initially they possess 
small, spindle-shaped, phase-daik cell bodies that later become laige, spherical and 
phase bright. In vitro studies have shown that E ll and E12 trigeminal sensory 
neurons from Bcl-2 deficient embiyos undergo these morphological change at a 
slower rate than neurons from wild type embryos. The delay in neuronal maturation 
is not attributable to the well characterized role of Bcl-2 in preventing apoptosis, as 
Bcl-2 deficient neurons were shown to survive as well as wild-type neurons at 
these ages. Trigeminal ganglia in early Bcl-2 deficient embryos contain a 
significantly smaller number of the more mature type of neurons than those in wild 
type embryos, yet the total number of neurons in the trigeminal ganglia of Bcl-2 
deficient and wild-type embryos is similar. The absence of Bcl-2 does not appear 
to cause a uniform delay in the developmental program of sensory neurons, as the 
time course and level of expression of ti'kA and p75 mRNAs are virtually identical 
in embryos of both Bcl-2 deficient and wild-type mice (Middleton et al., 1998). The 
demonstration that Bcl-2 accelerates the maturation of early sensory neurons could 
suggest that the observed reduction in axonal growth rates in Bcl-2 deficient
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neurons could be due to a delay in maturation. However, analysis of trigeminal 
neurons from wild type embryos and heterozygous Bcl-2 embryos has 
demonstrated that axonal growth is independent of Bcl-2 gene dosage, whereas 
maturation of immature neurons is not. This argues strongly that the role that Bcl-2 
plays in promoting maturation is distinct from the role that it plays in promoting 
axonal growth.
Recently, the pro-apoptotic Bcl-2 protein family member Bax has also 
been implicated in playing a role in regulating axonal growth rates (Lentz et al., 
1999). The axons of bipolar DRG neurons from Bax deficient embryos are 
significantly smaller in length than those of bipolar neurons from wild-type 
embryos. After 72 hrs incubation with NGF, the total length of axons from bipolar 
Bax deficient neurons is only 65% of that from wild type neurons. In contrast, the 
length of axons projecting from unipolar Bax deficient neurons cultured with NGF 
is not reduced compared to unipolar wild type neurons. Bipolar Bax deficient 
neurons cultured in other neurotrophins also do not appear to exibit shorter axons 
than wild type neurons cultured with the same neuiotrophin (Lentz et al., 1999).
The molecular mechanisms and signal transduction pathways that mediate 
the effects of Bcl-2 on axonal outgrowth are unknown. However Bcl-2 has been 
shown to interact with R-ras p23, a member of the Ras family of GTPase proteins 
(Femandez-Sarabia & Bischoff, 1993) and is co-immunoprecipitated with the 
serine/threonine specific protein kinase Raf-1 (Wang et al., 1994). These proteins 
have been shown to participate as components of growth-factor-mediated signal 
transduction pathways that regulate neurite outgrowth (Green & Kaplan, 1995). 
Whether the observed effect of Bcl-2 on the rate of axonal growth in developing 
sensory neurons is dependent upon these molecules has yet to be examined.
In summary, the data presented in this chapter iare consistent with a novel 
function for endogenously expressed Bcl-2 in embryonic sensory neurons shortly 
after they differentiate from progenitor cells and start extending axons to their 
targets. At this stage of development, Bcl-2 appears to enhance the rate of axonal
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growth. This action of Bcl-2 is not related to its well characterised anti-apoptotic 
role and may provide an explanation for the widespread expression of Bcl-2 in the 
embryonic nervous system during the earliest stages of neuronal development (Abe 
at al 1993, Merry et al 1994). Future comparative studies of axonal growth rate in 
Bcl-2 mutant and wild-type embryos in vivo will be cmcial in determining the 
significance of the in viti'o observations described in this chapter.
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CHAPTER?
Conclusion
The results presented in this thesis provide evidence for the role of intrinsic and 
extrinsic factors in regulating the axonal growth rate and survival of developing neural 
crest and placode derived neurons.
During embryogenesis, the HGF/Met system was shown to be required for the 
development of mice sensory neurons of the dorsal root gangUa (DRG). Although 
HGF alone did not promote neurite outgrowth in vitro, it was shown to markedly 
enhance the outgrowth that occurs in response to NGF, this observation was confirmed 
using DRG explants. In Vitro, HGF was also shown to enhance the numerous effects 
of NGF, including the maturation of sensory neirron progenitors, as well as their 
survival. The synergy with NGF seems to be specific; even though Met expression was 
observed in populations of DRG neurons that depend on BDNF and NT-3 rather than 
NGF for survival, HGF did not enhance responses to these neurotrophins. Similar 
results have been found with cranial sensory neurons from the tiigeminal and nodose 
ganglia, in \vhich effects of BDNF and NT-3 are not enhanced by HGF. Such 
specificity could be due to differences in signalling between the different neurotrophin 
receptors.
Similar experiments were done on developing mice sympathetic neurons. 
Sympathetic ganglia are neural-crest derived strictures in which proliferating 
neuroblasts mature in to postmitotic sympathetic neurons. In early sympathetic ganglia, 
HGF seems to be produced by the neuroblasts themselves, suggesting that HGF acts in 
an autocrine or local paracrine mode. Experiments in which the fate of single cells were 
followed over time in culture demonstrated that endogenously produced HGF enhanced
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the survival and differentiation, but not the proliferation, of sympathetic neuroblasts. 
Consistent with these in vitro effects, sympathetic ganglia of met mutant mice showed 
an approximately twcjfold increase in apoptotic cells, and a progressive reduction in the 
total number of cells. As with sensory neurons, HGF was shown to cooperate with 
NGF to enhance sympathetic neuron axonal outgrowth, and also to increase the 
numbers of neurites emerging from the cell bodies. In contrast to sensory neurons, 
however, HGF failed to cooperate with NGF in promoting the survival of postmitotic 
sympathetic neurons, suggesting that in sympathetic cells, met activates the survival 
pathways only weakly if at all.
To determine if HGF co-operates with other neurotrophic factors in regulating 
the survival and growth of other kinds of neurons in the developing peripheral nervous 
system, I studied the effect of HGF on the parasympathetic neurons of the ciliary 
ganglion and the proprioceptive neurons of the trigeminal mesencephalic nucleus 
(TMN), both of which survive and extend neurites in response to CNTF. HGF alone 
did not promote the survival of either of these kinds of neurons but increased the 
number of neurons surviving in cultures supplemented with CNTF. HGF also 
increased the overall length and branching of the neurite arbors of these neurons in the 
presence of CNTF. These results show that HGF is able to co-operate with CNTF in 
promoting tlie'smwival and growth of developing parasympathetic and proprioceptive 
neurons. The demonstration that HGF only enhanced the survival and growth of TMN 
neurons when these neurons were grown with CNTF and not when they were grown 
with BDNF (which promoted their survival as effectively as CNTF) demonstrates that 
within the same neurons, the effects of HGF on survival and growth are selectively 
dependent on which other signalling pathways are concurrently activated.
Finally, I examined the influence of the cytoplasmic protein Bcl-2 on regulating 
axonal growth rates, previous studies showed that overexpression of Bcl-2 in cultured
neurons prevented their death following neurotrophin deprivation/. Cultured neurons
/
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expressing antisense Bcl-2 RNA have an attenuated survival response to neurotrophins 
and neurons of postnatal Bcl-2 deficient mice die more rapidly following NGF 
deprivation in vitro and are present in reduced numbers in vivoSerial measurements of 
axonal length in the same neurons revealed that there were marked differences in axonal 
growth rate between Bcl-2-defîcient and wild type neurons irrespective of whether the 
neurons were grown with nerve growth factor, brain-derived neurotrophic factor or 
neurotrophin-3. Because there was no significant difference in the numbers of wild 
type and Bcl-2-deficient neurons surviving with each neurotrophin at this early stage of 
development, the effect of Bcl-2 on axonal growth rate was not a consequence of its 
well-documented role in preventing apoptosis.
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